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CHARACTERIZATION OF FILIFACTOR ALOCIS AND ITS IMMUNE 
EVASION STRATEGIES EMPLOYED AGAINST HUMAN 
NEUTROPHILS   
Cortney L. Armstrong 
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Periodontal disease is among the most common of inflammatory conditions and is caused 
by bacterial and host derived factors. The presence of bacteria drives the recruitment of 
neutrophils, professional phagocytes, to migrate to specific oral sites where they produce potent 
antimicrobials to kill their target. However, this inflammation and production of antimicrobials 
must be strictly regulated to minimize collateral host tissue damage. Human neutrophils 
recognized the oral pathogen Filifactor alocis through Toll-like receptor (TLR) 2 and upon 
binding, activated both p38 MAPK and ERK signaling pathways, known to be involved in 
neutrophil cell migration and degranulation. F. alocis also stimulated secretory vesicle and 
specific granule exocytosis and enhanced chemokinetic and chemotactic migration to interleukin 
(IL)-8, a key chemoattractant found in the oral cavity (Chapter 2).  
Once these challenged neutrophils have arrived at their targeted site, they will employ 
oxidative-mediated killing mechanisms, operating intracellularly in the bacterial-containing 
phagosome, and extracellularly, in the extracellular space. Neutrophils effectively perform 
phagocytosis to internalize F. alocis into their phagosomal compartment, however minimal 
intracellular respiratory burst response is produced. In addition, F. alocis-challenged neutrophils 
produced minimal superoxide release, however the bacterial challenge primed neutrophils for an 
enhanced respiratory burst response. F. alocis survived neutrophil oxygen-dependent intracellular 
and extracellular killing mechanisms up to 4 h post-infection (Chapter 3). Activated neutrophils 
can also undergo neutrophil extracellular trap (NET) formation as a means to trap and potentially 
 viii 
kill targets. NETs have been described to be formed in the oral cavity in response to oral biofilms. 
F. alocis failed to induce NETs from neutrophils, which may indicate this bacterium is unique to 
the oral cavity, as other oral bacteria Streptococcus gordonii and Peptoanaerobacter stomatis 
induce NETs. However, F. alocis can manipulate neutrophils and reduce their NET formation 
capacities to known pharmacological (PMA) and bacterial (S. gordonii) inducers (Chapter 4).  
Overall, our results are the first to show how F. alocis effectively evades human 
neutrophil killing mechanisms and manipulates some of their functional responses. These results 
provide information about the pathogenic potential of F. alocis which would help delineate the 
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CHAPTER 1  
INTRODUCTION 
Periodontal Disease 
Periodontitis is defined as an infection-induced chronic inflammatory disease impacting 
the tissues supporting the teeth (1, 2). Periodontal tissues are easily accessible to both bacteria 
and immune host cells, as it is comprised of a porous membrane of gingival epithelia cells with 
no protective mucous layer, as observed in the intestinal epithelium (1, 3, 4). The induction of 
infectious diseases requires both microbial and immunological factors, which are the shift in 
microbiota content and the destructive inflammatory response, respectively (5). The increase in 
the number of host inflammatory cells and mediators leads to resorption of the alveolar bone, a 
key marker of periodontitis (1, 6-8). 
Periodontal disease affects over 49 million people in the United States alone (2, 9-11) and 
it has been observed that ~50% of the population 30 years and older has experienced some form 
of the disease (10, 12).  Disease prevalence is increased with age and more common in males 
than in females, which may be due to poorer oral hygiene practices, higher usage of tobacco 
products, and less frequent visits to an oral health care provider (12, 13). According to the 
Centers for Medicare and Medicaid Services and the Bureau of Economic Analysis, as of 2014, 
the U.S. has spent ~113 million dollars on dental care expenditures. From an ethnic standpoint, 
it was determined that the disease has the highest prevalence in Hispanics, due to the association 
with the lowest levels of education and a higher population of smokers (12). The oral cavity 
represents a unique environment, as it is a major gateway to the rest of the human body (14). It 
is constantly utilized for passage of air and food, which will travel through
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the body systemically to its target site, however, microorganisms present will also use this 
transport to spread along the contiguous epithelial surfaces (14). Therefore, clear evidence is now 
available linking periodontitis to a number of systemic infections and diseases, such as 
cardiovascular disease, stroke, preterm birth, diabetes and pneumonia (2, 14). 
The prevention and reduction of periodontal diseases in the U.S. population is part of a 
national health initiative, Healthy People 2020, and is considered a strategic objective for the 
CDC (12, 15, 16); U.S. Department of Health and Human Services. Healthy People 2020: Oral 
Health Available at: 
http://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=32). The oral 
cavity is accessible for study, as the dental plaque containing the bacterial species and the 
gingival crevicular fluid containing the host-derived cytokines and chemokines can be sampled 
non-invasively (1, 17-23). Sampling of the gingival crevicular fluid can be accomplished by 
inserting a piece of filer paper, a paper point into the crevice and dental plaque is obtained 
through scraping of the tooth surface with a hand-held dental tool, a curette (1, 6, 24-29). 
The biofilm structure formed by the community of bacteria in the oral cavity provide a 
safe haven for residing in this environment, where there is resistance to antibiotics as well as 
host evasion of important immune cell responders like neutrophils and macrophages, due to the 
sticky and impenetrable nature of the biofilm (5, 30-32). While most human microbiome 
systems are in a homeostatic state, diseases are caused when there is a shift in the microbial 
population leading to dysbiosis.  The oral microbiome is more often found in a state of 
dysbiosis, as is evident by the disease it causes in a majority of people in their lifetime, as 
evidence supports half the U.S. population age 30 or older suffers from some form of 
periodontal disease (12, 33-35). Culture-dependent studies performed to characterize the oral 
microbiome implicated three bacterial species, Porphyromonas gingivalis, Tannerella forsythia, 
and Treponema denticola, were associated with disease development (1, 36, 37) However with 
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culture-independent sequencing studies, it has been determined there are many more potential 
pathogens associated with disease. To maintain homeostasis and a healthy gingival tissue, a 
delicate balance between the host and the indigenous oral microbial community is required  (5, 
38). Certain diseases caused by the shift in members comprising the oral microbiota, where 
there is an increase in the pathogenic bacteria and a decrease in the beneficial commensals,  lead 
to the current ‘microbial shift’ hypothesis, which explains the concept of a dysbiotic, disease-
favoring state (5). These states of dysbiosis are found to be associated with diseases other than 
periodontal disease, including: inflammatory bowel disease, bacterial vaginosis, 
gastroesophageal reflux disease, and otitis media, the common underlying mechanism being 
inflammation (5, 39-41). Furthermore, this shift also influences the host’s response, as now a 
potent and unresolving inflammatory environment is created, which leads to tissue destruction 
and eventually alveolar bone loss (5, 42). The key to the maintenance of a healthy periodontium 
is the expression of vital host defense mediators (1). 
It is estimated that there are over 700 bacterial species present in the oral cavity, with 
more than half of them remaining uncultivated (5, 43). It is a common misconception that those 
bacterial species that are easily cultivated and often present in high quantities in the oral cavity 
are solely responsible for the development of periodontal disease and those species are often the 
focus of further studies (1, 18, 44-49). However, it is now becoming apparent that pathogenicity 
and virulence properties are most important when determining which bacterial species are 
relevant in disease development, as those difficult to culture or in low quantities may represent 
an important species in disease progression that was previously excluded from studies. It was 
previously thought that gram positive bacteria were associated with health, while gram negative 
bacteria were associated with disease, however that concept is being reevaluated with the 
assessment of newly identified organisms, like Filifactor alocis (F. alocis) (5, 50). 
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Filifactor alocis. 
Species like F. alocis are recently identified due to the large expansion in knowledge of 
culture-independent approaches, like 16S ribosomal RNA (rRNA) gene-based molecular 
cloning techniques, which allows for the identification of species from their DNA directly (14, 
44). Due to these new identification methods being developed, previously overlooked bacterial 
species are coming to the forefront in study and are observed to be an important player in 
disease development (14, 44, 51, 52). Utilizing these culture-independent techniques promises 
further expansion of the diversity of the oral cavity and a deeper understanding of the nature of 
disease development by biofilm communities (14, 53). F. alocis is one of those overlooked and 
underappreciated species, as it was previously excluded from studies due to its slow growth and 
difficulty in detection by conventional culture-based methodologies (44). 
F. alocis is a gram-positive, asaccharolytic, fastidious, rod that grows under obligate 
anaerobic conditions (2, 54). This bacterium was first isolated from clinical patients afflicted 
with gingivitis and periodontitis in 1985 and given the name Fusobacterium alocis, before being 
reclassified in 1999 to Filifactor (2, 55). This bacterium is now determined to be related to 
Eubacterium, as opposed to a fusiform-like species (54, 56).  F. alocis has been associated with 
several oral conditions like peri-implantitis, and endodontic infection, however, it is now known 
to be linked to the development of periodontal disease. It is found to be significant to the 
pathogenic biofilm produced in a disease setting, can establish synergistic relationships with 
other oral pathogens, and possesses potential virulence properties like oxidative stress 
resistance, that allow it to effectively colonize, survive and out-compete other periodontal 
pathogens  (2, 57). Studies performed by Dahlen et al have determined F. alocis a species 
relevant in routine diagnostics for periodontal disease and this bacterium is also found to be 
associated with other oral pathogens such as P. gingivalis, Streptococcus gordonii (S. gordonii), 
Fusobacterium nucleatum (F. nucleatum), and Aggregatibacter actinomycetemcomitans (A. 
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actinomycetemcomitans) (54, 58) . In patients with periodontal disease, F. alocis is often 
present and it has been proposed that this bacterium should serve as a diagnostic indicator of the 
disease (2, 50, 52, 54, 59). Moreover, F. alocis is absent in healthy patients (2). 
F. alocis is known to survive and persist in the periodontal pocket through the use of its 
virulent properties: resistance to oxidase stress, stimulated growth in conditions of oxidative 
stress, induction of proinflammatory cytokines, and pro-apoptotic local infection (2, 44, 60). 
This bacterium has been studied in gingival epithelial cells, where it triggers apoptosis in a 
caspase-3-dependent manner, through suppression of MAPK/ERK kinases 1 and 2 (MEK1/2) 
activation (2, 44). Additionally, in mouse model studies by Wang et al F. alocis produces a 
local pro-apoptotic infection affecting the gingival epithelial cells, that can be cleared rapidly 
due to the massive influx of neutrophils (2, 61). As an asaccharolytic organism, F. alocis thrives 
on the amino acids for nutrition, survival and virulence, which it obtains through degradation of 
proteins of other bacteria and host tissues, mainly relying on arginine (2, 62). This bacterium 
produces proteases and neutrophil-activating protein A which are found to be upregulated when 
internalized, as observed in studies with gingival epithelial cells (63, 64). The F. alocis genome 
also includes another important mechanism that uses arginine, citrulline synthesis (2, 62). The 
process of protein citrullination is known to be an important post-translational modification 
linked to systemic complications, like the development of rheumatoid arthritis, as this process is 
a crucial epigenetic regulatory mechanism that can cause an ongoing state of inflammation (2, 
65). It has been reported that F. alocis has a highly efficient mechanism of protein-sorting/-
transport system, which is due to its large number of membrane proteins (2, 64). This system 
could be what is responsible for facilitating the efflux of reactive oxygen species (2). This 
bacterium is able to provide for its own nutritional needs, as the genome contains many 
important proteases (2, 64). Arginine is an essential amino acid for the growth and survival of 
F. alocis and to its benefit, there are large amounts of arginine present in the periodontal pocket 
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(2, 62). Additionally, F. alocis is abundant in arginine metabolism proteins which allow it to 
optimally utilize that arginine (2).  
As cytokine homeostasis is necessary for keeping a healthy periodontium, the disruption 
of this homeostasis is implicated in tissue destruction and further, periodontal disease (44, 66). 
F. alocis induces the release of pro-inflammatory cytokines like interleukin 1 beta (IL-1β), 
interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α) in studies performed on gingival 
epithelial cells (44) . These identified cytokines are important as they are known to stimulate 
osteoclasts, increase the resorption of alveolar bone and contribute to tissue degradation through 
inflammatory mediators like matrix metalloproteinases (44, 66-69). 
Additionally, it has been observed that F. alocis can partake in the formation of a biofilm 
community in both endodontic and periodontic infections (2, 70). It was determined through in 
vitro studies by Wang et al that F. alocis can participate in the development of a biofilm 
community with a variety of bacteria that have varying degrees of pathogenic potential 
including: Streptococcus gordonii, Fusobacterium nucleatum, P. gingivalis and 
Aggregatibacter actinomycetemcomitans (2, 61). Additionally, in studies performed on gingival 
epithelial cells by Moffatt et al, it was determined that F. alocis can form biofilms in vivo (44, 
70). The interaction of F. alocis with other oral pathogens indicates there could be a mutually 
beneficial relationship between the bacteria, allowing each to survive and evade host detection 
mechanisms (2). For instance, the interactions between F. alocis and P. gingivalis results in the 
upregulation of factors responsible for making both bacteria more virulent (2, 60, 71). In 
biofilm studies, it was determined that F. alocis forms a mutually beneficial relationship when 
in a two-species community with F. nucleatum, which is not observed for other oral pathogens 
S. gordonii, A. actinomycetemcomitans and P. gingivalis (63). Interactions between F. alocis 
and S. gordonii revealed that S. gordonii strongly inhibits colonization of F. alocis (63). This 
demonstrates that F. alocis may not be effective in colonizing regions of dental plaque that are 
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streptococcal rich (63).  F. alocis and A. actinomycetemcomitans showed that their interactions 
are strain-dependent, as the strain ATCC 35896 showed mutual accumulation of both species 
while strain D-62D did not stimulate accumulation of either bacterium (63). F. alocis and P. 
gingivalis will physically interact initially and then P. gingivalis demonstrates a highly 
inhibitory phenotype towards F. alocis (63). 
Neutrophils. 
Neutrophils were first described by Paul Ehrlich in the late 19th century as a 
subpopulation of leukocytes characterized by their “polymorphous nucleus”, which generally 
has 3-4 lobes (72). Their tendency to retain neutral dyes, lead to the name neutrophil or 
polymorphonuclear cell (PMN) (72). Due to their uniquely lobulated nucleus, they are easily 
identifiable by Wright staining (73). Initially, it was believed that these cells were present in 
large numbers at sites of infection due to their ability to serve as cellular shuttles in delivering 
bacteria to tissue sites (72).  
Neutrophils are in the granulocyte family and produced in the bone marrow where they 
first represent a population of pluripotent hematopoietic cells, which differentiate into 
myeloblasts, cells that are committed to future development into a granulocyte (72, 74). Their 
production is extensive as ~1-2 x 1011 cells per day in a normal adult can be generated in the 
steady state (73, 74). Granulocyte colony stimulation factor (G-CSF) is an essential component 
in regulating the production of neutrophils in order to meet their demands in the context of an 
infection, however when the neutrophils have reached their site of interest, the production of 
this factor is reduced (74).  
Neutrophils are among the shortest-lived cells in circulation in the human body, which is 
beneficial to the host for mounting an initial potent antimicrobial response, however, due to the 
toxic environment they create in response to their target, they should be effectively undergo 
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apoptosis and clearance by macrophages.  In vitro, neutrophils do not undergo proliferation and 
are estimated to have a half-life of 10-12 hrs (75). However, in vivo their life span is extended 
due to signals that delay their programmed cell death such as adhesion, transmigration, hypoxia, 
microbial components and cytokines (75, 76). Additionally, neutrophils will survive up to 1-5 
days at the tissue site of infection, where they can persist due to presence of immunoregulatory 
cytokines and bacterial-produced factors. This prolonged lifespan allows for neutrophils to more 
effectively respond to injury or inflammation, and further promotes interaction with other cell 
types such as macrophages, mesenchymal stem cells, dendritic cells, natural killer cells, B and T 
lymphocytes (75).  
In humans, neutrophils are the most abundant of the white blood cells in circulation (72). 
They are first responder cells in the innate immune response and are critical for host defense, as 
demonstrated in patient studies where life-threatening conditions develop when neutrophils are 
impaired either in number or function (74, 75, 77, 78). Once neutrophils are depleted at the site of 
injury or inflammation and neutropenia is sensed, granulopoiesis is signaled in order to replenish 
the neutrophil population and ensure the host will further function in combating microbial barrage 
(73). Interestingly, it has been shown that microbiota can help to regulate initiation of 
granulopoiesis, as studies found that germ-free mice are severely neutropenic (73, 79). 
Human neutrophils constitutively express all Toll-like receptors (TLRs), except TLR3 
(72, 73). TLRs are among the most recognized family of molecules known for their ability to be 
presented on a variety of immune cell types and recognize numerous stimuli (72). Upon 
encountering pro-inflammatory cytokines or bacterial stimuli, there is an enhanced expression 
of TLR4 or TLR2, respectively, on the surface of human neutrophils (80-83). 
Benefits to using human neutrophils for our studies. 
Neutrophils are terminally differentiated, they cannot undergo further growth in tissue 
culture conditions or be genetically modified (72, 73). Additionally, immortalized neutrophil-like 
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cell lines, such as HL-60s, are rarely capable of encompassing the vast functions of neutrophils 
that are found in primary cells (72). Although most often used for in vivo neutrophil studies, 
mouse neutrophils also possess limited capabilities in function and also only about 30% are found 
in circulation compared to about 70% in humans (72). Mouse neutrophils do not fully mimic 
human neutrophils and are different in many capacities: function, morphology, and physiology 
(73). Additionally, one of the major issues impeding neutrophil research is the lack of genetic 
tools (84-90). It has been demonstrated that in vivo mouse neutrophils can be depleted via 
antibodies, however this depletion is only transient, as low neutrophil counts will initiate the 
production of new neutrophils to be developed (73). Neutrophils can be specifically depleted 
from mice using Ly6G monoclonal antibody (91). Additionally, using a S100a8(MRP8)-
cre:ROSA-YFP knock-out mouse results in a neutrophil specific depletion (92).  However, it is 
necessary to interpret cell line and mouse neutrophil studies carefully, as the extrapolation to 
human physiology and pathophysiology may not be directly translational (84, 93-96).     
Neutrophil migration- from the blood stream to the site of injury, infection, or inflammation.  
 Neutrophils remain in circulation until different signals from cytokines, chemokines, and 
bacteria stimulate them to initiate their migration towards the site of inflammation. An extensive 
process referred to as ‘Rolling- Adhesion - Transmigration’ is responsible for neutrophil 
migration out of circulation to sites of infection or inflammation. The ‘Rolling’ step refers to the 
initial attachment of neutrophils to the endothelial cells and occurs when cells are stimulated with 
cytokines produced during an infection such as TNF-α, IL-1β, and interleukin 7 (IL-7) (74, 97-
99). This chemokine production stimulates expression of selectins (P- and E- selectin), integrins 
such as intracellular adhesion molecules (ICAMs) and vascular cell adhesion molecules 
(VCAMs) on the luminal surface of the endothelial cells which can bind to the selectin and 
integrin ligands located on the neutrophils (74, 98, 100). Firm adhesion is the second step in the 
process and ensures the cessation of rolling. This requires an activated endothelium to bind to 
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neutrophils through adhesion molecules (LFA-1). Once the endothelium is activated, it in turn 
secretes cytokines such as interleukin 8 (IL-8) and macrophage-inflammatory protein 2 (MIP-2), 
which are known to activate neutrophils (74). With the induction of firm adhesion, neutrophils 
will next undergo polarization upon the leading edge lamellipodium, allowing for receptors for 
phagocytosis and chemokine signaling to be expressed (74). The final step is transendothelial 
migration whereby neutrophils can penetrate the endothelium by either transcellular (penetration 
of a single endothelial cell) or paracellular migration (penetration between endothelial cells) (74). 
The transcellular route is mediated by Mac-1 and is only responsible for the migration of ~20% of 
neutrophils (74, 101). Once neutrophils have successfully migrated through the endothelium, they 
utilize proteases, collagens, laminins (elastase), matrix metalloproteases (MMP8, MMP9) in order 
to penetrate the basal membrane (74, 102).  
Neutrophils operating in the tissues are now more activated than when their journey 
began in the blood, making the transition from circulating cells to tissue phagocytes (103). Now 
active, neutrophils induce their transcriptional program, which results in production of 
chemokines like IL-8 and growth-regulated oncogene alpha (Gro-α), which are known to signal 
recruitment of other inflammatory cells, like macrophages and T cells, to the site of injury or 
inflammation (74, 104-106). While neutrophil activation is essential for a defensive response to a 
variety of microorganisms, it is also essential that their activation be tightly regulated to prevent 
host tissue damage. Neutrophils employ a very efficient intracellular negative feedback loop to 
help in regulation of their activity, mostly through factors like immunoreceptor tyrosine-based 
inhibitory motifs (ITIMs), signal inhibitory receptor on leukocytes-1 (SIRL-1), carcinoembryonic 
antigen related cell adhesion molecule 1 (CEACAM1), cluster of differentiation 300a (CD300a) 
and suppressor of cytokine signaling 3 (SOCS-3) (74, 107-111). Neutrophils operate in two 
waves of activation and recruitment following transendothelial migration. First, neutrophils found 
at the tissue site of injury or inflammation begin to respond and this is followed by a second wave 
of neutrophils that can be recruited from a distance as far as 200 µm from the site (103). 
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Neutrophil-neutrophil signaling makes it possible for distant cells to be recruited through 
chemoattractant signaling cues, further strengthening the capacity of the neutrophils to effectively 
respond at the tissue site (103). 
When presented with a chemotactic stimulus, neutrophils migrate very quickly (up to 12 
µm/min), which allows them to reach their target site within 3 h of the initial onset of injury or 
inflammation (112, 113). When neutrophils encounter a chemoattractant, they polarize and 
polymerized actin accumulates at the leading edge (114). Neutrophils have the ability to rapidly 
orient themselves and move through anterior extension and posterior contraction and retraction, 
upon exposure to a chemoattractant (115). 
In comparison, other white blood cells like monocytes take at least 12 h to be fully recruited 
(112, 116). Directional movement of leukocytes is necessary for a functional response to a variety 
of inflammatory signals (117). Leukocytes participate in directional movement toward sites of 
injury and inflammation by deciphering a chemoattractant gradient, a process referred to as 
chemotaxis (114, 117-120).  
As neutrophils express receptors for chemotactic factors, they are able to effectively 
detect gradient intensity and move toward the source with directionality (114, 117, 121). Cells 
with chemotactic functions are able to sense slight changes in the concentration of a 
chemoattractant, sensing changes 1% over the length of a single cell (8-12 µm) (119, 122). Once 
the neutrophils encounter a high concentration of chemoattractants, they further initiate the 
process of phagocytosis and killing (118).  
Since neutrophils are exposed to many chemoattractants that are released at various 
locations including the vascular endothelium, interstitial cells and the site of infection, it is 
necessary for them to assimilate and prioritize their response (120, 123, 124).  They can respond 
to signals from both intermediary chemoattractants (IL-8, platelet activated factor, chemotactic 
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cytokines, leukotriene B 4 (LTB4)) and end target cellular chemoattractants (formyl-methionyl-
leucyl phenylalanine (fMLF), complement fragment C5a, C3a, plasminogen activator), which 
guide them to a generalized region and then further to a more specific site, where they will 
encounter their target (118-120, 123).  Ultimately, neutrophils will dissociate from the 
intermediary chemoattractants and migrate toward the end-target chemoattractants of bacterial 
origin (119, 125).  Although the chemoattractants vary significantly in their structure, the 
receptors for these molecules are all members of the seven-transmembrane helix receptor family 
which operate through to heterotrimeric G proteins, which further activate downstream pathways 
responsible for cytoskeletal arrangements and chemotactic functions (119, 120, 123).  
Phagocytosis and killing mechanisms employed by neutrophils.  
Neutrophils serve as highly efficient phagocytes through the receptor-mediated process of 
phagocytosis, where a particulate is internalized into a phagosomal compartment (72). 
Phagocytosis can occur through the recognition of pattern-recognition receptors (PAMPs) or 
mediated through opsonins (72). Initially, upon internalization of the particle, the phagosomal 
compartment is benign; it is not until phagosome maturation that the phagosome exhibits 
lethality (72). This maturation process is initiated when neutrophil granules fuse with the 
phagosome and release their antimicrobial contents (72). Simultaneously, the nicotinamide 
adenine dinucleotide phosphate (NADPH) oxidase complex assembles at the phagosomal 
membrane, leading to the production of reactive oxygen species (ROS) (72). Using these two 
antimicrobial mechanisms, neutrophils create an inhospitable environment for most pathogens, 
which results in bacterial cell death (72). However, some pathogens have evolved mechanisms 
that allow for interference with the engulfment process or ensure their survival inside 
neutrophils through modulation of phagosomal maturation, and creation of a more hospitable 
phagosomal environment (72, 126-130).  
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Neutrophils are efficient and effective responders to sites of injury or inflammation, 
where they target microbes for elimination (72). In the most basic sense, they are in charge of 
killing the bad without causing too much damage to the host (72).  It is believed that the 
degranulation and ROS production may function in concert and potentiate one another, leading 
to a highly efficient killing process employed by neutrophils (73). Currently, it is still unclear 
whether neutrophils are triggered differently by various stimuli to employ a certain 
antimicrobial killing mechanism (73). 
a) Neutrophil granules. 
One of the most important features of neutrophils is their granules, a hallmark of 
granulocytes (neutrophils, eosinophils, basophils) (74). Granules are membrane vesicles that are 
composed of a wide variety of proteins, peptides and antimicrobial components and function 
either in vesicle delivery to the cell membrane for exocytosis or fusion with the bacterial-
containing phagosome, along with the assembly of the NADPH oxidase complex, for killing 
internalized microbes. Neutrophils possess three main types of antimicrobials: 1) cationic 
peptides and proteins which can bind to microbial membranes, 2) enzymes, and 3) proteins 
involved in deprivation of essential nutrients for microorganisms (72, 131).  They are stored in a 
specialized organelles that allows for the neutrophil to safely transport potent antimicrobial 
components through the blood stream to a site of infection or injury (72).  
In humans, there are four granule subtypes that are released in a hierarchal fashion, based 
on their density and content (Fig 1-1) (72, 74). The primary or azurophilic granules and the 
secondary or specific granules are crucial for their involvement in providing the neutrophil with a 
potent antimicrobial arsenal.  The azurophilic granules, the largest of the granules and formed 
first during neutrophil maturation are designated the most potent based on their abundance of 
molecular weaponry, most notably proteins such as myeloperoxidase (MPO), and neutrophil 
elastase (NE) (72). The next to be formed during the maturation process are the  secondary or  
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specific granules, which contain a variety of antimicrobial compounds, the most important being 
lactoferrin and lysozyme (72). Additionally, the specific granules contain cytochrome b558, 
which is a heterodimer composed of the cytosolic NADPH oxidase components gp91phox and 
p22phox  Following specific granules are the tertiary or gelatinase granules, which function mainly 
for storage of metalloproteases, such as gelatinase and leukolysin  (72). Lastly, the secretory 
granules are formed through endocytic processes in the late states of neutrophil maturation and 
their contents consist of plasma-derived proteins like albumin and membrane-bound molecules 
(72). 
 
Figure 1-1. Neutrophil granules and their hierarchal exocytosis. 
As neutrophils undergo activation, the granules are mobilized to either fuse with the 
plasma membrane or the bacteria-containing phagosome, which allows for efficient elimination 
of both intracellular and extracellular pathogens (72, 112), as granules can be released internally 
in the phagosome, or externally at the surface of the plasma membrane (75). 
b) Oxidative burst response. 
Once neutrophils are activated through recognition and binding of bacteria or bacterial-
derived factors to their surface, they undergo a process called respiratory burst, which is 
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characterized by the production of ROS (72). If the stimulus is particulate, it will be internalized 
to the phagosome and the intracellular respiratory burst response will occur inside the 
phagosomal compartment. However, if there is soluble stimuli present or the neutrophil cannot 
effectively internalize the stimuli, an extracellular respiratory burst response will be initiated on 
the cell membrane.  Respiratory burst is initiated following the assembly of the NADPH oxidase 
complex, which consists of two membrane components for specific granules, gp91phox and 
p22phox, and three cytosolic components p47phox and p67phox and p40 phox along with GTPase Rac2 
(132). In resting neutrophils, the components will be found either in the cytoplasm or the 
membrane, however upon stimulation or activation, p47phox is phosphorylated and moves to the 
phagosome or plasma membrane (132, 133). Following the translocation of p47phox, translocation 
of both p67phox and p40 phox is now facilitated and associates with membrane bound p22phox which 
interacts with GTP-bound Rac2 (Fig. 1-2)(132-137).  
 
Figure 1-2. NADPH oxidase activation and assembly leading to the respiratory burst 
response. 
Upon assembly of the NADPH complex at either the plasma membrane or the 
phagosomal compartment, the reactive oxygen cascade begins with the reduction of molecular 
oxygen to superoxide (72). Next, superoxide will rapidly dismutate, forming hydrogen peroxide 
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(72). In the phagosomal compartment, MPO is known to react with hydrogen peroxide to form a 
variety of reactive species, most notably hypochlorous acid, which is highly reactive and potent 
leading to a strong antimicrobial product (72).  
Without the assembly of the NADPH oxidase complex, no detectable ROS is able to be 
produced (132). Therefore, it has been reported that intracellular pathogens have evolved to 
incorporate strategies allowing them to inhibit assembly and/or activation of the NADPH oxidase 
complex, further allowing them to escape killing by ROS production of neutrophils (132, 138-
140).   It has been determined that ROS is important for antimicrobial activity in neutrophils, 
through the studies of patients with chronic granulomatous disease (CGD) (72). Neutrophils from 
CGD patients are fully functional when provided exogenous hydrogen peroxide, as normal 
antimicrobial activity is observed in this context, indicating the specific defect in ROS production 
(73). Patients suffering from CGD are unable to mount an efficient respiratory burst response by 
neutrophils, as they have a defect in one of the NADPH oxidase components, leading to 
inefficient assembly and activation, critical per-cursor steps to reactive oxygen species (ROS) 
production (73, 141).  The severity of CGD depends on the genetic mutation present in the 
patient, but in worse cases, the activity of the NADPH oxidase complex can be as low as 0.1% of 
a healthy individual (73, 141). About two-thirds of CGD patients are effected by recessive 
mutations in the X-linked CYBB gene which encodes for gp91phox (142) . The remaining patients 
have autosomal defects in genes for p22phox (CYBA), p47phox (NCF1) or p67phox (NCF2) (142). 
These gene defects result in the absence of the encoded protein responsible for superoxide 
production (142). 
The NADPH oxidase complex can assemble at the cell membrane if the neutrophil 
encounters a soluble (ex: fMLF) stimulus or at the phagosomal membrane when encountering a 
particulate stimulus (ex: bacteria or yeast) and further will generate superoxide release into the 
extracellular environment or phagosomal compartment, respectively (143, 144). NADPH oxidase 
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activity takes place in three stages: 1) initiation by assembly and activation, 2) maintenance of 
activation, 3) deactivation of the response through component disassembly (145). NADPH 
oxidase activity and the induction ROS response depends on the assembly and activation of the 
complex, however it is also important, most importantly to the host, to deactivate and disassemble 
(135, 145). Neutrophils that cannot effectively perform phagocytosis will undergo extracellular 
ROS production, releasing their antimicrobial reactive oxygen species in the extracellular space 
instead of the phagosome (146, 147).  
c) Neutrophil extracellular traps. 
Neutrophil extracellular traps (NETs), first described by Brinkmann and Zychlinsky in 
2004, are a newly appreciated mechanism of killing, which occurs when PMNs release their 
decondensed chromatin extracellularly (72, 148). NETs operate through two major mechanisms 
to perform their antimicrobial functions, trapping bacteria and preventing their spread both 
locally and systemically and killing through the use of embedded antimicrobial peptides (149, 
150). Their fibrous structure is known to contain histones, antimicrobial granular and cytoplasmic 
proteins, which can trap and kill microbes (72). NETs have been proposed to function in both 
trapping and killing various microbes as well as activating and recruiting other immune cells, via 
exposure to a concentrated form of antimicrobials that decorate their structures (73). Although 
trapping and killing would be the most effective strategy, merely trapping bacteria could serve 
beneficial in reducing spread of infection (103). Previous studies have shown that NETs are 
significant in limiting bacterial dissemination (149, 151). 
NETosis, the name designated for this process, is thought to be an alternative mechanism 
to death by apoptosis, which ensures resolution of inflammation, or by pyroptosis, secondary 
necrosis or necroptosis, which promote proinflammatory cytokine release and activation of 
macrophages (103, 152, 153). More recently, studies have shown that neutrophils can undergo 
‘vital NETosis’, whereby NETs are produced while neutrophils remain intact, alive, can still 
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undergo active phagocytosis and can migrate (103, 154, 155). While it was originally believed 
that NET formation is dependent on the NADPH oxidase activity, an ROS-dependent process, 
new research has led to the idea that NET formation can also occur via an ROS-independent 
mechanism (84, 148, 156, 157). 
A variety of stimuli have been associated with NET release: nitric oxide, cytokines, 
microbes and microbial products, antibodies, statins, platelets and antimicrobial peptides (148, 
149, 158-164). It has been determined by many studies that NETs can be induced and/or kill a 
large range of pathogens including bacteria (both Gram-positive and Gram-negative), fungi, 
protozoan parasites and viruses (165-167). Also, NETs can be formed in the presence of 
physiological inducers, like lipopolysaccharide (LPS) non-physiological agents like phorbol 12-
myristate 13-acetate (PMA) (168). The composition of NETs includes nuclear chromatin, nuclear 
citrullinated histones and also granular antimicrobial proteins, such as NE and MPO, which 
provide an extracellular matrix for trapping and killing pathogens (169-171). 
Excessive NET formation is associated with disease development  (149, 172). Their 
release must be highly regulated, as this process has been linked to harmful effects on the host, 
including tissue damage and even the development of autoimmunity (72, 159, 161, 173-175). 
Although the antimicrobial granule proteins play a vital role in bacterial killing, these proteins 
may also cause unnecessary damage to host tissue and potentially chronic inflammation, if not 
cleared from the infection site (149, 176). A link has been established between NET formation 
and autoimmune disease, like with systemic lupus erythematosus (SLE), which is caused by the 
formation of autoantibodies targeting chromatin and neutrophil components, and results in 
symptoms of fatigue, joint pain, rash and fever (72). The high levels of proinflammatory 
cytokines found in patients with autoimmune disease are proposed to sensitize neutrophils to 
form NETs (72). Additionally, the presence of circulating autoantibodies may induce a switch 
from PMN apoptosis to NETosis (72). The contents released during NET formation may serve as 
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a source of autoantigens, which has been implicated to lead to complications in the development 
of autoimmune diseases like rheumatoid arthritis, SLE and vasculitis (73, 103). 
The role of neutrophils in periodontal disease.  
The innate immune response, driven by neutrophils, is of critical importance to the 
maintenance of periodontal health in the host (1). It has been estimated that ~30,000 neutrophils 
circulate through the periodontal tissue per minute (1, 177, 178). Neutrophils are found in large 
numbers in the gingival crevice as well as in the epithelial tissue, designating them as the major 
effector cell of the periodontium (179-183). It has been proposed that neutrophils form a ‘wall’ 
of protection for their host, which is formed along the gingival epithelium and the pathogen-rich 
biofilm community (179, 181, 182). 
Neutrophils will be present in health, producing a low-level inflammatory state, 
stimulated through the presence of resident oral microbiota, where they serve as patrolling 
agents ready to respond if needed, until they will undergo eventual cell apoptosis and clearance 
by macrophages (184-186).  In the inflamed periodontal tissue, chemotactic factors such as IL-
8, as well as bacterial derived products, fMLF, will be abundant and guide neutrophils from the 
blood vessels through the gingival tissue towards the periodontal pocket (179, 187, 188).  
In the context of periodontal disease, neutrophils are impaired in their ability to perform 
chemotaxis, which impacts their migration to the site of bacterial presence in the oral cavity, 
allowing for bacterial persistence and survival in the host (184, 189). Additionally, these 
neutrophils are maintained in a ‘primed’ activation state both in the oral cavity and in the blood 
stream, which could have further implications in the association of oral disease with the 
development of other chronic inflammatory diseases like atherosclerosis, diabetes, and 
rheumatoid arthritis (184). Priming agents (e.g. fMLF, TNF-α) of bacterial and host origin serve 
to pre-activate or ‘prime’ neutrophils to form a more robust response upon encounter with a 
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secondary stimulus (190). In the context of disease, primed neutrophils can be critical to 
ensuring a robust effective killing response, however an excessive priming can lead to 
unnecessary collateral host tissue damage.  
There is a dynamic cross-talk between periodontal pathogens and neutrophils in the 
development and progression of periodontal disease (179, 182, 191-193). Neutrophils that are 
impaired in function, show increased susceptibility to bacterial infection and development of 
disease (179). However, if on the other hand, neutrophils are in a hyperactivated state, this 
could lead to chronic and unresolved inflammation and bacterial persistence and survival in the 
oral cavity, which would greatly damage host tissues while providing a constant nutrient-rich 
environment for the bacteria (179, 182).   
Due to the importance of neutrophils in the innate immune response to a variety of 
stimuli, it is anticipated that in response to these cells, pathogens have developed means to 
interfere with and prevent chemotaxis.  In studies performed by Darveau, it was observed that in 
gingival epithelial cells, P. gingivalis does not induce IL-8 production and it is known to 
antagonize IL-8 production which leads to suppression of neutrophil migration and further allows 
for bacterial overgrowth to occur (44, 194). Additionally, once homeostasis is disrupted, there is a 
reduction in the secretion of IL-8, which further impairs neutrophil recruitment to the site of 
infection and allows for growth and persistence of bacterial species (1). P. gingivalis also 
contains serine phosphatase, SerB, which operates to prevent granulocyte recruitment to 
periodontal tissues (179, 195). 
It has been suggested that NETs play an extensive role in both periodontal health and 
disease (149). In the context of periodontal disease, exacerbation of disease may occur if there is 
an excessive NET production (149, 196). On the other hand, ineffective NET production could be 
a contributing factor in periodontal disease development (149).  NETs have previously been 
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observed to be present in both purulent exudates from the gingiva as well as in gingival crevicular 
fluid from patients suffering from chronic periodontitis (149, 197). Using immunofluorescent 
imaging, NETs have been visualized in gingival connective tissues at inflammatory sites of 
infection, however, in healthy patients, less NET formation is detected (149).  
Neutrophil specific disorders play a role in periodontal disease development.  
The presence of fully functional neutrophils is crucial for ensuring periodontal health, as 
patients suffering from the neutrophil disorders listed below are plagued by the development of 
periodontitis (179). Overall, genetic diseases responsible for impaired neutrophil functions are 
found in less than 1 in 200,000 individuals, which can underscore the importance and relevance 
of these cells function in antimicrobial defense (73). However, it is important to point out that 
impairment of neutrophil functions leads to impairment of other immune cell types and greatly 
enhances the chance for the patient to succumb to a variety of bacterial and fungal infections (73). 
Additionally, numerous syndromes causing defects of neutrophil number or function show 
patients invariably develop periodontal disease (1, 198).  
Chronic neutropenia, meaning abnormally low levels of circulating neutrophils, is linked 
with the development of persistent and chronic bacterial infections, and most importantly for our 
studies, the development of aggressive periodontitis (198, 199).  In neutropenic patients, the most 
common pathogen found is S. aureus, which is easily eliminated from healthy individuals (73, 
200, 201). Additionally, fungi like Candida and Aspergillus species are known to be problematic 
when one or all of the neutrophil’s defense mechanism are deficient (73, 202).  
Patients that suffer from leukocyte adhesion deficiency type 1 and type 2 (LAD1, LAD2) 
have congenital deficiencies in neutrophil number or transit and will consistently develop 
periodontal disease (1, 203-206). LAD1 is fatal without bone marrow transplant (198). 
Chediak-Higashi syndrome effects the lysosomal regulator gene (LYST) and results in 
increased susceptibility to infection as well as large inclusion bodies seen in the bone marrow 
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(198, 207).  Additionally, in patients with Chediak-Higashi syndrome, an aggressive and 
unresponsive form of periodontitis develops (198, 208, 209).  Mutations in the cathepsin C gene 
(CTSC) cause Papillon-Lefèvre syndrome, which impairs activation and recruitment of 
leukocytes, as well as their degradation of microbes inside the phagosome (198). Papillon-
Lefèvre syndrome can cause pre-pubertal periodontitis and if enzymatic defects associated with 
this condition are left untreated, severe periodontitis affecting both dentitions will develop (198).  
Treatment of periodontal disease.  
There are many challenges associated with treating periodontal disease: salivary flow as 
well as large differences among individuals (5, 210). The oral microbiota shifts with changes in 
diet, hygiene and age of individuals and therefore, it is difficult to identify a ‘typical’ healthy vs. 
diseased individual, as there are many flavors for either context (5, 43, 211-213).  
The overall goal of periodontal therapy is to reduce and eliminate pathogenic bacteria 
while maintaining the community of commensal bacteria (57, 214, 215). The current standard 
treatment for periodontitis includes a combination of scaling and root planning with an 
antibiotic regimen (5). Although this method may prove effective against known pathogenic 
bacteria, it may not be effective against unusual and yet-to-be-cultivated species, leading to 
their persistence and growth in the oral cavity and a state of disease (57, 216-219). 
However, antibiotic therapy is usually unsuccessful due to the fact that biofilms are 
resistant to them (5, 30). Another important point of consideration is that a large number of oral 
bacteria have not yet been identified and antibiotic treatment may only be successful in treating 
some of the bacteria residing in the oral cavity (5, 43). Further, using antibiotic treatment not 
only impacts the bacteria, but also the host, making the host more susceptible to other infections 
(5). Antiseptics as treatment provides its own set of drawbacks, as there tends to be only a slight 
improvement and the issue of unnecessary host inflammation still remains (5, 220). This 
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method suggests that using anti-inflammatory drugs, bone sparing agents, and pro-resolving 
agents may provide a new angle into treating oral diseases (5, 221, 222). Another proposed 
method of treatment is photodynamic therapy, where long-wavelength visible light (red light) is 
used to activate photosensitizing agents that produce ROS response by the host, which proved 
to be more effective than treatment with antibiotics (5, 223).  
Perhaps the most promising of the treatment options being considered are those that 
involve targeting the host (5). It is possible that host modulation therapy treatment provides a 
promising outcome for patients afflicted with periodontal disease, as the resolution of host 
inflammation will provide a more homeostatic environment in the oral cavity (5). As the shift in 
microbiota is vital for maintaining a state of health over disease in the oral cavity, the use of 
probiotic treatment remains a promising avenue that needs further research (5, 224). It has been 
suggested that development of active or passive immunizations, known to target gingipains, 
proteases, and peptide-binding sites, may prove beneficial in the treatment of disease, as there 
were promising pre-clinical studies performed on P. gingivalis (1, 225-227). A passive local 
monoclonal antibody treatment targeting P. gingivalis proteins showed prevention of 
recolonization in periodontal lesions up to 9 months after initial treatment (1, 225). Perhaps a 
promising therapeutic for these studies are the attenuation of inflammation generated by 
neutrophils in response to bacterial presence in the oral cavity. Studies performed with P. 
gingivalis showed that direct targeting of receptors chemerin receptor 23 (CHEMR23) and 
leukotriene B4 receptor 1 (BLT1), known to play a role neutrophil infiltration and cytokine 
production, resulted in resolution of inflammation and prevention of disease development (1).  
Neutrophils are critical for providing the first response to invading microbes, in order to 
kill their target and allow for maintenance of host health; however, due to their production of 
toxic products, their resolution through apoptosis and macrophage clearance is just as important 
to ensuring host health rather than collateral host damage. Anti-neutrophil therapies have been 
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proposed as treatment methods for periodontal disease, however, it is necessary for their 
antibacterial killing mechanisms to not be impaired, as this could exacerbate infection of the 
periodontium, among other sites (179). An ideal therapeutic candidate would be able to 
manipulate neutrophil surface receptors and impact signaling, without comprising killing 
mechanisms (179, 228). Current classes of inhibitors under investigation include: leukotriene 
B4 (LTB4) antagonists, chemokine receptor 2 (CXCR2) antagonists, long-acting b2-agonists 
and histone deacetylase (HDAC) activators (179, 229).  
Dissertation goals.  
 The goals of this dissertation are to perform the first studies looking at the interaction of 
human neutrophils and periodontal pathogen, Filifactor alocis. In Chapter 2, we challenge 
neutrophils with F. alocis and analyze its effect on signaling pathway activation, degranulation 
and cell migration. In Chapter 3, we characterize the neutrophil oxidative-based killing 
mechanism employed against F. alocis and show how the bacterium evades this mechanism in 
order to promote its own survival. In Chapter 4, we show that F. alocis fails to induce NETs, but 
is capable of manipulating neutrophils, impacting their ability to form NETs by known 






FILIFACTOR ALOCIS PROMOTES NEUTROPHIL DEGRANULATION AND  
                                        CHEMOACTIC ACTIVITY
1 
 
Filifactor alocis is a recently recognized periodontal pathogen; however, little is known 
regarding its interactions with the immune system. As the first-responder phagocytic cells, 
neutrophils are recruited in large numbers to the periodontal pocket, where they play a crucial 
role in the innate defense of the periodontium. Thus, in order to colonize, successful periodontal 
pathogens must devise means to interfere with neutrophil chemotaxis and activation. In this 
study, we assessed major neutrophil functions, including degranulation and cell migration 
associated with the p38 mitogen-activated protein kinase (MAPK) signaling pathway upon 
challenge with F. alocis. Under conditions lacking a chemotactic gradient, F. alocis-challenged 
neutrophils had increased migration compared to uninfected cells, indicating that F. alocis 
increases chemokinesis in human neutrophils. In addition, neutrophil chemotaxis induced by 
interleukin-8 was significantly enhanced when cells were challenged with F. alocis compared to 
noninfected cells. Similar to live bacteria, heat-killed F. alocis induced both random and directed 
migration of human neutrophils. The interaction of F. alocis with Toll-like receptor 2 induced 
granule exocytosis along with a transient ERK1/2 and sustained p38 MAPK activation. 
Moreover, F. alocis-induced secretory vesicle and specific granule exocytosis were p38 MAPK 
dependent. Blocking neutrophil degranulation with TAT-SNAP23 fusion protein significantly 
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reduced the chemotactic and random migration induced by F. alocis. Therefore, we propose
 
that 
induction of random migration by F. alocis
 
will prolong neutrophil traffic time in the gingival 




Periodontitis is a multifactorial chronic inflammatory disease, induced by a dysbiotic 
polymicrobial community of bacteria (147, 230). It is the sixth most common infectious disease 
worldwide, and over half the U.S. population will experience some form of periodontal disease 
(231). Additionally, accumulating epidemiological and mechanistic studies establish a causal 
association of periodontal disease and periodontal pathogens with serious systemic conditions, 
including, pneumonia, cardiovascular disease, preterm low birthweight delivery and some forms 
of cancer (147, 232, 233).  
Recent human oral microbiome studies reveal the presence of large numbers and 
diversity of fastidious and ‘yet-to-be cultivated’ taxons, many of which show a strong correlation 
with disease severity (59, 234). Nonetheless, the contribution to disease by these newly 
appreciated organisms has been overshadowed by the more readily cultivable species, and 
appreciation of their pathogenicity is just beginning to emerge (235, 236).  Filifactor alocis is a 
slow-growing gram-positive anaerobe which in culture-independent studies is consistently found 
at increased frequency and in elevated numbers at periodontal disease sites compared to healthy 
sites (2, 44, 54, 57, 58, 60, 61, 63, 64, 234, 237, 238).  In vivo, F. alocis is found in subgingival 
biofilms (70), and the organism positively correlates with other periodontal pathogens such as P. 
gingivalis forming a co-occurrence group that is enriched across different oral habitats (239).  In 
vitro, the organism also participates in synergistic community formation with other common 
periodontal bacteria (63). Notably,  F. alocis is relatively resistant to oxidative stress (60), can 
produce trypsin-like proteases (60), and can invade and induce the secretion of proinflammatory 
cytokines from gingival epithelial cells (44), properties which could contribute to pathogenicity in 
the periodontal pocket.   
Neutrophils are the core phagocytic defenders of the periodontal pocket and are recruited 
in large numbers after adhesion to, and transmigration through, blood vessel walls (179).  As a 
 28 
major component of the innate host response, neutrophils contribute to the maintenance of 
periodontal health by protecting the tissue against bacterial infection (198).  Indeed, defects in 
neutrophil recruitment of function such as neutropenia, leukocyte adhesion deficiency (LAD), and 
Chediak-Higashi syndrome, strongly predispose to periodontitis (240). Directional movement, or 
chemotaxis, of neutrophils toward sites of injury and inflammation occurs by sensing and 
deciphering a chemoattractant gradient (114, 117-120). Neutrophils are able to respond to signals 
from both intermediary chemoattractants (such as interleukin (IL)-8), which are encountered upon 
travel to sites of infection and inflammation, and from end target cellular chemoattractants (such 
as formylated bacterial peptides like fMLF), operating at the site of infection (118, 120, 123).  A 
high concentration of chemoattractants is an indication to neutrophils that the cells had arrived at 
their final destination, and the process of phagocytosis and oxygen-independent and -dependent 
killing begins (118). 
In the inflamed periodontal tissue, chemotactic factor such as IL-8, as well as bacterial 
derived products, fMLF, will be abundant and guide neutrophils from the blood vessels through the 
gingival tissue towards the periodontal pocket. During the cell migration process, neutrophil 
granule exocytosis will take place and contribute to gingival tissue damage.  Given the importance 
of neutrophils in innate defense of the periodontium, successful periodontal pathogens, both 
individually and in the context of dysbiotic communities, have devised means to interfere with 
neutrophil chemotaxis and/or bacteria killing abilities (179, 241).   
In this study, we show for the first time that F. alocis interaction with human neutrophils 
results in enhanced random migration and chemotaxis towards IL-8.  In addition, F. alocis through 
TLR2 activation induced extracellular signal-regulated kinase (ERK) and p38 MAPK 
phosphorylation which preceded the enhanced random migration and stimulated neutrophil granule 
exocytosis.  Moreover, F. alocis-mediated neutrophil migration was dependent on the bacteria-
induced degranulation.   
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Results 
F. alocis challenge of human neutrophils resulted in stimulated cell migration with and without 
directionality. 
Neutrophil migration towards sites of infection is a key early event in the process of 
protection against pathogenic microorganisms and in periodontal disease, neutrophils are recruited 
in high numbers into the gingival tissues and crevicular fluid to control and combat the bacterial 
infection (242).  However, neutrophils from chronic periodontitis patients show dysfunctional 
chemotactic function which increase the cell transit time in the gingival connective tissue 
promoting collateral tissue damage (243).  Using a mouse chamber model, we recently showed that 
F. alocis infection resulted in a rapid neutrophil infiltration to the site of infection (61).   To 
determine whether F. alocis interaction with human neutrophils can impact neutrophil migration, 
chemotaxis assays were performed using the transwell system.  Assessed by light microscopic 
analysis and cell migration quantification, unstimulated cells showed minimal cell migration in the 
absence of a chemotactic source, while as expected, there was a significant neutrophil migration 
towards the potent chemotactic formylated peptide, fMLF, as expected (Fig. 2-1A).  Interestingly, 
F. alocis-challenged neutrophils showed significant migration towards buffer alone compared to 
unstimulated cells (Fig. 2-1A), which indicates that the bacterial challenge increased random cell 
migration in the absence of a chemoattractant source. However, migration towards fMLF was 
similar in all the conditions regardless of bacteria challenge. Thus, we sought to determine if the 
random migration induced by F. alocis would have no impact on directed migration independent 
of chemotactic source.  
Since IL-8 is an important chemotactic factor involved in neutrophil recruitment to the site 
of periodontal infection (179), we examined the impact of F. alocis-challenge on IL-8-dependent 
neutrophil chemotaxis.  Unlike what was observed with fMLF, the F. alocis-challenged cells 
showed a significant increase in chemotaxis towards IL-8 compared to unstimulated cells (Fig. 2-
1B).  Neutrophils can also be a source of IL-8 as they have pre-formed IL-8, which is stored in 
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rapid mobilized vesicles (244), and can also synthesize the chemokine upon stimulation (245). To 
determine if the enhanced migration observed after F. alocis stimulation could be related to the 
release of the IL-8 from the stored pools, neutrophil supernatants were collected after 60 min of 
bacterial challenge and added to the lower chamber of the transwell system.  As shown in Fig 2-
1C, supernatant collected after 60 min of F. alocis challenge did not induce neutrophil migration, 
whereas both fMLF and IL-8 induced significant neutrophil chemotaxis.  In addition, we were 
unable to detect IL-8 levels in the supernatant collected after 60 min of F. alocis challenge (data 
not shown), arguing against the possibility of an autocrine IL-8 effect induced by F. alocis 
responsible for the increased chemotaxis.    
We next examined if bacterial viability is critical for inducing neutrophil motility by 
challenging cells with viable or heat-killed F. alocis. Both viable and heat-killed F. alocis 
challenged neutrophils displayed significantly enhanced random migration in the absence of a 
chemotactic source (Fig. 2-1D), no difference in directed cell migration toward fMLF compared to 
unchallenged control cells (Fig. 2-1E) and enhanced chemotaxis towards IL-8 (Fig 2-1F).  
Collectively these results indicate that F. alocis heat-stable cell wall components can stimulate 
random migration and can enhance the migration of neutrophils with directionality towards 
intermediary chemoattractants such as IL-8.   
F. alocis interaction with human neutrophils induced granule exocytosis through TLR2 with ERK 
and p38 MAPK activation. 
Components of gram-positive bacteria are usually recognized by Toll-like receptor (TLR) 
2 which is expressed by neutrophils (246). Moreover, TLR2 agonists, such as P3CSK4, can induce 
neutrophil random migration by triggering extracellular signal-regulated kinase (ERK) and p38 
mitogen-activated protein kinase (MAPK) signal transduction pathways (247).  To examine the 
ability of F. alocis to activate the MAPK signaling pathways, phosphorylation of ERK1/2 and p38 
MAPK was measured by immunoblot analysis.  Figures 2-2 A and B show that F. alocis infection 
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increased the levels of ERK1/2 and p38 MAPK phosphorylation in neutrophils with maximum 
activation reached at 15 min for ERK 1/2 and 30 min for p38.  By 60 min after F. alocis challenge, 
a decrease in both ERK1/2 and p38 MAPK phosphorylation was observed. To further characterize 
the dependence of F. alocis- induced MAPK signaling on TLR2 recognition, the bacterium-
receptor interaction was blocked by a TLR2 mAB.  Figure 2-3 lane 3 shows that blocking TLR2 
significantly inhibited F. alocis-induced phosphorylation of ERK1/2.  A similar inhibitory trend, 
although not reaching statistical significance, was observed for p38 MAPK phosphorylation.  These 
results indicate that F. alocis- induced ERK1/2 signaling pathway is TLR2 dependent.  
In addition to its role in MAPK signaling pathways, TLR activation can also induce other 
neutrophil functions such as exocytosis of neutrophil granule, which has also been linked to 
chemotaxis (246, 248, 249).  The exocytosis of secretory vesicles and specific granules increases 
not only the number but also the diversity of the receptor repertoire on neutrophil plasma membrane 
and facilitates cell firm adhesion and extravasation from the blood to the tissue (250). Hence, to 
examine whether F. alocis-enhanced random migration in the absence of a chemotactic source 
could be linked to granule mobilization, the increases on the cell plasma membrane of secretory 
vesicles and specific granule markers were determined by flow cytometry. Stimulation of 
neutrophils for 30 min with F. alocis resulted in a significant secretory vesicle release similar to 
the exocytosis induced by fMLF (Fig. 2-4A). In addition, specific granule exocytosis, as measured 
by expression of CD66b on the plasma membrane, was significantly increased by F. alocis 
stimulation (Fig. 2-4B). Activation of p38 MAPK has been associated with cell migration and with 
TNF and LPS-induced neutrophil granule exocytosis (249).  In order to test the involvement of p38 
MAPK signaling in F. alocis-stimulated granule exocytosis, neutrophils were pretreated with the 
p38 inhibitor SB-203580 before bacterial challenge.  Figures 2-4C and D shows that blocking p38 
MAPK resulted in a significant decrease of secretory vesicles and specific granule exocytosis. To 
confirm that F. alocis- induced upregulation of CD35 and CD66b at the plasma membrane was 
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accompanied by the release of granule content, the extracellular release of albumin and lactoferrin, 
respectively, was determined by ELISA. Figure 2-4E and F show that F. alocis induced significant 
release of both albumin and lactoferrin in a p38 MAPK-dependent manner. These results 
demonstrate that F. alocis challenge triggered secretory vesicles and specific granule exocytosis, 
and that the process was p38 MAPK dependent.  
Chemotactic factors can induce release of azurophil granule components such as β-
glucuronidase (251), and the contribution of lysosome exocytosis and fusion with the plasma 
membrane, through the regulation of Rab27a, to the promotion of cell migration has been 
established (252). Hence, exocytosis of azurophil granules upon F. alocis challenge was measured 
by both increase of plasma membrane expression of the granule marker CD63 by flow cytometry 
and the release of the granule component myeloperoxidase (MPO). Figure 2-5A and B show that 
F. alocis challenge did not induce azurophil granule exocytosis. Moreover, increasing the amount 
of bacteria per neutrophil from an MOI of 10 to 50 did not result in azurophil granule mobilization, 
measured both by upregulation of the granule marker (Fig. 2-5A) and the release of MPO (Fig. 2-
5B).  
Our data thus far show that F. alocis interaction with human neutrophils results in TLR2- 
mediated phosphorylation of ERK1/2 and p38 MAPK, although the latter may not be solely 
dependent on TLR2.  Moreover, F. alocis induced the exocytosis of secretory vesicles and 
specific granules through activation of the p38 MAPK signaling pathway. Hence, we wanted to 
determine if upstream of the p38 MAPK signaling pathway, F. alocis interaction with TLR 
receptors could be the initial trigger that induces granule release. Figure 6A shows that blocking 
TLR2 with mAB resulted in a significant inhibition of F. alocis-induced secretory vesicle 
exocytosis, as measured by expression of CD35 on the plasma membrane; whereas TLR4 mAB 
had a minimal inhibitory effect.  Similarly, F. alocis-induced specific granule exocytosis was 
inhibited to the same extent in anti-TLR2 treated cells (data not shown).  To provide additional 
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evidence for a lack of TLR4 activation by F. alocis, a pharmacologic inhibitor CLI-095, which 
blocks the intracellular domain of TLR4 (253), was used with lipoprotein-free LPS as a control.  
Figure 6B shows that, as expected, blocking TLR4 signaling resulted in a significant inhibition of 
LPS-induced secretory vesicle exocytosis. In contrast, and concordant with the anti-TLR4 data, 
chemical blocking TLR4 resulted in a minimal inhibition of F. alocis-induced secretory vesicle 
exocytosis.  These results show that F. alocis stimulation of both secretory vesicles and specific 
granule exocytosis is TLR2 and p38 MAPK dependent.   
Blocking neutrophil degranulation inhibits F. alocis-induced neutrophil cell migration. 
Both p38 MAPK activation and neutrophil granule exocytosis play a key role in early stage 
neutrophil responses, such as diapedesis and chemotaxis (249, 252). Therefore, we sought to assess 
whether neutrophil granule exocytosis played a role in F. alocis-induced neutrophil migration in 
the presence or in the absence of a chemotactic source.  Neutrophil degranulation can be blocked, 
without affecting neutrophil phagocytic ability and activation of p38 MAPK, by using the TAT-
SNAP-23 fusion protein (146). First, we wanted to confirm that the TAT-SNAP-23 pre-treatment 
would block F. alocis- induced granule exocytosis.  Figure 2-7 A and B shows that the TAT-SNAP-
23 fusion protein, as previously characterized (146), significantly blocked fMLF-stimulated 
secretory vesicles and specific granule exocytosis (Fig. 2-7A and B) and had no nonspecific effect 
when using a stimulation procedure, in this case with zymosan, that did not induce granule 
exocytosis. Upon verification that TAT-SNAP-23 was significantly blocking F. alocis-induced 
granule exocytosis, we tested the effect on cell migration. Figure 2-7C shows that treatment of 
unstimulated cells with the TAT-SNAP-23 fusion protein reduced the number of neutrophils 
crossing the membrane towards fMLF, which further emphasizes the role of granule exocytosis in 
neutrophil chemotaxis. On the contrary, when zymosan was used to stimulate neutrophils, the 
particulate stimuli induced chemotaxis toward IL-8, but pretreatment with the TAT-SNAP-23 
fusion protein had no effect on zymosan-induced chemotaxis (Fig. 2-7D). However, as shown in 
Fig 2-7E, blocking neutrophil degranulation with TAT-SNAP-23 resulted in a significant inhibition 
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of F. alocis- induced random migration in the absence of a chemotactic source.  In addition, 
blocking granule release significantly reduced the ability of F. alocis-challenged neutrophils to 
migrate towards both chemotactic sources, fMLF and IL-8 (Fig 2-7E and F). These results 
demonstrate that when granule exocytosis is involved in cell migration, pre-treatment with the 
TAT-SNAP-23 fusion protein prevents exocytosis-mediated cell migration. Collectively, these data 
suggest that the enhanced migration of F. alocis-challenged neutrophils observed in the presence 
or in the absence of a chemotactic source is due in part to the p38 MAPK-dependent granule 
exocytosis induced by the bacteria challenge.  
Discussion 
Given the importance of neutrophils in innate defense of the periodontium, successful 
periodontal pathogens, both individually and in the context of dysbiotic communities, have devised 
means to interfere with neutrophil chemotaxis and killing (179, 241).  Furthermore, congenital 
diseases, such as Leukocyte Adhesion Deficiency, that impair neutrophil chemotaxis result in 
severe periodontitis at early stage in life (254, 255).  In the mouse subcutaneous chamber model of 
infection, the newly appreciated periodontal pathogen F. alocis elicits a local inflammatory 
response with extensive neutrophil recruitment, and spread to remote tissues, inducing lung edema 
with neutrophil recruitment, and causing acute kidney injury (61).  However, very little is known 
about the pathogenic nature of F. alocis and its interaction with the innate immune system.  In the 
present study, we showed that F. alocis interaction with human neutrophils, through TLR2 
recognition, resulted in enhanced random and directed migration, and degranulation via activation 
of the p38 MAPK signaling pathway.  Degranulation and sustained p38 MAPK activation induced 
by F. alocis were major contributors of the enhanced cell migration. Based on our data, a schematic 
model for neutrophil degranulation and enhanced migration in response to F. alocis challenge is 
proposed in Fig. 8.  
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In the periodontal pocket, there is a continual influx of neutrophils that decipher and 
migrate through a chemotactic gradient. Our results showed that F. alocis interaction with human 
neutrophils resulted in a significant increase in random migration.  Pre-exposure to F. alocis did 
not affect the ability of the cells to migrate with directionality towards fMLF; which is consistent 
with previous observations of human neutrophils challenged with either TLR 2/1 or TLR4 agonists 
such as N-palmitoyl-S-[2, 3-bis (palmitoyloxy)-(2RS)-propyl]-(R)-cysteinyl-seryl-(lysyl)(3)-lysine 
(P3CSK4) or LPS respectively (247).  In an inflamed tissue different neutrophil chemotactic 
products, such as IL-8, formylated peptides, and complement products such as C5a, are produced 
by different sources; however, neutrophils efficiently transit towards the end target by migrating in 
sequence from one chemotactic source to another (256).  Fan and Malik showed that neutrophils 
activated by the TLR4 agonist, LPS, display enhance migration towards IL-8 by modulating 
CXCR2 expression and preventing receptor desensitization (257).  We found here that F. alocis 
significantly enhanced neutrophil chemotaxis towards IL-8 through TLR2 activation. Hence, both 
TLR2 and TLR4 activation of neutrophils can result in enhanced migration towards IL-8. Another 
important signaling mechanism linked to neutrophil chemotaxis towards IL-8 or fMLF is 
differential activation of the two integrin molecules MAC-1 or LFA-1 (124).  Activation of LFA-
1 or MAC-1 enhances neutrophil chemotaxis towards IL-8 or fMLF, respectively (124).  Therefore, 
it is possible that F. alocis-enhanced chemotaxis towards IL-8 is due to LFA-1 activation. In 
addition, F. alocis-induced secretory vesicle exocytosis would increase the number and variety of 
receptors on the cell plasma membrane, making neutrophils more prone to mounting an enhanced 
response upon subsequent stimulation. Moreover, the F. alocis- induced release of specific granule 
content, which, among other proteins, includes members of the matrix metalloprotease family, such 
as collagenase and gelatinase, will contribute to tissue damage.  
The MAP kinase family signaling components ERK and p38 MAPK play important roles 
in the regulation of fMLF-induced neutrophil migration (119, 122, 258, 259), whereas  IL-8 
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stimulation results in  activation of the PI3K signaling pathway (260). Stimulation of neutrophils 
with TLR2 or TLR4 agonists signals through ERK and p38 MAPK to control random migration 
and chemotactic activity (247).  Hence, the role of the different kinases in human neutrophil 
migration is dependent on the agonist.  Our study showed that F. alocis triggered activation of both 
ERK and p38 MAPK but with temporal differences, with ERK activation, which occurred through 
TLR2, peaking at 15 min, whereas p38 MAPK showed a different phosphorylation pattern, 
increasing with time and peaking at 30 min.  Neutrophils migrate with directionality to sites of 
infection by following increasing concentrations of a chemoattractant, but when the 
chemoattractant concentrations are elevated, it is an indication that the cells reached their final 
destination, so a stop signal is triggered to prevent more migratory movement (261). The balance 
between ERK and p38 MAPK activation fine tunes neutrophil chemotaxis, as ERK regulates the 
stop signal and p38 MAPK promotes constant migration by suppression of the stop mechanism 
(261). Thus, the phosphorylation pattern of p38 MAPK, along with the transient phosphorylation 
of ERK induced by F. alocis, would lead to enhanced random migration and chemotaxis toward 
IL-8 as the result of the constant suppression of the stop signal by p38 MAPK, allowing sustained 
migration.  In addition, fMLF-induced chemotaxis is regulated by ERK and p38 MAPK, and 
similarly, F. alocis challenge results in activation of both MAP kinases, which suggests that the 
oral pathogen induces signaling pathways similar to those of fMLF to stimulate neutrophil 
chemotaxis. 
Upon stimulation, neutrophils will mobilize their granules which will either fuse with the 
cytoplasmic membrane or the phagosomal membrane, ultimately resulting in functional responses 
including exocytosis, extravasation, phagocytosis and elimination of various microorganisms (262-
264).  Several neutrophil responses, including exocytosis, chemotaxis, respiratory burst activity 
and chemokine synthesis, are mediated through the p38 MAPK pathway (249).  Activation of p38 
MAPK signaling has been associated also with permitting neutrophils to sense and interpret the 
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chemotactic sources, by controlling the surface expression of adhesion molecules like CD11b and 
CD66b, and chemoattractant receptors for fMLF and IL-8 (9).  In this study, F. alocis induced 
secretory vesicle and specific granule exocytosis, which was mediated through TLR2 activation 
and dependent on p38 MAPK.  Secretory vesicles are organelles that are easy to mobilize and are 
involved in augmenting the number of receptors and adhesion molecules like CD11b/CD18, which 
participate in the adhesion and transmigration process.  F. alocis also induced a significant increase 
in the plasma membrane expression of CD66b, a specific granule marker used to evaluate granule 
exocytosis, and also involved in adhesion to fibronectin and E-selectin (265). When granule 
exocytosis was blocked by the use of TAT-SNAP-23 fusion protein (146), both random and 
directed migration induced by F. alocis challenge were impeded. It is plausible that F. alocis-
induced secretory vesicle and specific granule exocytosis contributes to the enhanced chemotaxis 
towards IL-8 by increasing the availability of CXCR2 receptors, as well as neutrophils adhesion 
capabilities by increase plasma membrane expression of CD66b. Moreover, we can speculate that 
in the context of periodontitis, besides the role of granule exocytosis on cell migration, the release 
of granule content to the extracellular space induced by F. alocis will contribute to tissue damage 
and disease progression.  
Successful periodontal bacteria employ a variety of strategies to compromise neutrophil 
function. The major outer sheath protein (Msp) of Treponema denticola alters the balance of 
intracellular phosphoinositide, causing impairment of neutrophil directional migration towards 
fMLF and inhibition of downstream events leading to chemotactic responses (266). Msp does not 
form a pore in neutrophils but remains associated to the plasma membrane and triggers “outside-
in” signaling that results in inhibition of PI3-kinase activity and an increase in the activity of the 
phosphatase PTEN. The MSP virulence factor favors neutrophil PTEN activity over PI3K,  
resulting in a decrease on the amount of the phosphoinositide PIP3, which compromises actin 
dynamics, preventing the cell from having proper directed chemotaxis (266). The keystone 
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periodontal pathogen, P. gingivalis, generates a local and transient chemokine paralysis by 
antagonizing the synthesis and release of IL-8 from gingival epithelial cells (267).  The transient 
suppression of neutrophil recruitment to the gingival tissue facilitates the colonization of the tissue 
by P. gingivalis and other oral bacteria (268).  Interaction between F. alocis and gingival epithelial 
cells results in release of IL-8 (44) , and the current study shows that when F. alocis interacts with 
human neutrophils, there is no significant difference in cell migration towards fMLF compared to 
unstimulated cells, but significantly enhanced migration towards IL-8. Hence F. alocis may 
function in obstructing the neutrophil from distinguishing between intermediary (IL-8) and end-
target chemoattractants (fMLF). As it is necessary for neutrophils to eventually migrate towards 
end-target chemoattractants in order to reach sites of infection, F. alocis manipulation of 
neutrophils could lead to defective deciphering abilities between chemoattractant sources, leading 
to constant migration and cell activation which could contribute to dysregulated and sustained 
inflammation and to tissue damage.  
In conclusion, we showed that F. alocis induces a significant random and directed 
migration of human neutrophils towards IL-8.  Activation of TLR2 by F. alocis incites a transient 
ERK 1/2 activation secretory vesicle and a sustained p38 MAPK activation, which results in 
exocytosis of secretory vesicles and specific granules. Ultimately, the p38 MAPK-dependent 
degranulation was responsible for F. alocis-enhanced neutrophil migration, which may contribute 
to dysbiotic host responses and promote tissue damage by activated neutrophils (Fig. 8).   
Material and Methods 
Neutrophil isolation. 
Neutrophils were isolated from blood of healthy donors using plasma-Percoll gradients as 
previously described (146), and in accordance with the guidelines approved by the Institutional 
Review Board of the University of Louisville.  Microscopic evaluation of the isolated cells showed 
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that > 95% of the cells were neutrophils. Trypan blue exclusion indicated that > 97% of cells were 
viable.   
Bacterial strains and growth conditions.  
F. alocis ATCC 38596 was cultured in brain heart infusion (BHI) broth supplemented with 
L-cysteine (0.1%) and arginine (20%) for 7 days anaerobically at 37°C as previously described [27, 
42].  Heat killed F. alocis was generated by incubation at 90 °C for 60 min. 
 
TAT-SNAP-23 fusion protein.  
Fusion proteins were created as previously described (146). E. coli BL21-AI cells 
(Invitrogen) were transformed to overexpress the recombinant TAT fusion proteins. Purification of 
TAT-SNAP-23 was performed by sonication and lysis of the bacterial pellet with a denaturing 
buffer (7 M urea, 0.5 M NaCl, 50 mM NaPO4 [pH 8], 20 mM imidazole), followed by protein 
separation from the supernatant by Ni-NTA beads (Invitrogen). Protein eluted from the beads was 
dialyzed against 10% glycerol, 0.01% Triton X-100 in PBS, pH 7.4, and stored at -80 0C until use.  
Neutrophil chemotaxis. 
Freshly isolated neutrophils (4 x 106 cells/mL) were unstimulated, or challenged with F. 
alocis (multiplicity of infection (MOI) 10), or pre-treated with TAT-SNAP23 (0.9 µg/mL, 10 min) 
followed by F. alocis challenge at 37°C for 30 min.  After appropriate treatment, 100 µl of cell 
suspension were added to the upper chamber of the transwell inserts contained in 24 well plates 
(VWR, Corning, NY). Chemotaxis was initiated by adding 600 µL of chemoattractants into the 
lower chamber. The chemoattractants used were fMLF (10 µM, Sigma), IL-8 (100 ng/mL, Sigma), 
along with supernatants collected from unstimulated or F. alocis-challenged neutrophils (MOI 10, 
1-4-20 h).  After 30 min, the transwell membranes were stained with a HEMA 3 stain set kit 
following the manufacturer’s instructions (Thermo Fisher Scientific,).  Chemotaxis was assessed 
by light microscopic (VWR Compound Trinocular Microscope) examination (magnification x100) 
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of the underside of the membrane.  The average number of cells from a total of 10 fields was 
determined and data were normalized by the area of membrane circle and field of view.  
ERK1/2 and p38 MAPK Kinase phosphorylation. 
Phosphorylation of ERK1/2 and p38 MAPK was determined as previously described (146, 
269). In brief, neutrophils (1x107 cells/mL) were unstimulated, stimulated with fMLF (10 µM, 1 
min), or F. alocis (MOI 10, for 5-15-30-60 min), or for some experiments cells were pre-treated 
with anti-TLR2 antibody (50 µg/ml, Biolegend, clone TL2.1), or isotype control IgG2akappa (50 
µg/ml, Biolegend clone MOPC-173) followed by F. alocis (MOI 10, 15 min).  After the different 
experimental conditions, cells were centrifuged at 2500 g for 20 s and lysed in ice-cold lysis buffer 
[20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 % (vol/vol) Triton X-100, 0.5 % (vol/vol) Nonidet P-
40, 20 mM NaF, 20 mM NaVO3, 1 mM EDTA, 1 mM EGTA, 5 mM PMSF, 21 µg/mL aprotinin, 
and 5 µg/mL leupeptin]. Cell lysates were separated by 4-12 % gradient SDS-PAGE, and 
immunoblotted with antibodies to phospho ERK1/2, total ERK1/2, phospho-p38 MAPK, or total 
p38 MAPK (Cell Signaling) all at 1:1000.  The appropriate secondary antibodies were used at 
1:5000 (Santa Cruz).  The ECL system (Amersham Pharmacia Biotech) was used to visualize 
antigen-antibody reactions.  Densitometric values of each band was calculated using ImageJ 
software. 
Neutrophil granule exocytosis. 
Neutrophils (4x106 cell/mL) were incubated with buffer (basal), or with F. alocis at MOI 
10 for 30 min.  Inhibitors, pre-treated with the cells for 30 min, were SB-203580 (3 µM), anti-
TLR2 antibody (50 µg/ml, Biolegend, clone TL2.1), anti-TLR4 antibody (50 µg/ml, Biolegend, 
clone HTA125), and isotype control IgG2akappa (50 µg/ml, Biolegend clone MOPC-173).  For the 
role of TLR4 in F. alocis induced exocytosis, neutrophils were unstimulated, or stimulated with 
ultra-pure Lipopolysaccharide (LPS; 100 ng/ml, 60 min) (ENZO Life Sciences), or pre-treated with 
a TLR4 signaling inhibitor CLI-095 (1 µg/ml, 15 min) (Invivogen) followed by either LPS (100 
ng/ml, 60 min) or F. alocis (MOI 10, 30 min).  Exocytosis of secretory vesicles and specific 
 41 
granules was determined by measuring the increase in plasma membrane expression of PE-
conjugated anti-human CD35 (Biolegend, clone E11) and FITC-conjugated anti human CD66b 
(Biolegend, clone G10F5). Antibody reactivity was measured with a BD FACSCalibur Flow 
Cytometer (Becton Dickinson).  
 
Statistical analysis. 
For all the experimental conditions tested in this study, the statistical analysis used was a one-way 
ANOVA with the Tukey-Kramer multiple-comparison test (GraphPad Prism software, San 
Diego, CA, USA).  Differences were considered statistically significant at the level of P <0.05.  
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Figure 2-1. Effect of F. alocis stimulation on neutrophil chemotaxis. 
Neutrophils were left unchallenged (control), challenged with F. alocis (30 min), or challenged 
with heat-killed F. alocis (HK-F. alocis; 30 min). (A to F) Following the bacterial challenge, cells 
were placed in the upper chamber of the transwell system, and after 30 min of incubation, the 
membrane was stained with a HEMA 3 stain set kit. Chemotaxis was assessed by light microscopic 
examination (magnification, 100). (A) Buffer or fMLF (100 nM) was placed in the lower well. Data 
are expressed as mean numbers standard errors of the mean (SEM) of migrated cells/insert from 9 
independent experiments. (B) Buffer or IL-8 (100 ng/ml) was placed in the lower well. Data are 
expressed as mean numbers SEM of migrated cells/insert from 5 independent experiments. (C) 
Unstimulated cells were placed in the upper chamber of the transwell plate, and buffer, conditioned 
supernatant collected from unstimulated cells (UT-cond-sup), or conditioned supernatant collected 
after 60 min of stimulation with F. alocis (F. alocis-cond-sup), IL-8 (100 ng/ml), or fMLF (100 
nM) was placed in the lower well. Data are means SEM from 6 independent experiments. (D to F) 
Buffer (D), fMLF (E), or IL-8 (F) was placed in the lower well. Data are expressed as mean 






















Figure 2-2. F. alocis-induced ERK1/2 and p38 MAPK activation in human neutrophils. 
Neutrophils were unchallenged (basal), stimulated with fMLF (300 nM, 1 min), or challenged with 
F. alocis for the indicated times. Cells were lysed, and proteins were separated by SDS-PAGE and 
immunoblotted for phospho-p38 (P-p38) or phospho-ERK1/2 (P-ERK1/2). Blots were stripped and 
reblot-ted for total p38 (p38) or total ERK1/2 (ERK1/2), respectively. (A) Represen-tative 
immunoblot of 5 independent experiments. (B) Densitometric analysis of the 5 immunoblots for P-
p38 or P-ERK1/2 normalized to the total amount of p38 or ERK1/2, respectively. Data are 


















Figure 2-3. TLR2 activation is involved in F. alocis-induced phosphorylation of both 
ERK1/2 and p38 MAPK. 
Neutrophils were unchallenged (basal), challenged with F. alocis (MOI of 10, 15 min), or 
pretreated with either anti-TLR2 MAb or isotype control (isotype-Ctrol), followed by F. alocis 
challenge. Cells were lysed and proteins separated by SDS-PAGE and immunoblotted for phospho-
p38 (P-p38) or phospho-ERK1/2 (P-ERK1/2). Blots were stripped and reblotted for total p38 (p38) 
or total ERK1/2 (ERK1/2), respectively. (A) Representative immunoblot of 4 independent 
experiments. (B) Densitometric analysis of the 4 immunoblots for P-ERK1/2/total ERK1/2. (C) 
Densitometric analysis of the 4 immunoblots for P-p38 MAPK/total p38 MAPK. Data are 














Figure 2-4. F. alocis stimulation of secretory vesicle and specific granule exocytosis is p38 
MAPK dependent. 
Neutrophils were left unchallenged (basal), challenged with fMLF (300 nM, 5 min), challenged 
with F. alocis (MOI of 10, 30 min), or pretreated for 30 min with SB203580 followed by F. alocis 
challenge (SB F. alocis). (A to D) Secretory vesicle and specific granule exocytosis were 
determined by the increase in plasma membrane expression of the CD35 or CD66b marker, 
respectively, by flow cytometry. Data are expressed as the mean channel of fluorescence (mcf) 
SEM from 5 independent experiments. (E and F) Supernatants from all of the different experimental 
conditions were collected, and the release of albumin or lactoferrin to determine secretory vesicle 
or specific granule exocytosis, respectively, was measured by ELISA. Data from albumin or 
lactoferrin release are expressed as means SEM in ng/4 106 cells from 5 independent experiments 
























Figure 2-5. F. alocis challenge does not induce azurophil granule exocytosis. 
Neutrophils were left unchallenged (basal), were pretreated with latrunculin-A (1 M, 30 min) 
followed by fMLF stimulation (Lat fMLF, 300 nM, 5 min), challenged with TNF (2 ng/ml, 10 min) 
followed by fMLF stimulation (TNF fMLF, 300 nM, 5 min), or challenged with F. alocis (MOI of 
10, 25, and 50 for 30 or 60 min). (A) Azurophil granule exocytosis was determined by the increase 
in plasma mem-brane expression of CD63 by flow cytometry. Data are expressed as mean mcf 
SEM from 3 independent experiments. (B) Extracellular release of myeloperoxi-dase (MPO), to 
determine azurophil granule exocytosis, was measured as described in Materials and Methods. Data 

























Figure 2-6. F. alocis interaction with TLR2 triggered secretory vesicle exocytosis. 
 (A) Neutrophils were left unchallenged (basal), challenged with F. alocis (M0I of 10, 30 min), or 
pretreated for 30 min with either anti-TLR2 MAb, anti-TLR4 MAb, or isotype control (isotype 
ctrol) followed by F. alocis challenge. (B) Neutrophils were left unchallenged (basal), challenged 
with LPS (100 ng/ml, 60 min), pretreated for 15 min with CLI-095 followed by LPS challenge, 
challenged with F. alocis, or pretreated with CLI-095 followed by F. alocis challenge. In both 
panels, secretory vesicle exocytosis was determined by the increase in plasma membrane 
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Figure 2-7. Blocking neutrophil granule exocytosis inhibits F. alocis-induced random and 
directed migration. 
Neutrophils were left unchallenged (control), stimulated with fMLF (300 nM, 5 min), treated with 
TAT-SNAP23 (10 min), pretreated with TAT-SNAP23 followed by fMLF stimulation, 
challenged with F. alocis (30 min), challenged with zymosan (Zy; 30 min), pretreated with TAT-
SNAP23 (10 min) followed by F. alocis challenge (TAT-SNAP23 F. alocis), or pretreated with 
TAT-SNAP23 followed by zymosan challenge (TAT-SNAP23 Zy). (A and B) Secretory vesicle 
and specific granule exocytosis were determined by the increase in plasma membrane expression 
of the CD35 or CD66b marker, respectively, by flow cytometry. Data are expressed as mean mcf 
SEM from 5 independent experiments. (C to F) Following cell stimulation or bacterial challenge, 
cells were placed in the upper chamber of the transwell system. After 30 min of incubation, the 
membrane was stained with a HEMA 3 stain set kit. Chemotaxis was assessed by light 
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microscopic examination (magnification, 100). (C and E) Buffer or fMLF (100 nM) was placed in 
the lower well. Data are means SEM from 5 independent experiments. (D and F) Buffer or IL-8 
(100 ng/ml) was placed in the lower well. Data are expressed as mean (SEM) number of migrated 



















Figure 2-8. Schematic representation of F. alocis-induced neutrophil granule exocytosis, 
random and directed migration. 
F. alocis binding to TLR2 on the neutrophil plasma membrane induces phosphorylation of 
ERK1/2 and p38 MAPK. Activation of p38 MAPK promotes the exocytosis of secretory vesicles 
and specific granules, which contribute to F. alocis-induced random and directed migration. F. 
alocis-induced neutrophil granule exocytosis, enhanced random migration and chemotaxis toward 





F. ALOCIS EVADES NEUTROPHIL OXYGEN-DEPENDEN KILLING MECHANISMS  
Introduction 
Neutrophils are the prominent immune cell in circulation and known as the earliest 
responders of the innate immune system (270). Highlighting the importance of neutrophils is the 
fact that in patients with decreased numbers of circulating neutrophils, there is an enhanced risk 
for morbidity and mortality from infection; additionally, patients with a neutrophil genetic 
disorder often encounter frequent and severe infections following microbial challenge (270-272).   
Following receptor-mediated phagocytosis of microbes, neutrophils are activated and 
utilize both oxygen-dependent and oxygen-independent killing mechanisms to kill their target 
(143, 273-275). The focus of our studies is on the oxygen-dependent respiratory burst response 
employed by human neutrophils in response to F. alocis challenge. Once the target is effectively 
internalized into the phagosome, a maturation process occurs where neutrophil granules fuse with 
the phagosome and release their antimicrobial compounds to cause an inhospitable environment 
(72). Additionally, granules can fuse with the plasma membrane, which results in the release of 
antimicrobial components into the extracellular space. Along with granule fusion to the 
phagosome or to the plasma membrane is the requirement of the activation of the NADPH 
oxidase complex at these sites, both processes occurring simultaneously (72). The NADPH 
oxidase complex can only become activated once its cytosolic components (p47phox, p67phox, 
p40phox, Rac) translocate from the cytosol and bind membrane components of the complex 
(gp91phox, p22phox). The necessity for a functional NADPH oxidase is demonstrated clearly in 
CGD patients, a genetic disorder, which results in mutations in components of the complex
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and renders an inactive oxidase and leads to severe and recurrent bacterial and fungal infection 
(276-280). 
After efficient NADPH oxidase assembly and activation and granule fusion, neutrophils 
will mount the oxidative respiratory burst response with generation of reactive oxygen species 
(ROS), which ultimately are responsible for killing targeted microbes, in the phagosome and in 
the extracellular space. It is believed that the degranulation and ROS production may function in 
concert and potentiate one another, leading to a highly efficient killing process employed by 
neutrophils (73).  
The respiratory burst response by neutrophils is named so due to the rapid increase in 
oxygen consumption by activated neutrophils and results from a step-wise production of 
superoxide from the NADPH oxidase complex which dismutates and yields H2O2, and in the 
presence of MPO and chloride, the potent HOCl is produced (143, 270, 281). The timing of 
superoxide production and whether this occurs at the plasma membrane or the phagosome 
depends on the type of stimulus encountered (282, 283). When neutrophils encounter soluble 
stimuli, like bacterial-derived peptide N-formyl-L-methionyl-L-leucyl-L-phenylalanine (fMLF), 
recognized by formyl peptide receptors (FPRs), the oxidase complex will assemble at the plasma 
membrane, targeting superoxide production in the extracellular space that usually lasts less than 5 
min. (282, 283). However, in the context of bacterial induction of the respiratory burst response, 
the NADPH oxidase complex assembly will be targeted for the phagosome, in order to ensure 
superoxide will be produced inside the phagosomal compartment containing the bacteria (127). 
Targeting ROS production to the phagosomal compartment is an effective strategy for 
neutrophils, as they will attempt to eliminate the bacteria without causing unnecessary host tissue 
damage, as can occur when superoxide is produced and released in the extracellular space. Is has 
been determined that the majority of intracellular pathogens are effectively controlled and 
eliminated through the respiratory burst response, as the response occurs rapidly (30-60 min post-
infection) and neutrophils produce large amounts of highly potent ROS, like HOCl (143).  
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Neutrophil priming is a pre-activation stage, where neutrophils are not fully active, but 
will become activated upon encountering a secondary stimulus (190). Once neutrophils are 
primed, they will induce an enhanced response to a secondary stimulus (284).  Priming agents, 
administered both in vitro (e.g. TNF- α, fMLF) and in vivo (e.g. GM-CSF, LPS, IL-8) turn on 
activation pathways without starting the activation process and they function to enhance fMLF-
induced ROS production (190). In the primed state, the NADPH oxidase begins to undergo a pre-
activation process which includes protein redistribution, partial phosphorylation of the cytosolic 
component, p47phox, as well as conformational changes; the activated state requires assembly of 
the complex (190). As observed in studies with LPS treatment of neutrophils, it enhances 
NADPH oxidase assembly and activation at the plasma membrane and simultaneously there is a 
pre-assembly of the neutrophil granules to the plasma membrane, which serves to pre-activate 
neutrophils (285). A regulated priming response induced by host- or bacterial- derived factors 
presents an effective immune surveillance mechanism that promotes host defense; however, an 
excessive priming response results in an excessive production of ROS, leading to host tissue 
damage (190). 
It has been documented that periodontal pathogens can induce neutrophil phagocytosis 
and intracellular and extracellular ROS production. ROS produced by neutrophils in response to 
bacterial plaque formation in the oral cavity plays a crucial role in antimicrobial killing (286-
289). However excessive uncontrolled ROS leads to a variety of detrimental host effects, 
including: damage to DNA and proteins, interference with cell growth and cell cycle progression 
and induction of apoptosis of the gingival fibroblasts (286, 290-293). Additionally, ROS can 
impact signaling involved with osteoclastogenesis, which leads to bone destruction and 
periodontal disease development (286, 294). ROS can directly stimulate the degradation of 
extracellular matrix (ECM) through breakdown of glycosaminoglycan and matrix proteinases 
(286, 295-297). Clinical studies have shown that markers of oxidative stress found in saliva could 
be used as biomarkers for periodontal disease (286, 298-301). 
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Periodontal pathogens like P. gingivalis, T. denticola, F. nucleatum and A. 
actinomycetemcomitans challenge neutrophils and activate them to produce potent antimicrobial, 
but tissue-destructive compounds like ROS, MMPs, elastases and pro-inflammatory cytokines 
(179, 302-305). Studies performed by Jayaprakash et al determined that P. gingivalis (ATCC3277 
strain) was effectively able to induce intracellular ROS production by human neutrophils, which 
led to only ~35% survival post neutrophil challenge (306). Peptoanaerobacter stomatis (P. 
stomatis), a newly appreciated oral pathogen, does not on its own induce much extracellular 
superoxide response by human neutrophils, however it has the ability to prime human neutrophils 
for an enhanced respiratory burst response to other stimuli, which may help the oral community 
(307). Although P stomatis induced a robust intracellular respiratory burst, it did not contribute to 
the neutrophil’s ability to effectively kill this organism (307). However, P. stomatis was 
susceptible to extracellular killing due to the release of antimicrobial contents from the neutrophil 
granules (307).  
As an evasion strategy from oxygen-dependent antimicrobial responses by neutrophils, 
numerous pathogens have developed interference mechanisms to avoid phagocytosis, prevent the 
fusion of neutrophil granules to the phagosome, and target the NADPH oxidase complex 
assembly and activation. This targeting of the NADPH oxidase of both neutrophils and 
macrophages is observed by gram-negative, gram-positive, anaerobic and aerobic bacteria (127, 
128, 132, 139, 140, 142, 285, 308-324). 
In this chapter, we demonstrate how F. alocis manipulates the human neutrophils in order 
to evade oxygen-dependent killing mechanisms. These results suggest that F. alocis is capable of 
surviving in the neutrophil phagosome and mounts a minimal intracellular respiratory burst 
response. Additionally, the bacterium does not produce a significant superoxide release; however, 
F. alocis challenge can prime human neutrophils to an enhanced respiratory burst response.   
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Results 
F. alocis survives both intracellularly and extracellularly up to 4 h post-neutrophil challenge. 
As neutrophils are function to recognize and kill their target, it is important to determine 
if neutrophils are effective in their ability to kill F. alocis or if the bacteria persist and survive. In 
order to determine F. alocis viability when challenged with neutrophils, we utilized BacLight 
viability dyes to assess the intracellular and extracellular bacterial viability. We challenged 
neutrophils with opsonized F. alocis for 0.5-2-4 h and then stained the bacteria using Syto9 
(membrane-permeable fluorescent dye that stains all bacteria) and PI (membrane-impermeable 
fluorescent dye that detects damaged or dead bacteria), which can distinguish the viability of 
individual bacteria (Fig. 3-1 A). Our data revealed that after 30 min of F. alocis challenge, ~65% 
remained viable inside the neutrophil, which increased to ~82% at 2 h, and then showed a non-
significant decrease to ~67% at 4 h (Fig. 3-1 B). However, when detecting extracellular viability 
of F. alocis, we saw a similar trend as with internal viable bacteria at 30 min (~66%) and 2 h 
(~71%), however a more pronounced decrease, although not statistically significant, in viability 
was observed at 4 h (~41%) (Fig. 3-1 C). F. alocis is able to survive after 4 hours post neutrophil 
challenge, which indicates neutrophils may be ineffective at clearing this pathogen through both 
intracellular and extracellular killing mechanisms. However, neutrophils are effective at 
eliminating pathogens like Shigella, Listeria, and Salmonella through the degradation of bacterial 
virulence factors, their delivery of potent antimicrobials (e.g. neutrophil elastase) or oxidants to 
the bacterial-containing phagosome (143). 
F. alocis induces minimal intracellular ROS but primes neutrophils. 
Having established that F. alocis can survive intracellularly, our laboratory set out to 
determine the intracellular respiratory response employed by human neutrophils in response to F. 
alocis challenge. In order to assess this, our laboratory performed flow cytometry to determine 
the respiratory burst produced by neutrophils challenged with F. alocis, as detected by the 
oxidation of DCF by the presence of reactive oxygen species. In comparison with known 
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intracellular ROS (iROS) stimulator S. aureus, both non-opsonized and opsonized viable F. 
alocis induced a minimal level of iROS, significantly less than opsonized S. aureus. However, 
opsonized heat-killed F. alocis induced a robust iROS response, similar to the level induced by 
opsonized S. aureus. Next, we sought to determine if upon F. alocis challenge, neutrophils 
generate ROS extracellularly.  
Neutrophils are also capable of performing extracellular killing mechanisms through the 
targeting of neutrophil granule exocytosis and the assembly of the NADPH oxidase complex at 
the plasma membrane, resulting in the extracellular release of ROS. In this mechanism, they 
release ROS from their cell membrane and kill targets that are not internalized into a phagosomal 
compartment within the neutrophil, but instead reside in the extracellular space. In order to 
determine if F. alocis challenge of neutrophils stimulated extracellular production of superoxide, 
the amount of superoxide release was measured using a spectrophotometer to detect the oxidation 
of ferricytochrome C. Neutrophils challenged with F. alocis showed minimal superoxide 
production across a time course (5-15-30-60-90-120-150 mins) compared with fMLF, a moderate 
superoxide stimulator (Fig. 3-2). However, in our time course studies, we observed that F. alocis 
pre-treatment primes neutrophils to a secondary stimulus, as we saw a time-dependent increase in 
fMLF-stimulated superoxide production compared to fMLF alone, a response similar to that 
observed with a positive control for neutrophil priming, TNF-α plus fMLF (Fig. 3-2).  This data 
also allowed us to conclude that 60 mins is the optimal time point for neutrophil priming induced 
by F. alocis and that at later time points this response plateaus (Fig. 3-2).  
Knowing that bacteria viability is an important determinant for F. alocis manipulation of 
intracellular ROS production, we next sought to determine if there was a difference in the 
production of extracellular superoxide. Similarly, to the studies performed with viable F. alocis 
(Fig. 3-2), we challenged neutrophils with heat-killed F. alocis at 60 mins time point (peak time 
observed in our time course in Fig. 3-2) and measured superoxide production. We observe that 
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similar to live bacterium, there was no induction of superoxide production with heat-killed F. 
alocis alone. Furthermore, a similar priming effect was observed, as the results obtained with 
viable F. alocis (Fig. 3-2, 3-3 A). In order to determine if secreted bacterial factors present in the 
spent supernatants of F. alocis culture were sufficient to stimulate superoxide production, we also 
challenged neutrophils with the spent supernatants of F. alocis and compared to the response 
elicited by viable F. alocis. Our data showed that similarly to viable and heat-killed F. alocis, the 
spent supernatants of F. alocis induce minimal superoxide production, however they are effective 
at priming the neutrophil (Fig.3- 3 B). These results help us to determine that F. alocis induces 
minimal extracellular ROS, however the bacteria are able to prime the fMLF-stimulated 
superoxide release.  
F. alocis challenge of human neutrophils resulted in signaling through a TLR 2/6-dependent 
mechanism. 
In order to combat organisms and particulates, neutrophils recognize and initiate binding 
of their target, undergo phagocytosis to engulf their target and then aim to control and kill using 
many of their potent antimicrobial killing mechanisms, eliminating threat to the host and 
maintaining homeostasis. In the context of our studies, we sought to characterize the human 
neutrophil ability to recognize, signal and employ its oxidative burst response to F. alocis 
challenge.  
Neutrophils recognize F. alocis through TLR2, which triggers degranulation and cell 
migration (325). However, TLR2 can form heterodimer with either TLR1 or TLR6, depending on 
the stimuli. Additionally, due to the data we obtained showing that F. alocis challenge primes 
neutrophils, we chose a priming assay to further help us to characterize the signaling of TLR2. In 
order to determine whether F. alocis stimulates signaling through TLR 2/1 or TLR 2/6, we used 
commercially available agonists, PAM3CSK4 (TLR 2/1) and FSL-1 (TLR 2/6) as positive 
controls. PAM3CSK4 is a synthetic triacylated lipopeptide that can mimic bacterial lipopeptides 
through its acylated amino terminus, is known to be a potent activator of pro-inflammatory 
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transcription factor, NF-κB, and is recognized by the TLR2/1 heterodimer. FSL-1 is a synthetic 
lipopeptide (derived from Mycoplasma salivarium) containing a diaglycerol structure, with 
diacylated cysteine resides and is recognized by the TLR2/6 heterodimer. Previous literature from 
Whitmore et al. observed that the PAM3CSK4 (TLR 2/1 agonist) was able to only prime 
neutrophils from certain donor populations to induce an enhanced respiratory burst response 
(284). However, neutrophils from all the donors exposed to FSL-1 (TLR 2/6 agonist) showed a 
primed neutrophil phenotype with an enhanced respiratory burst response (284) Using genotypic 
analysis, it was revealed that certain human patients have a single nucleotide polymorphism in 
TLR1 (rs5743618) that allows for an enhanced priming response by neutrophils, as their 
neutrophils have enhanced TLR1 surface expression (284). Therefore, we tested our donor 
population to identify high and low primers depending on the responses we obtained when 
neutrophils were exposed to PAM3CSK4.  Similarly to results obtained by Whitmore et al., we 
saw that PAM3CSK4 induced priming in only certain neutrophil donor populations, however FSL-
1 induced priming in neutrophils from all of our donor pool (Fig. 3-4 A-B). 
After exposing neutrophils to PAM3CSK4 or FSL-1 or challenging them with F. alocis 
for 60 min (based on the peak response we observed with our priming studies in Fig. 3-2), we 
determined the superoxide production. Our data showed that neutrophils primed with F. alocis 
and then stimulated with fMLF showed a robust superoxide response to the same extent as the 
priming positive control, TNF-α + fMLF and the TLR 2/6 agonist FSL-1 + fMLF (Fig.3-4 A-B). 
However, when neutrophils were primed with the PAM3CSK4 prior to exposure to fMLF, we 
observed a variable induction of superoxide response, as some donors showed a high priming 
response and some showed a low priming response to the TLR 2/1 agonist, PAM3CSK4 (Fig. 3-4 
A-B).  This data led us to conclude that F. alocis may signal through at TLR 2/6-dependent 
mechanism, based on the ability to prime neutrophils to the same extent as TLR 2/6 agonist, FSL-
1.  
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Similar percent recruitment of membrane and some of the cytosolic NADPH oxidase components 
to F. alocis and HK-F. alocis phagosomes. 
Following effective phagocytosis, neutrophils rely on the rapid assembly and activation 
of the NADPH oxidase complex, to effectively utilize its oxygen-dependent killing mechanisms. 
The NADPH cytosolic components (p47phox, p67phox, p40phox, GTP-Rac2) upon cell stimulation 
will be translocated and phosphorylated to dock on the cell phagosome or plasma membrane and 
bind along with membrane components (cytochrome b558 consisting of gp91phox, p22phox). The 
translocation and phosphorylation of these components is a rapid process, occurring within 30 
seconds of cell stimulation. Once the complex is fully assembled and phosphorylated, only then 
will the oxidative burst response will be initiated. After initiating the oxygen-dependent killing 
responses, the cytosolic components will be de-phosphorylated and disassemble from the 
phagosomal membrane, ensuring the oxidative burst response is halted as it should be tightly 
controlled to ensure unnecessary host damage. 
 Therefore, since viable, but not heat-killed, F. alocis induced minimal intracellular ROS 
production, we sought to determine if this was due to the ability of F. alocis to prevent or delay 
recruitment of all or some of the NADPH oxidase components. In order to more closely 
determine the role of NADPH oxidase assembly upon neutrophil challenge with F. alocis, we 
used confocal immunostaining to detect oxidase components and their localization to the 
bacterial-containing phagosome. Several studies in human and mice neutrophils show that 
different pathogenic microbes can prevent or delay ROS production when 40% or less of the 
oxidase components were recruited to the phagosomal structure (127, 128, 132, 139, 140, 142, 
285, 308-324). 
  We first assessed the recruitment of the membrane components gp91phox (Fig. 3-5A) and 
p22phox (Fig. 3-6 A) at an early time point using neutrophils challenged for 15 mins with CFSE-
labeled opsonized viable or CFSE-labeled opsonized heat-killed F. alocis. Our data showed that 
gp91phox was effectively recruited to the live (67%) or heat-killed (70%) bacteria-containing 
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phagosomes. Also, p22phox (65%, 69%) was effectively recruited to live (65%) or heat-killed 
(69%) bacteria-containing phagosomes (Fig. 3-5-6). There was a significant enhancement in 
gp91phox and p22phox positive phagosomes exposed to the positive control used for this assay, 
opsonized Zymosan (95% gp91phox, 90% p22phox), which is known to effectively stimulate 
efficient oxidase assembly, at early time points (127, 309, 317, 324). Recruitment of p47phox is 
essential for a functional oxidase, and several pathogenic bacteria prevent its recruitment to 
compromise the ROS production (127, 309, 311, 321) (314, 316) (308, 314) As the assembly, 
activation and disassembly of the NADPH oxidase complex is a dynamic process, we sought to 
determine the recruitment of the components at 15-30-60 min time points. At later time points, it 
is expected that the NADPH oxidase complex will deactivate and disassemble. Hence, we 
assessed recruitment of p47phox to live or heat-killed F. alocis phagosomes at different time points 
of 15-30 and 60 min post challenge (Fig. 3-7A).  At the 15-30 mins time point, it was observed 
that p47phox was effectively recruited to the phagosomal membrane containing viable (60%-15 
mins, 65%-30 mins) or heat-killed (60%-15 mins, 65%-30 mins) (Fig. 3-7 B). F. alocis, to a 
similar extent. Positive control Zymosan more effectively recruited p47phox to its phagosome 
compared with viable or heat-killed F. alocis at 15 mins (96%) (Fig. 3-7 B). However, at 30-60 
mins, as expected based on previous literature (127), p47phox begins to dissociate from the 
phagosomal membrane containing Zymosan (31%-15 mins, 18%-60 mins) (Fig. 3-7 B).  Our data 
showed that at 60 mins, p47phox starts to dissociate from the phagosome in neutrophils challenged 
with viable F. alocis (42%), however this trend is not the same as with the heat-killed F. alocis 
(52%), which retains p47phox to the phagosome (Fig. 3-7 B).  
  It was observed that p67phox was observed to be effectively recruited to the phagosomal 
membrane containing viable (63%) or heat-killed (64%) F. alocis, to a similar extent (Fig. 3-8). 
Positive control Zymosan more effectively recruited p67phox to its phagosome compared with 
viable or heat-killed F. alocis at 15 mins (94%) (Fig. 3-8).  
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  However, when we assessed the recruitment of p40phox to the F. alocis-containing 
phagosome at 15 mins, we saw significant differences in the percent positive phagosomes 
between viable and heat-killed F. alocis, 46% and 60%, respectively (Fig. 3-9 A, B). Positive 
control Zymosan more effectively recruited p40phox to its phagosome compared with viable or 
heat-killed F. alocis at 15 mins (83%) (Fig. 3-9 B). This delay in recruitment of p40phox to the 
viable F. alocis-containing phagosome could help explain the impaired induction of the 
intracellular respiratory burst response, as compared with the heat-killed F. alocis-containing 
phagosome. At the 30-60 mins time point, we saw effective recruitment of p40phox to both the 
viable (65%-30 mins, 66%-30 mins) and heat-killed (65%-30 mins, 75%-60 mins) F. alocis 
phagosomes (Fig. 3-9 B). Similar to what was observed with the disassembly of p47phox, our data 
showed that p40phox begins to dissociate from the Zymosan containing phagosomes (127) at 30 
mins (31%) and 60 mins (13%), as expected (Fig. 3-9 B). While the p47phox is disassembling from 
the bacterial-containing phagosome at later time points, as expected, the p40phox is retained on the 
bacterial-containing phagosome.  
Impaired Rac activation when neutrophils were challenged with F. alocis. 
Another important cytosolic component of the NADPH oxidase complex that is activated 
and recruited to the bacterial-containing phagosome is the small GTP-bound Rac2.  As it was 
determined that GTPase Rac is critical for regulating and activating the NADPH oxidase 
complex, we next wanted to determine its recruitment capabilities to an F. alocis-containing 
neutrophil phagosome. We performed a time course (6-15-30-60 mins) study using a G-protein 
activation assay to detect the GTP-bound form of Rac from neutrophil lysates collected from 
neutrophils challenged with opsonized viable F. alocis and opsonized heat-killed F. alocis. As 
fMLF is a known Rac activator after exposure at early time points, we used this as our positive 
control for induction. Our data suggests that there is an impaired Rac activation with viable F. 
alocis compared to heat-killed F. alocis at the 30 min time point (Fig. 3-10). The ineffective Rac 
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activation could help to explain the impaired induction of the intracellular respiratory burst 
response seen with the viable F. alocis.  
Discussion 
Neutrophil oxidative killing mechanisms are employed when these cells become 
activated by a stimulus at a site of injury or inflammation. It has been implicated that bacterial 
survival is dependent on manipulating neutrophils ability to perform phagocytosis and induce an 
ROS response (127). As neutrophils effectively employ their respiratory burst response upon 
challenge with numerous bacterial and fungal pathogens, these pathogens must utilize their stress 
response mechanisms to ensure avoidance or evasion of the neutrophil, leading to their 
persistence and survival (326). It is known that neutrophils are efficiently recruited and found in 
the oral cavity, therefore the studies into the killing mechanisms at this site are important to 
determine in the context of F. alocis infection and further periodontal disease. We determined 
that F. alocis manipulates neutrophil oxygen-dependent killing mechanisms to promote its 
survival both intracellularly and extracellularly.  
Bacteria are known to employ a variety of mechanisms to counter-act killing mechanisms 
employed by neutrophils, including: inhibiting the oxidative burst in the phagosome (F. 
tularensis, H. pylori), inhibiting the V-ATPase activity, blocking neutrophil granule fusion with 
the phagosomal compartment (Mycobacteria, S. pyogenes, Salmonella), using catalase to disrupt 
the production of oxidative metabolites, employing proteases to target host factors and also 
producing pore-forming enzymes to allow for phagosomal escape (F. tularensis, S. pyogenes). 
Some bacterial pathogens are able to effectively replicate inside neutrophils, these include: A. 
phagocytophilium, C. trachomatis, L. pneumophila (143, 144). 
After internalization by neutrophils, Staphylococcus aureus upregulates agr virulence 
genes which allows for it to survive inside the neutrophil, potentially through the use of 
membrane lytic toxins (326, 327). Catalase aids S. aureus survival by protecting the bacterium 
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once it has been internalized, through the conversion of hydrogen peroxide to oxygen and water 
(328, 329). S. aureus secretes cytolytic toxins to protect itself from killing both inside the 
phagosome and in the extracellular space (329). Through the use of proteins that can sense 
oxidation and in turn act as transcriptional regulator of antioxidant enzyme production, S. aureus 
can facilitate defense mechanisms against neutrophils (328). Periodontal pathogen, A. 
actinomycetemcomitans, damages neutrophils through the production of leukotoxins, allowing 
them to dampen the immune responses and cause more destruction of periodontal tissue (330). 
Additionally, through sensing the production of hydrogen peroxide, A. actinomycetemcomitans 
upregulates genes that allow this bacterium to effectively resist neutrophil killing (331). Bacteria 
can impair numerous steps involved in the activation and use of oxidative-killing mechanisms by 
neutrophils, highlighting the importance of elucidating these secreted virulence factors and their 
functions (332). As little is known regarding the virulence factors F. alocis possesses, it is 
possible that the survival of our bacterium is mediated through virulence genes, proteins or 
enzymes.  
Through the manipulation of granule targeting and fusion to the bacterial phagosome, N. 
gonorrhoeae avoids killing by neutrophils, remaining viable intracellularly (319, 333, 334). 
Studies performed in our laboratory reveal that specific and azurophil granule fusion to the 
membrane of the F. alocis-containing phagosome is impaired, which can reduce the antimicrobial 
capacities of neutrophils targeting the phagosome, further promoting bacterial survival.  
Additionally, pathogens can use superoxide dismutase (SOD) or catalase to mediate the 
effects of ROS production, as they are capable of catabolysis and detoxification (326, 335). As 
observed with S. aureus, it is critical for bacterial survival to demonstrate an effective means for 
reduce or inhibit ROS production. S. aureus scavenges and neutralizes ROS (superoxide and 
H2O2) through the use of SODs (SodA and Sod M) and catalases (336-338). Additionally, S. 
aureus uses staphyloxanthin to evade neutrophil killing as it serves as an antioxidant against 
peroxide and singlet oxygen (329, 339). Psuedomonas aeruginosa is able to effectively scavenge 
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neutrophil ROS (hydrogen peroxide and superoxide) through the kynurenine pathway, which 
catabolizes tryptophan, in order to evade the innate immune response (340). It is possible that F. 
alocis may utilize superoxide reductase(64) to scavenge and neutralize ROS, as an effective 
survival strategy.  
Another mechanism of avoidance of neutrophil killing mechanisms is observed with 
microbial siderophores, which function in scavenging iron, neutralizing the neutrophils from 
effectively utilizing their antimicrobial radical oxygen species production (341). Neutrophils also 
rely on iron for the production of their oxidative burst response and their pro-inflammatory 
mediators (like MPO, NADPH oxidase) are part of the heme family proteins (341, 342). As iron 
is a critical nutrient for certain microbes, they employ an iron chelator to steal iron from their host 
once the host induces a stressful hypoferremic state of low iron (341, 343). E. coli encodes for 
Ent, a siderophore, that is observed to inhibit neutrophil functions, like ROS (341). Bacterial 
siderophores have far-reaching implications, as they are not merely responsible for the 
scavenging of iron, but also can be involved in the production of immunoregulatory metabolites 
(341). Through the use of small molecule thiols, which are highly reactive with the ROS 
produced by neutrophils, bacteria generate thiols as a defense strategy to combat neutrophil 
killing capabilities by ROS  (328, 344-346). As we see that F. alocis has iron binding domains 
(64), this could aid the bacterium in scavenging iron, which may effectively promote its survival 
despite neutrophils employing their killing mechanisms.  
Due to the rapid assembly of the NADPH oxidase complex, most microbes effectively 
internalized by neutrophils will be killed within 30-60 min (143, 347). Additionally, it has been 
reported that the NADPH oxidase assembly and activation play a role in inflammatory disease 
development (like rheumatoid arthritis) (135, 348-350). As an evasion and survival strategy from 
the effects of the potent ROS response by neutrophils, numerous pathogens have developed 
interference mechanisms targeted at the NADPH oxidase complex assembly and activation (See 
Table 1). F. alocis appears to behave similarly to the microorganism S. aureus and the yeast 
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particle Zymosan, in its ability to effectively induce recruitment of NADPH oxidase components 
to the phagosome. Additionally, as expected based on the NADPH components being effectively 
recruited, S. aureus produces a robust intracellular respiratory burst response.  However, in our 
studies, F. alocis manipulates neutrophils, as the recruitment of the complex to the phagosome is 
unaffected, yet a minimal respiratory burst response is produced.  
Previous studies highlight the importance of NADPH oxidase assembly for activation and 
induction of the respiratory burst response by neutrophils (132). In our studies, there does not 
seem to be an impaired recruitment of the NADPH oxidase components to the bacterial-
containing phagosome, however challenging neutrophils with F. alocis results in a minimal 
respiratory burst response. Therefore, it may be important to consider if the F. alocis is able to 
manipulate the neutrophils to retain components, that may be dysfunctional, to the phagosomal 
compartment, as observed in our studies with p40phox. Additionally, there could be an impairment 
in the recycling in of “fresh” subunits, which is required for a sustained oxidase activation. 
Through the kinetic studies performed by Karimi et al, it was determined that the proteins must 
all be activated simultaneously, as even a short delay of 10 seconds resulted in decreased activity 
(351). In our studies, F. alocis could be manipulating the timing of the activation of the 
components of the NADPH oxidase complex, leading to an ineffective respiratory burst response. 
Neither virulent nor avirulent strains of F. tularensis were effectively killed by neutrophils and 
~70% of internalized bacteria remained viable 2-4-8 hrs after neutrophil challenge (128). The live 
vaccine strain of F. tularensis (LVS) induces a minimal respiratory burst response compared to 
formalin or periodate- killed LVS as assessed by NBT staining (347).  LVS may impact a 
signaling pathway involved in ROS production, as it showed that it can block NADPH oxidase 
activity once it is triggered by a known stimulus like PMA or zymosan. Given the results 
observed by LVS, it is possible that in our studies, F. alocis can trigger the translocation of the 
NADPH oxidase complex, however it can block the enzyme activity.  
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The NADPH oxidase complex is a finely-tuned machine and can operate through varied 
mechanisms of assembly-activation-disassembly-inactivation, depending on the stimuli 
encountered. Numerous studies point to factors involved to impact component recruitment and 
phosphorylation, all of which can affect the magnitude of the respiratory burst produced, which 
can help to explain our observations with F. alocis.  Interestingly, it has been reported in studies 
with receptor-mediated stimulation that the phosphorylation of both p47phox and p67phox could be 
dissociated from the function of translocation or that a certain degree of phosphorylation must be 
attained before translocation can occur (352). It has also been determined that translocation of 
phox proteins requires a phosphorylated p47phox at multiple serine residue sites (143, 317); which 
could lead us to interpret that despite effective translocation of our NADPH oxidase components, 
phosphorylation status has yet to be determined, which could help to explain the low iROS 
response produced by neutrophils challenged with F. alocis. Also, studies have suggested that 
phosphorylation may not be the only protein modification on the NADPH oxidase components 
that is necessary for translocation and activation of the NADPH oxidase complex, as calcium 
release and electron transfer may also play a role (352-354). Additionally, it was reported that the 
NADPH oxidase complex can assemble properly, however an impairment in the electron transfer 
resulted in minimal production of ROS (276, 355). 
Our results also suggest that viability could be a factor in the assembly, activation, and 
disassembly of the p40phox component, as heat-killed F. alocis retained this component on the 
phagosome to induce a more robust and sustained downstream ROS response. Additionally, 
viable F. alocis may be required for disassembly and inactivation of the oxidase complex, as by 
60 mins the heat-killed F. alocis retained p47phox to the phagosomes, where viable F. alocis did 
not. Studies performed by Keith et al with B. cenocepacia demonstrated that viable bacteria could 
delay assembly and recruitment of the NADPH oxidase complex, however heat-inactivated 
bacteria could not (320). p40phox ability to effectively bind to PI3Ps is crucial for necessary high-
level intracellular production of ROS effective in killing (142), which may be the case in the 
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context of F. alocis challenge, as there is minimal ROS production and impaired p40phox 
recruitment at 15 mins. At the later time points, p40phox is effectively recruited and retained, but it 
is unclear whether it is bound to the PI3P. The importance of this binding interaction was 
demonstrated in mice lacking p40phox or a mutant PX domain, where it was observed that in vitro 
oxidant-dependent killing was reduced to the level of complete absence of NADPH activity 
(142). 
Kinase signaling, like PKC and PI3P, is involved in phosphorylation of the NADPH 
oxidase components (356), therefore the possibility exists that F. alocis could manipulate these 
pathways. The GTP-Rac is deemed necessary for the activation of the kinases that ensure 
phosphorylation of oxidase components (356). Multiple pathways have been implicated to be 
involved in regulating Rac2 and how its deficiency leads to deficient superoxide production (136, 
357-359). Downstream effector neutrophil functions are regulated by Rac2, especially those 
involved in chemotaxis and Fc receptor signaling (136). Using Rac-2 deficient studies, it was 
determined that GTPase Rac is critical for regulating the NADPH oxidase and that the GTP-
bound form Rac is necessary for activation and further catalytic functions of the complex (145, 
356). As our studies revealed an impaired activation of GTP-bound Rac induced by neutrophils 
challenged with viable F. alocis, this could help to explain a way that our bacterium manipulates 
neutrophils to produce a minimal respiratory burst response.  
The final battle of host and pathogen results in either success of the host, by elimination 
of the pathogen or success of the pathogen, by survival and persistence in the host. We saw that 
F. alocis effectively over time remains viable and resistant to intracellular and extracellular 
oxygen-dependent killing mechanisms utilized by neutrophils. This indicates further implications 
for periodontal disease development, as neutrophils may lose the host-pathogen battle, leaving 
room for the manipulative F. alocis to survive and persist while promoting chronic inflammation. 
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Table 1. NADPH oxidase component assembly and activation impairment upon challenge  
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Material and Methods 
Neutrophil isolation 
Neutrophils were isolated from blood of healthy donors using plasma-Percoll gradients as 
previously described (146), and in accordance with the guidelines approved by the Institutional 
Review Board of the University of Louisville.  Microscopic evaluation of the isolated cells showed 
that > 95% of the cells were neutrophils. Trypan blue exclusion indicated that > 97% of cells were 
viable.   
Bacterial strains and growth conditions.  
F. alocis ATCC 38596 was cultured in brain heart infusion (BHI) broth supplemented with 
L-cysteine (0.1%) and arginine (20%) for 7 days anaerobically at 37°C as previously described [27, 
42].  Opsonized F. alocis was prepared in 10% normal human serum at 37°C for 20 min and cultures 
were washed three times with PBS prior to use (Complement Technology, Tyler, Texas). For 
viability studies, heat killed F. alocis was generated by incubation at 90 °C for 60 min. For 
fluorescence microscopy assays, CFSE-labeled F. alocis was labeled with CFSE (4 mg/mL) for 30 
mins at room temperature in the dark, and the cultures were washed three times with PBS prior to 
use. 
BacLight assay. 
The combination of two DNA dyes, membrane-permeable Syto9 (stains all bacteria) and 
membrane-impermeable propidium iodide (PI) (stains only nonviable bacteria), was used to 
determine bacteria viability associated with human neutrophils as previously described (360). 
Human neutrophils (2 x 106 cells/mL) were settled on human serum-coated coverslips, incubated 
in RPMI 1640 with 10% fetal bovine serum, and challenged with opsonized F. alocis (MOI 10) 
and centrifuged at 600 x g for 4 min at 14°C to synchronize phagocytosis. Following challenge of 
0.5-2-4 h, in a cell culture incubator at 37°C, mixed dye solutions (5 µM Syto9, 30 µM PI in 0.1 
MOPS (morpholinepropanesulfonic acid) (pH 7.2)–1 mM MgCl2) were added to samples. 
Confocal images were acquired within 30 min using a Fluoview FV1000 confocal microscope and 
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analyzed by FV-10ASW software. Quantification was performed by counting the total viable and 
nonviable bacteria both intracellularly and extracellularly from 100 neutrophils in 3 independent 
experiments. 
Extracellular respiratory burst response. 
Human neutrophils (4 x 106 cells/mL) were left unstimulated or were challenged with 
fMLF (300 nM; Sigma) for 5 min or with F. alocis for 5, 15, 30, 60, 90, 120, 150 min or with heat-
killed F. alocis for 60 mins or with spent supernatant from F. alocis for 60 mins or with PAM3CSK4 
(1 µg/mL, Invivogen) for 30 mins or with FSL-1 (100 ng/mL, Invivogen) for 30 mins at 37°C. For 
neutrophil priming assays, neutrophils were pretreated with TNF-α (2 ng/ml) for 10 min or with 
heat-killed F. alocis for 60 mins or with spent supernatant from F. alocis for 60 mins or with 
PAM3CSK4 (1 µg/mL, Invivogen) for 30 mins or with FSL-1 (100 ng/mL, Invivogen) for 30 mins 
at 37°C, followed by stimulation with fMLF (300 nM) for 5 min. After stimulation, the samples 
were centrifuged for 10 min at 600 x g and 4°C, and supernatants were collected. Superoxide anion 
release was measured spectrophotometrically at 550 nm as the superoxide dismutase-inhibitable 
reduction of ferricytochrome c as previously described (146).  
NADPH oxidase immunofluorescence microscopy.  
To assess localization of NADPH oxidase subunits to F. alocis-infected neutrophils, we 
used previously established methods (127). Briefly, human neutrophils (2 x 106 cells/mL) were 
plated onto serum-coated coverslips in RPMI 1640 with 10% fetal bovine serum and then 
infected with F. alocis at an MOI of 10:1 or with Zymosan (2 mg/mL). Phagocytosis was 
synchronized by centrifugation at 600 x g at 14°C and after 15-30-60 min in a 37°C cell culture 
incubator, samples were washed with PBS, fixed in 10% formalin, permeabilized in -20°C 
acetone/methanol solution, and then blocked in buffer containing PBS + 0.02% saponin with 10% 
goat serum. Cells were stained with antibodies to gp91phox (Santa Cruz Biotechnology, sc-130543, 
1:1000) or p22phox (Santa Cruz Biotechnology, sc-130550, 1:500) or p67phox (BD Biosciences, 
610912, 1:500) or p47phox (BD Biosciences, 610354, 1:500) or p40phox (Abcam, ab76158, 1:500). 
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Secondary antibodies were conjugated to AlexaFluor 555 (Life Technologies, 1:500) or 
AlexaFluor 647 (Life Technologies, 1:1000) and DAPI (3 µM) was applied for 5 min at room 
temperature as a nuclear stain. Confocal images and z-stacks (1-µm thickness for each slice) were 
obtained using a Fluoview FV1000 confocal microscope with a 63X oil objective to determine 
NADPH oxidase component recruitment to bacterium or particulate-containing phagosomes. To 
quantify the enrichment of the phagosomes for each NADPH oxidase component, 100 neutrophils 
were counted per condition, and if ≥ 50% of the phagosome was surrounded by the component, it 
was considered positive recruitment.  
Rac activation assay. 
Human neutrophils (18 x 106 cells/condition) were left unstimulated, challenged with 
fMLF (300 nM), or with opsonized F. alocis or with opsonized heat-killed F. alocis at an MOI of 
10 for 6 min, or challenged with opsonized F. alocis or with opsonized heat-killed F. alocis at an 
MOI of 10 for 15 min, or challenged with opsonized F. alocis or with opsonized heat-killed F. 
alocis at an MOI of 10 for 30 min, or left unstimulated or challenged with opsonized F. alocis or 
with opsonized heat-killed F. alocis at an MOI of 10 for 60 min. Samples were collected, processed, 
and analyzed according to manufacturer’s protocol (Rac 1/2/3 G-LISA activation assay, 
Cytoskeleton, Inc.) Briefly, following challenge, cells were washed and lysed in cell lysis buffer. 
Lysates were snap frozen in liquid nitrogen to ensure samples collected were GTP-bound Rac. 
After measuring protein concentration and equalizing the lysates, lysates were added to Rac-GTP 
binding 96-well plate. Lysates were bound to plate in provided binding buffer on a cold orbital 
microplate shaker (200 rpm) at 4°C for 30 min. Following washes, the plate was incubated with 
anti-Rac primary antibody on the orbital microplate shaker (200 rpm) at room temperature for 45 
min. Following washes, the plate was incubated with HRP-labeled secondary antibody on the 
orbital microplate shaker (200 rpm) at room temperature for 45 min. Following washes, the plate 
was incubated with HRP detection reagents at room temperature for 20 min. Following the 20 min 
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incubation, HRP Stop Buffer was added to each well. The signal, detecting GTP-bound Rac, was 
measured at 490 nm using a SpectraMax Soft Max Pro 5.4 spectrophotometer. 
Statistical analysis. 
For all the experimental conditions tested in this study, the statistical analysis used was a 
one-way ANOVA with the Tukey-Kramer multiple-comparison test (GraphPad Prism software, 
San Diego, CA, USA).  Differences were considered statistically significant at the level of P <0.05.  
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Figure 3-1. F. alocis remains viable intracellularly and extracellularly up to 4 h post-
neutrophil challenge.   
Neutrophils were challenged with opsonized F. alocis for 0.5-2-4 h. (A) Representative confocal 
image of viable (green) and nonviable (red) F. alocis, which were distinguished by using the 
BacLight viability dyes Syto9 and PI. White solid arrow indicates viable intracellular bacteria; 
White dashed arrow indicates nonviable intracellular bacteria; Blue solid arrow indicates viable 
extracellular bacteria; Blue dashed arrow indicates nonviable extracellular bacteria. N, neutrophil 
nucleus. (B) Percentage of viable intracellular bacteria from 100 neutrophils from 4 independent 
experiments (0.5 h) time point and from 3 independent experiments (2-4 h) time points. ns, 
nonsignificant (C) Percentage of viable extracellular bacteria from 100 neutrophils from 3 



























5                15              30              60              90               120            150
+    +    +   +     +   +     +    +    +   +    +    +    +    + F. alocis


























Figure 3-2. Neutrophils challenged with F. alocis produce minimal extracellular ROS 
production, but can prime neutrophils to secondary stimuli. 
Neutrophils were unchallenged (Basal), stimulated with fMLF, or challenged with non-opsonized 
F. alocis for 5-15-30-60-90-120-150 min, or pre-treated with TNF-α followed by fMLF 
stimulation, or challenged with non-opsonized F. alocis for 5-15-30-60-90-120-150 min followed 
by fMLF stimulation. Following stimulation, extracellular production of superoxide was 
measured by the colorimetric reduction of ferricytochrome c. Data are expressed as the means ± 




















Figure 3-3. Neutrophils challenged with heat-killed F. alocis and F. alocis spent supernatant 
produce minimal extracellular ROS production, but can prime neutrophils to secondary 
stimuli. 
(A) Neutrophils were unchallenged (Basal), stimulated with fMLF, or challenged with non-
opsonized viable F. alocis for 60 min, or with non-opsonized heat-killed F. alocis (HK-F. alocis) 
for 60 min, or pre-treated with TNF-α followed by fMLF stimulation, or challenged with viable 
F. alocis for 60 min followed by fMLF stimulation, or challenged with heat-killed F. alocis for 
60 min followed by fMLF stimulation (HK-F. alocis + fMLF). Following stimulation, 
extracellular production of superoxide was measured by the colorimetric reduction of 
ferricytochrome c. Data are expressed as the means ± SEM of [O2-] nanomoles per 4 x 106 cells 
released from 6 independent experiments. *** p < 0.0001. (B) Neutrophils were unchallenged 
(Basal), stimulated with fMLF, or challenged with viable F. alocis for 60 min, or with F. alocis 
spent supernatants (Spent sup) for 60 min, or pre-treated with TNF-α followed by fMLF 










































































































































challenged with F. alocis spent supernatants for 60 min followed by fMLF stimulation (Spent sup 
+ fMLF). Following stimulation, extracellular production of superoxide was measured by the 
colorimetric reduction of ferricytochrome c. Data are expressed as the means ± SEM of [O2-] 
nanomoles per 4 x 106 cells released from 3 independent experiments. * p < 0.05, ** p < 0.001. 































































































































































 Figure 3-4. F. alocis challenge of human neutrophils may signal through TLR 2/6 
Neutrophils were unchallenged (Basal), stimulated with fMLF, challenged with non-opsonized F. 
alocis or stimulated with PAM3CSK4 or stimulated with FSL-1, or pre-treated with TNF-α, non-
opsonized F. alocis, PAM3CSK4, FSL-1 followed by stimulation with fMLF. Following the 
different stimulation, extracellular production of superoxide was measured by the colorimetric 
reduction of ferricytochrome c. Data are expressed as the means ± SEM of [O2-] nanomoles per 4 
x 106 cells released from 5 independent experiments (Fig. 3-4 A) or from 4 independent 






































































Figure 3-5. No difference in recruitment of gp91phox to bacteria-containing phagosomes 
between live and heat-killed F. alocis. 
(A) Neutrophils were left unchallenged or challenged with opsonized Zymosan, or with 
opsonized CFSE-labeled heat-killed F. alocis (HK-F. alocis) or with opsonized CFSE-labeled 
viable F. alocis (F. alocis). Following challenge of 15 mins, cells were fixed, permeabilized, and 
stained with gp91phox antibody to visualize its recruitment to the bacterium or particulate-
containing phagosome by confocal microscopy. (B) Approximately 100 infected cells per 
condition were examined, and phagosomes were labeled as gp91phox positive if ≥ 50% of the 
phagosome was surrounded by gp91phox. Solid arrows indicate gp91phox positive phagosomes and 
dashed arrows indicate gp91phox negative phagosomes. Data are expressed as the means ± SEM of 
the percentage of gp91-phox positive phagosomes from 3 independent experiments. * p < 0.05. 
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Figure 3-6. No difference in recruitment of p22phox to bacteria-containing phagosomes 
between live and heat-killed F. alocis. 
(A) Neutrophils were left unchallenged or challenged with Zymosan, or with CFSE-labeled heat-
killed opsonized F. alocis (HK-F. alocis) or with CFSE-labeled viable opsonized F. alocis (F. 
alocis). Following challenge of 15 mins, cells were fixed, permeabilized, and stained with p22phox 
antibody to visualize its recruitment to the bacterium or particulate-containing phagosome by 
confocal microscopy. (B) Approximately 100 infected cells per condition were examined, and 
phagosomes were labeled as p22phox positive if ≥ 50% of the phagosome was surrounded by 
p22phox. Solid arrows indicate p22phox positive phagosomes and dashed arrows indicate p22phox 
negative phagosomes. Data are expressed as the means ± SEM of the percentage of p22phox 





























































Figure 3-7. No difference in recruitment of p47phox to bacteria-containing phagosomes 
between live and heat-killed F. alocis at 15-30 mins. 
(A) Neutrophils were left unchallenged or challenged with Zymosan, or with CFSE-labeled heat-
killed opsonized F. alocis (HK-F. alocis) or with CFSE-labeled viable opsonized F. alocis (F. 
alocis). Following challenge of 15 mins, cells were fixed, permeabilized, and stained with p47phox 
antibody to visualize its recruitment to the bacterium or particulate-containing phagosome by 
B 
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confocal microscopy. (B) At 15 mins post F. alocis challenge, approximately 100 infected cells 
per condition were examined, and phagosomes were labeled as p47phox positive if ≥ 50% of the 
phagosome was surrounded by p47phox. Solid arrows indicate p47phox positive phagosomes and 
dashed arrows indicate p47phox negative phagosomes. Data are expressed as the means ± SEM of 
the percentage of p47phox positive phagosomes from 3 independent experiments. ** p<0.01, *** p 
< 0.0001. ns, nonsignificant. At 30 mins post F. alocis challenge, approximately 100 infected 
cells per condition were examined, and phagosomes were labeled as p47phox positive if ≥ 50% of 
the phagosome was surrounded by p47phox. Data are expressed as the means ± SEM of the 
percentage of p47phox positive phagosomes from 3 independent experiments. *** p < 0.0001. At 
60 mins post F. alocis challenge, approximately 100 infected cells per condition were examined, 
and phagosomes were labeled as p47phox positive if ≥ 50% of the phagosome was surrounded by 
p47phox. Data are expressed as the means ± SEM of the percentage of p47phox positive phagosomes 
































































                                




























Figure 3-8. No difference in recruitment of p67phox to bacteria-containing phagosomes 
between live and heat-killed F. alocis. 
 (A) Neutrophils were left unchallenged or challenged with Zymosan, or with CFSE-labeled heat-
killed opsonized F. alocis (HK-F. alocis) or with CFSE-labeled viable opsonized F. alocis (F. 
alocis). Following challenge of 15 mins, cells were fixed, permeabilized, and stained with p67phox 
antibody to visualize its recruitment to the bacterium or particulate-containing phagosome by 
confocal microscopy. (B) Approximately 100 infected cells per condition were examined, and 
phagosomes were labeled as p67phox positive if ≥ 50% of the phagosome was surrounded by 
p67phox. Solid arrows indicate p67phox positive phagosomes and dashed arrows indicate p67phox 
negative phagosomes. Data are expressed as the means ± SEM of the percentage of p67phox 

































































Figure 3-9. Impaired recruitment of p40phox to viable F. alocis-containing phagosomes at 15 
and 60 mins. 
 (A) Neutrophils were left unchallenged or challenged with Zymosan, or with CFSE-labeled heat-
killed opsonized F. alocis (HK-F. alocis) or with CFSE-labeled viable opsonized F. alocis (F. 
B 
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alocis). Following challenge of 15 mins, cells were fixed, permeabilized, and stained with p40phox 
antibody to visualize its recruitment to the bacterium or particulate-containing phagosome by 
confocal microscopy. (B) At 15 mins post F. alocis challenge, approximately 100 infected cells 
per condition were examined, and phagosomes were labeled as p40phox positive if ≥ 50% of the 
phagosome was surrounded by p40phox. Solid arrows indicate p40phox positive phagosomes and 
dashed arrows indicate p40phox negative phagosomes. Data are expressed as the means ± SEM of 
the percentage of p40phox positive phagosomes from 3 independent experiments. *** p < 0.0001. 
At 30 mins post F. alocis challenge, approximately 100 infected cells per condition were 
examined, and phagosomes were labeled as p40phox positive if ≥ 50% of the phagosome was 
surrounded by p40phox. Data are expressed as the means ± SEM of the percentage of p40phox 
positive phagosomes from 3 independent experiments. *** p < 0.0001. At 60 mins post F. alocis 
challenge, approximately 100 infected cells per condition were examined, and phagosomes were 
labeled as p40phox positive if ≥ 50% of the phagosome was surrounded by p40phox. Data are 
expressed as the means ± SEM of the percentage of p40phox positive phagosomes from 3 
independent experiments. ** p < 0.001, *** p < 0.0001.  
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Figure 3-10. Rac activation by neutrophils challenged with F. alocis is impaired in viable 
bacteria at 30 mins. 
Neutrophils were left unchallenged (Basal), stimulated with fMLF or challenged with opsonized 
viable F. alocis (F. alocis) or challenged with opsonized heat-killed F. alocis (HK- F. alocis) for 
6-15-30-60 mins. Following stimulation, cell lysates were collected, plated with a binding buffer, 
washed, incubated with anti-Rac primary antibody, washed, incubated with HRP secondary 
antibody, incubated with HRP detection reagent and then the reaction was stopped using HRP 
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Stop Solution. Conditions were read at 490 nm on a spectrophotometer. Data are expressed as 





FILIFACTOR ALOCIS MANIPULATES HUMAN NEUTROPHILS AFFECTING THEIR 
ABILITY TO INDUCE NEUTROPHIL EXTRACELLULAR TRAPS (NETs)  
Introduction 
Neutrophils are phagocytic polymorphonuclear leukocytes that function as the principal 
innate immune cell recruited to sites of infection or inflammation in the periodontal pocket. They 
contribute to the maintenance of periodontal health by protecting the tissue against bacterial 
infection through employing a variety of anti-microbial killing mechanisms (198). One such 
mechanism of killing is neutrophil extracellular trap (NET) formation. Although NETs were first 
described by Brinkmann and Zychlinsky in 2004, much work has been done since their discovery, 
but questions still remain on their composition, roles, regulation and contribution to diseases 
(165). Additionally, NETs studies remain controversial, especially in whether their effects are 
beneficial or detrimental to the host in the presence of infection (165, 168, 361, 362). It is 
essential to strictly regulate NET formation in a time and dose-dependent fashion to ensure 
production and clearance processes occur when it is most beneficial to the host (168). 
In NET formation, neutrophils extrude their DNA extracellularly, which are decorated 
with antimicrobial granular proteins, like myeloperoxidase, neutrophil elastase, and histones. This 
process can occur in viable or dying neutrophils and is effective in trapping bacteria due to its 
electrostatic charge interactions and in killing due to its ability to produce a localized high 
concentration of antimicrobial peptides in the presence of a wide variety of stimuli (154, 157, 
168, 363, 364). Depending on the stimuli used to activate neutrophils, activation of the NADPH 
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oxidase and production of intracellular ROS may or may not be required for NET formation (157, 
197, 364-366). 
NETs have been discovered in the gingival epithelium and can be attributed to a first 
response to periodontal bacteria presence by the host (197, 367). In the context of periodontal 
disease, both excessive and ineffective NET production have been associated with development 
of the disease (149). Many oral bacteria can produce DNase, which serves to degrade DNA, and 
may provide a means to escape trapping and killing by NETs (151, 197, 368-372).  However, 
crevicular exudate outflow may inhibit optimal functioning of the bacterial DNases, and work in 
concert with NETs to clear pathogens from the oral cavity and prevent development of 
periodontitis (197).   
In this chapter, we show that F. alocis fails to induce NET formation, but may be able to 
manipulate and prevent neutrophils from forming NETs once they have been exposed to a 
pharmacological or bacterial stimulus that can induce NETs. These results suggest that F. alocis 
may produce a secreted factor, have an active DNA-degrading enzyme, or employ an 
undetermined virulence mechanism that allows for its ability to control neutrophils and prevent 
induction of NETs. 
Results 
F. alocis challenge of human neutrophils fails to induce NETs across a time course. 
Since NETs have implications in periodontal disease, using in vitro studies, we sought to 
determine if F. alocis, a periodontal pathogen, is capable of inducing NET formation in human 
neutrophils, the primary cells recruited to the gingival epithelium (149, 363, 373). We 
hypothesized that F. alocis will modulate human neutrophil production of NETs and the 
subsequent response of bactericidal proteins in order to evade killing.  
Our preliminary observations showed minimal intracellular ROS production when 
neutrophils were challenged with F. alocis. This could indicate that if NETs were formed in the 
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context of F. alocis infection this may occur in an ROS-independent manner. However, using 
confocal immunofluorescence, we discovered on an initial screening that neutrophils challenged 
with serum-opsonized (Op) F. alocis for 1-4-20 h did not induce NET formation compared with 
PMA or S. aureus, two well-established pharmacological and bacterial inducers of NET 
formation (data not shown).  
As it has been demonstrated that NETs can be induced at an early or late time point 
depending on the stimulus (157, 363), we performed another time course experiment challenging 
neutrophils with Op-F. alocis for 15-30-60-90-180 min to determine if F. alocis induced NETs 
early on upon challenge. Positive NET formation was determined by confocal microscopy, 
staining the neutrophil chromatin with DAPI and its colocalization with a known granule 
component, MPO; and using PMA as a known NET inducer (Fig. 4-1A). Our data showed that F. 
alocis did not induce NETs at any of the early time points tested (Fig. 4-1 A). Quantification of 
the confocal images, using the approach described by Zychlinsky et al. (374), showed that F. 
alocis induced less than 5% of NETs, independent of the infection time (Fig. 4-1B). For a 
stimulus to be considered an inducer of NET formation, ≥ 10% NETs need to be formed (168). 
Hence, F. alocis induced minimal NET formation.  
Due to previous studies suggesting the negative impacts serum and complement could 
have on NET induction (364, 375), we sought to rule out the impacts serum may play on the lack 
of NETs observed with F. alocis challenge by using non-opsonized F. alocis (Fig. 4-2 A). 
Additionally, in the context of the oral cavity, host-derived serum will be present, therefore 
testing opsonized bacteria is more physiologically relevant. We saw that similarly to the 
opsonized bacterium, the non-opsonized bacterium did not induce NET formation at any of the 
time points tested (Fig. 4-2 B), which suggests serum opsonization does not impact our 
conclusions that F. alocis is not an inducer of NETs. 
Since preliminary data from our laboratory has shown that heat-killed F. alocis was able 
to induce a robust intracellular respiratory burst response compared to the live organisms, we 
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sought to determine if this difference would be observed with NET formation. However, in our 
time course induction of NETs with heat-killed F. alocis, the bacterium did not induce NET 
formation (Fig. 4-3 A, B). This demonstrates that viability is not playing a role in the induction of 
NETs by F. alocis challenge.  
F. alocis challenge of neutrophils produces minimal levels of extracellular NE.  
Several studies have highlighted the importance of NET component neutrophil elastase 
(NE) to the effective formation and function of NETs (170, 376, 377). Therefore, using a kit to 
detect extracellular release of NE, we sought to determine if its presence was found with non-
opsonized and opsonized F. alocis challenge of neutrophils. We performed a time course study 
with basal, and F. alocis -challenged neutrophils and detected the levels of NE released 
extracellularly at 15-30-60-90 min. Basal neutrophils and non-opsonized and opsonized F. alocis 
challenged neutrophils released NE to similar levels, which was expected based on the previous 
observations of minimal presence of NETs (Fig. 4-4 A). For the later time points of 60-90-120 
min, PMA was included as a positive control, which showed higher levels of NE compared to the 
bacteria challenge (Fig. 4-4 B). This data indicates that F. alocis challenge of neutrophils does not 
produce a significant amount of extracellular NE, which is critical for effective NET formation, 
which may help explain minimal NET induction by F. alocis that is observed by 
immunofluorescence microscopy.   
Priming neutrophils before bacterial challenge does not impact NET formation.  
Previous studies have reported primed neutrophils can undergo NET formation, so we 
wanted to determine if NETs would be induced if we primed neutrophils with TNF-α for 10 min 
and then challenged with non-opsonized or opsonized F. alocis for 180 min. There was no 
significant induction of NETs following priming and then bacterial challenge with F. alocis 
compared with F. alocis alone (Fig. 4-5). This suggests that priming neutrophils with TNF does 
not seem to pre-activate/dispose neutrophils to form NETs in response to F. alocis challenge.  
S. gordonii and P. stomatis induce NET formation in an MOI-dependent manner.  
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Interestingly, F. alocis, a pathogen known to be an indicator of oral disease presence, did 
not induce NET formation by human neutrophils. In order to determine if F. alocis is unique in its 
lack of NET induction, other species common to the oral cavity, Streptococcus gordonii and 
Peptoanaerobacter stomatis, were used to challenge neutrophils and determine if NETs were 
produced. No significant NET formation was observed with either S. gordonii or P. stomatis 
between 5 up to 90 min; only by 180 min both oral bacteria showed NET induction (data not 
shown). Using immunofluorescence microscopy, we were able to determine that after 180 min 
bacterial challenge at MOI 10 both S. gordonii and P. stomatis induced NET formation 
significantly higher than non-opsonized and opsonized F. alocis (Fig. 4-6 A, B). Additionally, S. 
gordonii is able to induce a significantly more robust NET response than P. stomatis (Fig. 4-6 B).  
Challenging neutrophils with an increasing MOI of bacteria can result in NET induction, 
as observed by previous studies (378, 379). Hence, we challenged neutrophils with all three oral 
bacteria, F. alocis, S. gordonii and P. stomatis at higher bacteria loads of MOI 50 and 100 (Fig. 4-
6A). Our data showed that S. gordonii induced NETs in a concentration-dependent manner, 
however P. stomatis NET induction peaked at MOI 50; but was not significantly different at MOI 
100 (Fig.4-6 D). In contrast, challenging neutrophils with F. alocis at MOIs of 50 and 100, did 
not induce NET formation (Fig. 4-6 C, D). Our results indicate that F. alocis does not induce 
NETs in an MOI-dependent manner. In summary, these results led us to the conclusion that F. 
alocis may be unique to the oral community in its lack of NET induction, independent of MOI 
and time.  
In order to more closely study F. alocis in the context of an oral community, we 
performed 180 min time point co-infection studies with non-opsonized and opsonized F. alocis 
and S. gordonii or P. stomatis. In comparison with S. gordonii alone at 180 min, we observed that 
there was no significant increase or decrease in NET formation in the presence of F. alocis 
challenge (Fig.4-7 A). Similarly, in comparison with P. stomatis alone at 180 min, we observed 
that there was no significant increase or decrease in NET formation in the presence of F. alocis 
 104 
challenge (Fig. 4-7 B). This led us to determine that in a co-infection setting, F. alocis cannot 
inhibit or exacerbate NETs formed by S. gordonii or P. stomatis, bacterial stimuli that we 
determined can effectively induce NETs.  
We next sought to determine if F. alocis can actively degrade pre-formed NETs. To 
accomplish this, we challenged neutrophils with S. gordonii or P. stomatis, which were already 
determined to induce NETs, for 90 min and then introduced non-opsonized and opsonized F. 
alocis for 90 min. We saw no significant increase or decrease in NET formation (Fig. 8). Based 
on this data, we can conclude that once NETs are formed, F. alocis does not have the capacity to 
degrade them or inhibit their formation. 
Based on the results obtained in Figures 4-7 and 4-8, we thought it was necessary to 
determine if F. alocis has the capabilities of preventing or inhibiting NET formation. We decided 
pre-treat neutrophils with F. alocis followed by the well-established, non-physiological, positive 
stimulus for NET formation, PMA. In this experiment, we pre-treated neutrophils with non-
opsonized F. alocis for 30-60 min before PMA exposure (180 min) and compared the percentage 
of NETs formed to PMA alone at 180 min. Our results showed a significant reduction in PMA 
induced when cells were pre-treated with non-opsonized F. alocis compared to PMA alone (Fig. 
4-9 A-B). 
Now that we have determined what occurs with F. alocis pre-treatment of neutrophils 
before challenge with PMA, a pharmacological inducer of NETs, we sought to determine if F. 
alocis has the capabilities of manipulating the NET-forming neutrophils prior to exposure to 
known oral bacterial-inducers S. gordonii and P. stomatis. We pre-treated neutrophils with non-
opsonized F. alocis for 30-60 min before S. gordonii challenge (180 min) and compared the 
percentage of NETs formed to S. gordonii alone at 180 min. There was no significant change in 
NET induction by S. gordonii when cells were pre-treated with non-opsonized F. alocis for 30 
min or 60 min compared to S. gordonii alone (Fig. 4-10 A). Additionally, we pre-treated 
neutrophils with opsonized F. alocis for 30-60 min before S. gordonii challenge (180 min) and 
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compared the percentage of NETs formed to S. gordonii alone at 180 min. However, unlike with 
non-opsonized bacteria, there was a significant decrease in NET induction by S. gordonii when 
cells were pre-treated with opsonized F. alocis for 30 min and 60 min compared to S. gordonii 
alone (Fig. 4-10 B). Next, we pre-treated neutrophils with non-opsonized F. alocis for 30-60 min 
before P. stomatis challenge (180 min) and compared the percentage of NETs formed to P. 
stomatis alone at 180 min. There was no significant change in NET induction between non-
opsonized or opsonized F. alocis pre-treatment at 30 min or 60 min time point before P. stomatis 
challenge compared to P. stomatis alone (Fig. 4-10 C, D). These results indicate that F. alocis 
requires pre-treatment time prior to presence of positive NET stimulator to inhibit them, which 
means that the bacterium manipulates the neutrophils so that NET formation will not be triggered. 
Due to the results we obtained in Figures 4-8-11, it is more likely that F. alocis is manipulating 
neutrophil signaling mechanisms as opposed to DNase, nuclease or thermonuclease secretion, 
unless the secretion of the enzymes is too low in concentration to have an impact.  
S. gordonii and P. stomatis induce NETs in an ROS-dependent manner.  
The rapid formation of NETs seems to use an oxidase-independent process that does not 
involve cell death, where the lengthy NET induction is often oxidant-dependent and is considered 
a form of cell death (155, 366). It has been determined that S. gordonii and P. stomatis induce 
significant NET formation, therefore we sought to determine if these bacteria induced NETs in an 
ROS-dependent or independent manner. To do so, we exposed neutrophils to diphenyleneiodonium 
(DPI), a known inhibitor of NADPH oxidase activity, prior to challenge with S. gordonii or P. 
stomatis. As a control, we pre-treated neutrophils with DPI and then challenged with PMA, a 
known ROS-dependent inducer of NETs, to ensure our DPI was working effectively to inhibit the 
oxidase (Fig. 4-11 A, B). To accomplish this, we performed immunofluorescence microscopy 
where we exposed neutrophils to DPI and then challenged neutrophils with S. gordonii (MOI 10-
50-100) for 180 min and compared the NET induction to S. gordonii alone (MOI 10-50-100) for 
180 min. It was observed that at MOI 50 and MOI 100, DPI pre-treatment significantly reduced 
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NET formation compared to S. gordonii alone indicating that S. gordonii may induce NETs in an 
ROS and MOI-dependent manner (Fig. 4-11 A).  
Similarly, we performed this assay with exposure of neutrophils to DPI and then challenged 
neutrophils with P. stomatis (MOI 10-50-100) for 180 min and compared the NET induction to P. 
stomatis alone for 180 min (Fig. 4-11 B). It was observed that only at MOI 100, DPI pre-treatment 
significantly reduced NET formation compared to P. stomatis alone indicating that P. stomatis may 
induce NETs in an ROS-dependent manner (Fig. 4-11 B).   
Discussion 
In vivo observation of neutrophils revealed their presence in the dental plaque and that 
NET formation is detected in the oral biofilm, the saliva, and also the crevicular exudate (155, 
197, 380-382). Due to the large quantity of bacteria present dispersed throughout the gingival 
crevice, phagocytosis is an ineffective means for bacterial control, therefore NETs could serve as 
a more effective strategy for neutrophils to respond to infection (197). Furthermore, when these 
dispersed bacteria attempt to adhere to the gingival epithelium, they encounter NETs, which 
impair their chances for attachment and colonization (197, 367, 382).  
Given the importance of neutrophils to the field of periodontology, being the principal 
inflammatory cell, NET formation needs further study to determine its potential to periodontal 
disease pathogenesis (363, 373). Little has been characterized in the periodontal field in regard to 
NET formation; however, it has been implicated to occur as it is involved in other chronic 
inflammatory conditions. Due to the presence of a functional peptidyl arginine deiminase (PAD) 
enzyme in P. gingivalis, it is speculated that the bacterium can citrullinate its own proteins as well 
as host proteins, which is important for inducing NET release (363). In addition to chronic 
inflammatory diseases, NETs have been suggested to have a role in cancer and metastasis (166, 
383). 
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NET components found decorated within the extracellular matrix each play important 
roles in the stages of neutrophil activation and eventual release from neutrophils. First, neutrophil 
elastase (NE), a neutrophil-specific serine protease, functions in histone degradation, promotion 
of chromatin decondensation in the neutrophil nucleus, degradation of the nuclear envelope, 
antimicrobial activities within the neutrophil phagosome (170, 376, 377). Studies performed with 
both NE and MPO knockout mice show failed induction of NETs and an increased susceptibility 
to infection (170). Tightly associated with NE is myeloperoxidase, which is necessary for NE, as 
it functions in conjunction with the ROS to translocate NE to the neutrophil nucleus (376). MPO 
is an enzyme that works to consume hydrogen peroxide in order to form hypochlorous acid 
(HOCl) among other important anti-microbial oxidants (376). There are four core histones in 
NETs (H2A, H2B, H3 and H4), which are responsible for the majority of their protein mass and 
serve as potent antimicrobials (168). Another important enzyme for NET production is peptidyl 
arginine deiminase-4, which functions in decondensation of the nuclear chromatin through 
citrullination of histones and also degradation of the nuclear envelope (149, 377). Similarly, as 
observed with knock-out studies in NE and MPO, PAD4 knock out mice are impaired in their 
NET capabilities (377, 384).  
Neutrophil elastase is an enzyme that is believed to be crucial for the successful 
formation of NETs. We detected low levels of NE release by both non-opsonized and opsonized 
F. alocis across a time course, which indicates that this component could help to explain why 
NETs are not induced by this oral bacterium.  
NET formation, depending on the stimuli, can occur rapidly, as observed with 10 min of 
Staphylococcus aureus challenge (363) or take more time to occur, as observed with 90-180 min 
of PMA treatment (157, 364, 385). The rapid formation of NETs seems to use an oxidase-
independent process that does not involve cell death, where the lengthy NET induction is often 
oxidant-dependent and is considered a form of cell death (155, 366). As it has been determined 
that NETs can be induced at an early or late time point depending on the stimulus, time course 
 108 
studies with F. alocis allowed us to determine if induction of NETs was time-dependent and 
potentially whether it operated through an ROS-dependent or ROS-independent mechanism. Our 
observations showed that there is no significant induction of NETs at any time point.  
 It is known that different factors can impact and influence the capability of NET 
production, one of these factors being the multiplicity of infection (MOI) of the bacterial 
challenge (168). Hirschfeld et al reports that Aggregatibacter actinomycetemcomitans will induce 
NETs, but only at the high level of MOI 100 (378). It has been reported that the gingipain mutant 
strains K1A (Kgp) and E8 (RgpA/B) of P. gingivalis can induce NETs, however the wild type 
ATCC33277 and W50 strains do not induce them (306). Studies performed with Burkholderia 
psuedomallei showed that with increasing MOI and later time intervals, more NETs were formed 
(379). It is typical that with an increase in bacterial MOI, a minimal or intermediary NET 
induction may progress to a higher percentage of NETs formed. However, in our work, increasing 
the MOI of F. alocis did not impact the formation of NETs, which suggests that MOI increase 
does not promote enhanced NET formation.  
 In Scharrig et al, live Leptospira spp. were observed to induce significantly more NETs 
compared to heat-inactivated Leptospira spp. (386). In assays performed with B. pseudomallei, it 
was determined that killed bacteria induced significantly more NETs than live bacteria (379). 
However, when challenging neutrophils with heat-killed F. alocis, the bacterium did not induce 
NET formation. This suggests that F. alocis must not require viability to perform its manipulation 
of neutrophils, as it may employ heat-stable effector mechanisms.  
It has been suggested that NET formation can impact the colonization of oral bacteria, 
which may impact the ability of S. gordonii to attach to the surface of the tooth and further effect 
other bacteria from residing on the early colonizers, disrupting the entire biofilm architecture. 
Unlike F. alocis, we observed both S. gordonii and P. stomatis induced NETs in an MOI-
dependent manner. Hirschfield et al reported NET formation was observed by a variety of oral 
bacteria, including S. gordonii, taken from supragingival biofilm and whole saliva samples in 
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healthy donors (380). Similarly to the observations obtained with my data, S. gordonii challenge 
at MOI 10 produced ~10% NET formation (380).These results suggest that F. alocis may 
represent a unique species to the oral community, as NET formation is not observed.  
Although previous work demonstrates that “primed” or pre-activated neutrophils can 
induce NET formation, when priming neutrophils with TNF-alpha (72), it does not seem to pre-
activate neutrophils to form NETs in response to secondary bacterial stimulation of F. alocis. 
These results show that priming of neutrophils is not successful in promoting the NET formation 
by F. alocis.  Future studies could be used to determine if these results are specific to TNF 
priming or if this result would change with a different priming agent.  
Depending on the stimuli used to activate neutrophils, activation of the NADPH oxidase 
and production of intracellular ROS may or may not be required for NET formation (157, 167, 
364-366). Additionally, PMA induction of NETs usually occurs after 90 min of stimulation, but 
the ROS response happens within minutes, therefore a certain threshold level of ROS may be 
required for trigger of NETs (387). It has been reported that NETs may function to trap and kill 
microbes, or they may only be able to trap and the microbe evades the killing mechanism (149, 
151, 386, 388, 389). In the context of Streptococcus pneumoniae, NETs are effective in trapping 
bacteria, reducing the spread of further infection, however ineffective at killing the microbe 
(151). Studies performed by Wang et al determined that even different strains of the same 
species, as shown with Klebsiella pneumoniae, can be more resistant to trapping or killing by 
NETs (390). However, capturing the bacteria in its trap still provides benefit to the neutrophil, as 
it can limit dissemination of the bacteria (149, 151, 386, 388, 389).  
While the potential signaling pathways leading to NET formation have been outlined, 
few studies have been able to directly tie signaling mechanism inhibition with NET inhibition.  A 
recent study found that TLR signaling could be linked to NET formation, as observed with anti-
inflammatory drug, dexamethasone (DXM) treatment on S. aureus and PMA-induced NETs 
(391). In S. aureus-induced NET formation it was concluded that TLR2 and TLR4 are involved, 
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as DXM treatment inhibited NET formation, which could be rescued using TLR2 and TLR4 
agonists (391).  
The first link was established between NET degradation and bacterial pathogenicity 
(Group A streptococcus) as inhibition of GAS DNase led to enhanced pathogen clearance by 
neutrophils in vitro and less virulence in vivo (368).  It has been reported that numerous Gram 
positive bacteria, like S. pneumoniae, will express DNases, which can aid in NET degradation 
(151). The production of extracellular nucleases is well known for bacterial pathogens, and were 
first reported to be active in anaerobic bacteria in 1974, but their role in virulence was only 
recently appreciated (148, 367). Pathogens can employ nucleases to aid in their resistance to 
NET-mediated killing mechanisms (171, 392). Presence of extracellular nucleases has been 
reported in these Gram-positive pathogens: Staphylococcus aureus, Streptococcus pyogenes, 
Streptococcus agalactiae, Streptococcus suis, Streptococcus sanguinis, Streptococcus 
pneumoniae (151, 171, 367-369, 392-395). Additionally, Palmer et al reported that 
periodontopathogenic bacteria can produce extracellular nucleases (367, 375). Recently, it was 
determined that Neisseria gonorrhoeae encodes for a heat-stable thermonuclease (Nuc), which 
provides the bacterium an effective virulence factor against NETs, as it is capable of DNA 
degradation (396). After NETs were produced, the presence of thermonuclease aided the 
bacterium in degrading the DNA and enhancing their survival capabilities (396). No significant 
reduction in NET formation when NETs stimulated with PMA are then exposed to F. alocis broth 
or growth supernatant (data not shown) which suggests that although F. alocis possesses a 
thermonuclease, it may be present at a low concentration, therefore deeming it ineffective in 
degradation of NETs.  
Another method employed by microbes to evade NET-mediated killing is molecular 
mimicry, where bacteria will mimic host-specific surfaces to evade detection and further inhibit 
initiation and activation of an immune response against them (149, 363). They can also conceal 
their antigenic molecules or alter their surface modifications or electrochemical charges, which 
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all serve as virulence factors that aid in their stealthy escape from the host’s detection, allowing 
them to persist and further infection and inflammation (149, 363, 397).  
Host-pathogen balance is a very important factor in maintaining homeostasis and health 
in the oral cavity and the disruption of this balance is what leads to “Polymicrobial Synergy and 
Dysbiosis” (PSD) (241). In a synergistic biofilm, oral bacteria operate in a biofilm community 
which leads to exacerbation of their virulence potential allowing them to survive against the host 
anti-bacterial mechanisms. Additionally, they cause significant host tissue damage, which allows 
them to thrive in a nutrient-rich environment where they can successfully colonize the gingival 
epithelium (241). Periodontal disease caused by polymicrobial synergy among periodontal 
bacteria in subgingival biofilms may be successful in their colonization of the region through 
their NET degradation capacities (367). It has been reported in a few studies that biofilm 
formation can inhibit NETs and this can be attributed to the extracellular matrix structure, as 
detached planktonic bacteria can induce NETs (398). NET formation is an effective mechanism 
employed by neutrophils to respond to infection, therefore, lack of NET formation has disease 
promoting implications. This phenomenon was observed with CGD patients; these patients do not 
have an operational (inactive) NADPH oxidase complex and suffer from recurrent infections 
(168, 387). 
Given the importance of neutrophils to the field of periodontology, being the principal 
inflammatory cell, NET formation needs further study to determine its potential to periodontal 
disease pathogenesis (363, 373). Little has been characterized in the periodontal field in regard to 
NET formation; however, it has been implicated to occur as it is involved in other chronic 
inflammatory conditions.  
As NET formation has been demonstrated to occur in the oral cavity, especially in the 
context of periodontal disease presence, we first wanted to determine if F. alocis is able to 
participate in or induce NET formation. We determined that F. alocis does not induce NET 
formation and that it may function to manipulate neutrophils by an unknown mechanism. This 
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manipulation by F. alocis could serve to disrupt the biofilm community and impact their ability to 
colonize the host as the as well as manipulate the host in its ability to effectively detect and 
respond to microbes through NET formation.  
NETs have potentially different kinetic and functional properties depending on where 
they are operating, whether it be in the bloodstream or in the tissue, at the site of an infection 
(384). If in the bloodstream, they could aid in spreading bacteria, however, if they are at the 
tissue-level, they may prevent adhesion and colonization of the host tissue by bacteria. There is 
also potential that NETs could also operate in a biofilm formation and overgrowth (380). This 
leads to the question of whether the presence of NETs may be of benefit to the host and limit 
disease progression or be detrimental to the host and further disease progression (155). It is also 
not well-defined if and how NETs are effectively being cleared from the host, which may 
propagate unnecessary host inflammation and damage (363). However, it is also a possibility that 
neutrophils or other immune cells in interaction with neutrophils have adapted to create inhibitory 
feedback mechanisms, sending signals to their neighboring cells not to produce any more NETs 
(365, 399).  
A recent study has implicated the potential interplay between NETs and other neutrophil 
mechanisms, like phagocytosis and autophagy and it may be necessary to further define the 
kinetics of these neutrophil functional mechanisms (400). Many studies suggest that interplay 
may also occur between both signaling pathways and NETs components, which could be better 
defined to help distinguish why certain pathways/components are utilized (157, 365, 401). It is 
controversial whether certain signaling pathways and NETs components are required, which 
needs to be better defined for many microbes. It is also a possibility that there are inhibitory 
feedback mechanisms, paracrine signaling between neutrophils sensing neighbors don’t produce 
any more NETs. It is still to be determined what causes only a certain percentage of neutrophils to 
produce NETs and whether factors such as age and health status determine this ability (365, 402). 
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Furthermore, it is important to determine if ‘all NETs are created equal’ (384) among 
pathogens and diseases and why they could be phenotypically and functionally similar or 
different. Through using patient studies, it will be possible to help determine what causes the 
inter-patient variability seen in NET formation and the impact this has on disease development 
and progression (380, 403). Studies have suggested that NETs could be useful as predictors of 
disease development (170, 404, 405). 
Numerous studies have implicated that future studies have the potential to develop NETs 
therapeutics. There is promising potential for development of molecules/drugs that will: inhibit 
nuclease activity, oxygen radicals or even certain signaling pathways, like the Raf-MEK-ERK 
(171, 387, 406). It has also been suggested that DNase activity can be neutralized (368). 
Although serum and complement have been observed to negatively impact NET 
formation as they can cause its degradation, when we challenged neutrophils with either non-
opsonized or opsonized F. alocis, no NET formation was observed. This suggests serum 
opsonization does not impact our studies and that the presence of opsonins did not favor a 
phagocytic killing mechanism, such as NETs. It has been determined that the relationship 
between complement opsonization and NET formation is dependent on the bacterial stimulus, 
some examples including oral bacterial like A. actinomycetemcomitans and Fusobacterium 
nucleatum, impair NET formation when opsonized (18, 375, 407), therefore this could explain the 
differences we observe in the manipulation of opsonized compared to non-opsonized F. alocis in 
relation to its manipulation capacities of NET formation when exposed to S. gordonii 
differentially than PMA. Additionally, S. gordonii may be impacted by the presence of opsonins 
on F. alocis, which may explain the decrease in NET formation when Op-F. alocis challenge 
precedes S. gordonii challenge.  
Previous studies performed on pathogenic Bordatella parapertussia show its capable of 
inhibiting PMA-induced NET formation when pre-treated with the bacterium prior to exposure to 
PMA, through the use of adenylate cyclase toxin (CyaA), that operates by inhibition of ROS 
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production (408). The only other bacteria known to be able to avoid NET induction, as 
determined using murine neutrophils and the HL-60 neutrophil-like cell line, is Lactobacillus 
rhamnosus, which is a probiotic (409). Similarly, with F. alocis pre-treatment prior to PMA 
exposure, we see an inhibition in NET formation, which may be due to an unknown virulence 
factor. This implicates the involvement of F. alocis in preventing excessive inflammation created 
by NET formation and further allowing evasion and potentially survival from neutrophils.  
Based on survival studies with F. alocis and human neutrophils, we determined that 
although the bacterium is able to be effectively internalized, it can survive up to 4 hrs 
intracellularly (See Chapter 3 Figure 3-1). Therefore, it is possible that F. alocis possesses a 
virulence factor that may facilitate its survival in phagocytic-based killing mechanisms, however, 
in the context of extracellular NET formation it is unclear whether F. alocis would survive. In our 
studies, we observe that F. alocis is effectively trapped in the NETs that are formed by other 
inducers, however further studies of bacterial killing are needed to determine if F. alocis is 
effectively killed in the NETs.   
As it has been shown that the use of DPI inhibitor will target and inhibit ROS-dependent 
NET induction by impacting the NADPH oxidase complex, our studies with DPI inhibition 
showed that NET formation is ROS-dependent in both S. gordonii and P. stomatis.    
Due to the lack of NET induction by F. alocis, we further looked into our proteomic 
analysis performed on the bacteria to determine if our bacteria possessed a DNase, nuclease or 
thermonuclease that may be aiding in the bacterium’s ability to degrade NETs. We observed that 
F. alocis did possess an active and functional thermonuclease, however due to the low coverage 
and concentration of the enzyme in our culture, this may explain why, unlike observed with the 
thermonuclease in N. gonorrhoeae, NETs that are formed are not successfully degraded by F. 
alocis presence.  
These results suggest that F. alocis is more likely to be manipulating the neutrophil NET 
signaling mechanisms, because if NETs are already formed, the bacterium is ineffective at 
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degrading them; however, it prevents them from being formed even with exposure to a known 
stimulator of NET formation like PMA. Additionally, F. alocis is able to control the neutrophils 
at an earlier time point in their NET formation induced by S. gordonii than with PMA, which 
could be due to the potency and pharmacological nature of PMA. It is possible that F. alocis can 
inhibit a crucial pathway involved in the formation of NETs, for example, as the bacterium does 
not induce an ROS response and NET formation could be ROS-dependent, this could help to 
explain why F. alocis fails to induce NETs.  
Disruption of the entire microbial community by NET formation could potentially inhibit 
colonization of primary colonizers, like S. gordonii, bacteria that are critical to the initial structure 
of the dental plaque. This will occur by competitive inhibition, whereby the NETs will colonize 
the space of the gingival epithelium, which will not allow for bacterial colonization (367, 382). 
As S. gordonii is also a commensal organism, it is possible that if it is not allowed to colonize the 
host due to NET formation, the host will be further disadvantaged when presented with a 
pathogenic organism. However, much to the detriment of the host, NETs can also serve as a 
potential substrate for bacterial attachment in building their biofilm.  
F. alocis is able to evade detection and a potential killing by neutrophils via NETs, as it 
does not induce NETs and could inhibit their formation. However, it is possible that the entire 
biofilm community benefits from F. alocis as its presence is known to manipulate neutrophils, 
leading to the potential for other bacteria that would normally be recognized and effectively killed 
by NETs go undetected, survive and persist in the host. This could be especially important for 
those bacteria that are not effectively internalized and neutrophils rely on extracellular killing 
mechanisms to effectively clear the pathogen.  
Material and Methods 
Neutrophil isolation. 
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Neutrophils were isolated from blood of healthy donors using plasma-Percoll gradients as 
previously described (146), and in accordance with the guidelines approved by the Institutional 
Review Board of the University of Louisville.  Microscopic evaluation of the isolated cells showed 
that > 95% of the cells were neutrophils. Trypan blue exclusion indicated that > 97% of cells were 
viable.  
Bacterial strains, growth conditions and preparation.  
F. alocis ATCC 38596 was cultured in brain heart infusion (BHI) broth supplemented with 
L-cysteine (0.1%) and arginine (20%) for 7 days anaerobically at 37°C as previously described [27, 
42].  Opsonized F. alocis was prepared in 10% normal human serum at 37°C for 20 min and cultures 
were washed three times with PBS prior to use (Complement Technology, Tyler, Texas). For 
viability studies, heat killed F. alocis was generated by incubation at 90 °C for 60 min. For 
fluorescence microscopy assays, F. alocis was labeled with 5(6)-Carboxyfluorescein N-
hydroxysuccinimide ester (CFSE; Life Technologies, 4 mg/mL) for 30 min at room temperature in 
the dark, and the cultures were washed three times with PBS prior to use. 
S. gordonii strain DL1 was cultured in BHI broth overnight anaerobically at 37°C. S. 
gordonii was labeled with CFSE (4 mg/mL) or Hexidium iodide (HI; Life Technologies, 5 mg/mL) 
for 30 min at room temperature in the dark, and the cultures were washed three times with PBS 
prior to use. 
P. stomatis strain CM2 was cultured in tryptic soy broth supplemented with 20 g/liter yeast 
extract, 1% hemin, and 1% reducing agent (37.5 g/liter NH4Cl, 25 g/liter MgCl2·6H2O, 5 g/liter 
CaCl2·2H2O, 50 g/liter L-cysteine HCl, 5 g/liter FeCl2·4H2O) overnight anaerobically at 37°C. P. 
stomatis was labeled with CFSE (4 mg/mL) or Hexidium iodide (HI; Life Technologies, 5 mg/mL) 
for 30 min at room temperature in the dark, and the cultures were washed three times with PBS 
prior to use. 
NETs immunofluorescence microscopy.  
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To assess NET formation of neutrophils, we used an adaption of a previously described 
method (410). Neutrophils (1 x 106 cells/condition) were seeded onto sterile 12 mm coverslips in 
a 24-well plate in NETs assay media (RPMI + 0.5% BSA + 10 mM HEPES) and incubated for 1 
h in a tissue culture incubator at 37°C to allow cells to attach to coverslips. After 1 h incubation, 
neutrophils were left unstimulated, or stimulated with Phorbol 12-myristate 13-acetate (PMA, 
Sigma, 50 nM, 180 min), or challenged with CFSE-labeled non-opsonized F. alocis (MOI 10-50-
100, 15-30-60-90-180 min), or with CFSE-labeled opsonized F. alocis (MOI 10-50-100, 15-30-
60-90-180 min), or with CFSE-labeled non-opsonized heat-killed F. alocis (MOI 10-50-100, 15-
30-60-90-180 min), or with CFSE-labeled opsonized heat-killed F. alocis (MOI 10-50-100, 15-
30-60-90-180 min), or with CFSE-labeled S. gordonii (MOI 10-50-100, 180 min), or with HI-
labeled S. gordonii (MOI 10-50-100, 90-180 min), or with CFSE-labeled P. stomatis (MOI 10-
50-100, 180 min), or with HI-labeled P. stomatis (MOI 10-50-100, 90-180 min).  
For co-infection studies, neutrophils were challenged with HI-labeled S. gordonii (MOI 
100) + CFSE-labeled non-opsonized F. alocis (MOI 10) or CFSE-labeled opsonized F. alocis 
(MOI 10) for 180 min, or with HI-labeled P. stomatis (MOI 50) + CFSE-labeled non-opsonized 
F. alocis (MOI 10) or CFSE-labeled opsonized F. alocis (MOI 10) for 180 min.  
For pre-treatment studies, neutrophils were challenged with HI-labeled S. gordonii (MOI 
100) for 90 min + CFSE-labeled non-opsonized F. alocis (MOI 10) or CFSE-labeled opsonized 
F. alocis (MOI 10) for 90 min, or with HI-labeled P. stomatis (MOI 50) for 90 min + CFSE-
labeled non-opsonized F. alocis (MOI 10) or CFSE-labeled opsonized F. alocis (MOI 10) for 90 
min, or stimulated with TNF-α (10 min, 2 mg/mL), or stimulated with TNF-α (10 min) and then 
challenged with CFSE-labeled non-opsonized F. alocis (MOI 10, 180 min), or with CFSE-labeled 
opsonized F. alocis (MOI 10, 180 min) or challenged with CFSE-labeled non-opsonized F. alocis 
(MOI 10, 30-60 min) or with CFSE-labeled opsonized F. alocis (MOI 10, 30-60 min) and then 
stimulated with PMA (180 min) or challenged with HI-labeled S. gordonii (MOI 100, 180 min) or 
challenged with HI-labeled P. stomatis (MOI 50).  
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For inhibition studies, neutrophils were stimulated with diphenyleneiodonium chloride, 
(DPI, Sigma, 10 µM), an inhibitor of the NAPDH oxidase, and then stimulated with PMA for 180 
min, or challenged with HI-labeled S. gordonii (MOI 10-50-100, 180 min), or challenged with 
HI-labeled P. stomatis (MOI 10-50-100, 180 min).  
Following challenge of neutrophils, for bacterial-challenged conditions, phagocytosis was 
synchronized by centrifugation at 600 x g at 14°C and plates were put in a 37°C cell culture 
incubator for time point (15-30-60-90-180 min). After challenge, cells were fixed in 2% 
paraformaldehyde (PFA) for 2 h, washed in PBS 3 times for 5 min and then blocked overnight at 
4°C with 1% BSA. After overnight blocking, cells were stained with MPO antibody (Biolegend, 
667802, 1:1000) in a 37°C cell culture incubator for 1 h. After wash in PBS 3 times for 5 min, 
cells were stained with secondary antibody AlexaFluor 647 (Life Technologies, 1:1000) in a 
37°C cell culture incubator for 1 h and washed in PBS 3 times for 5 min. DAPI (3 µM) was 
applied for 5 min at room temperature as a nuclear stain and cells were washed in PBS 1 time for 
5 min. Confocal images (1-µm thickness for each slice) were obtained using a Fluoview FV1000 
confocal microscope with a 63X oil objective to determine NET induction. Ten images taken 
randomly from different regions of each coverslip in an experiment were taken.  
To quantify the NET induction, we used methods previously described (374). The image 
files were loaded as separate image stacks for each channel in ImageJ/FIJI software. To collect 
the data of total cell number in the DAPI fluorescence image stack, automatic particle analysis 
was set to 20 pixels minimum size and summarized the result output. To collect the data of total 
cell number in the MPO fluorescence image stack, automatic particle analysis was set to 75 pixels 
minimum size and summarized the result output. The output list results were imported into an 
Excel spreadsheet for further processing. The percentage of NETs formed was calculated by the 
following formula: 
 
NET-rate (%) = 100 x Objects counted (MPO channel) / Objects counted (DAPI channel).  
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The percentage of NETs formed was calculated for each of the ten images per condition 
acquired and then summarized as an average per condition. 
Neutrophil elastase extracellular release assay.  
In order to detect neutrophil extracellular trap release, we utilized the Cayman Chemical 
NET assay kit, which allowed for the detection of extracellular neutrophil elastase (NE). The assay 
was performed according to the manufacturer’s protocol. Neutrophils (1 x 106 cells/condition) were 
seeded into a 24-well plate in NETs assay media (RPMI + 0.5% BSA + 1 M CaCl2) and incubated 
for 30 min in a tissue culture incubator at 37°C to allow cells to settle. After 30 min incubation, 
neutrophils (1 x 106 cells/condition) were left unstimulated, challenged with non-opsonized F. 
alocis, or with opsonized F. alocis at an MOI of 10 and phagocytosis was synchronized (for 
bacterial-challenged conditions) by centrifugation at 600 x g at 14°C. Plates were put in a tissue 
culture incubator at 37°C for 15-30-60-90 min. Following challenge, conditions were aspirated and 
washed three times with NETs assay media to ensure removal of soluble neutrophil elastase (NE). 
Next, NET assay S7 nuclease was added to each condition and incubated for 15 min at 37°C, to 
disrupt the NETs. The supernatants for each sample were then collected and NET assay EDTA 
solution was added to inactivate the nuclease. Cell supernatants were added to a 96-well plate. 
Next, NET assay neutrophil elastase substrate was added to each well. The plate was covered and 
incubated at 37°C for 2 h. Following the 2 h incubation, the signal, detecting extracellular NE, was 
measured at 405 nm using a SpectraMax Soft Max Pro 5.4 spectrophotometer. 
Statistical analysis. 
For all the experimental conditions tested in this study, the statistical analysis used was a 
one-way ANOVA with the Tukey-Kramer multiple-comparison test (GraphPad Prism software, 
San Diego, CA, USA).  Differences were considered statistically significant at the level of P <0.05.  
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Figure 4-1. Opsonized F. alocis challenge fails to induce NET formation by human 
neutrophils.   
Neutrophils were unchallenged (Basal), exposed to PMA-50 nM (180 min) or challenged with 
CFSE-labeled opsonized F. alocis (MOI 10) for 15-30-60-90-180 min. Following infection, cells 
were fixed, exposed to antibodies directed against MPO (Red- AlexaFluor647), stained with 
DAPI (blue), and then imaged for NET immunofluorescence by confocal microscopy. (A) 
Representative confocal images (from 3 replicates of 100 quantified cells) of unstimulated (Basal) 
neutrophils or neutrophils challenged with CFSE-labeled opsonized F. alocis-challenged 
neutrophils across a time course (15-30-60-90-180 min). CFSE (green): bacteria, DAPI (blue): 
neutrophil nucleus/DNA, AlexaFluor647 (red): MPO, Merge: NET formation.  (B) 
Quantification, using ImageJ analysis (see details in Materials & Methods), of percentage of 
NETs formed from unchallenged neutrophils (Basal), exposed to PMA (180 min) or challenged 
with opsonized F. alocis (15-30-60-90-180 min).  Data are means +/- SEM from 4 independent 




Figure 4-2. Non-opsonized F. alocis challenge fails to induce NET formation by human 
neutrophils.   
Neutrophils were unchallenged (Basal), exposed to PMA-50 nM (180 min) or challenged with 
CFSE-labeled non-opsonized F. alocis (MOI 10) for 15-30-60-90-180 min. Following infection, 
cells were fixed, exposed to antibodies directed against MPO (Red- AlexaFluor647), stained with 
DAPI, and then imaged for NET immunofluorescence by confocal microscopy. (A) 
Representative confocal images (from 3 replicates of 100 quantified cells) of unstimulated (Basal) 
neutrophils or neutrophils challenged with CFSE-labeled opsonized F. alocis-challenged 
neutrophils across a time course (15-30-60-90-180 min). CFSE (green): bacteria, DAPI (blue): 
neutrophil nucleus/DNA, AlexaFluor647 (red): MPO, Merge: NET formation.  (B) Representative 
confocal images (from 3 replicates of 100 quantified cells) of neutrophils challenged with CFSE-



























labeled non-opsonized F. alocis-challenged neutrophils across a time course (15-30-60-90-180 








Figure 4-3. Heat-killed F. alocis challenge fails to induce NET formation by human 
neutrophils.   
Neutrophils were unchallenged (Basal), exposed to PMA-50 nM (180 min) or challenged with 
heat-killed CFSE-labeled non-opsonized F. alocis (MOI 10), or CFSE-labeled heat-killed 
opsonized F. alocis (MOI 10) for 15-30-60-90-180 min. Following infection, cells were fixed, 
exposed to antibodies directed against MPO (Red- AlexaFluor647), stained with DAPI, and then 
imaged for NET immunofluorescence by confocal microscopy. (A) Representative confocal 
images (from 3 replicates of 100 quantified cells) of unstimulated (Basal) neutrophils or 
neutrophils challenged with heat-killed CFSE-labeled non-opsonized and heat-killed CFSE-
labeled opsonized F. alocis-challenged neutrophils across a time course (15-30-60-90-180 min). 
CFSE (green): bacteria, DAPI (blue): neutrophil nucleus/DNA, AlexaFluor647 (red): MPO, 
Merge: NET formation. (B) Quantification, using ImageJ analysis, of percentage of NETs formed 
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from unchallenged neutrophils (Basal), exposed to PMA (180 min) or challenged with heat-killed 
non-opsonized F. alocis (15-30-60-90-180 min) or heat-killed opsonized F. alocis (15-30-60-90-






Figure 4-4. F. alocis fails to induce the release of extracellular neutrophil elastase. 
(A) Neutrophils were left unstimulated (Basal), challenged with non-opsonized F. alocis (Non-op 
F.a.) or challenged with opsonized F. alocis (Op F.a.) for 15-30 min. (B) Neutrophils were left 
unstimulated (Basal), challenged with non-opsonized F. alocis (Non-op F.a.) or challenged with 
opsonized F. alocis (Op F.a.) for 60-90-120 min. As a positive control, neutrophils were 
stimulated with PMA (20 nM) for 60-90-120 min. Following treatment, soluble elastase was 
removed through aspiration and washing, and nuclease was added for 15 min. Next, the 
supernatants were collected and EDTA solution was added. Supernatants were assessed for 
extracellular neutrophil elastase through the addition of elastase substrate to the samples. The 
samples were read by a spectrophotometer at 405 nm. Data are means +/- SEM from 2 





Figure 4-5. TNF-α pre-treatment fails to stimulate NET formation in response to challenge 
with F. alocis. 
Neutrophils were stimulated with TNF-α (10 min) or challenged with CFSE-labeled non-
opsonized F. alocis (MOI 10), CFSE-labeled opsonized F. alocis (MOI 10) for 180 min, or pre-
treated with TNF-α (10 min) and then challenged with CFSE-labeled non-opsonized F. alocis 
(MOI 10), CFSE-labeled opsonized F. alocis (MOI 10) for 180 min. Following infection, cells 
were fixed, exposed to antibodies directed against MPO (Red- AlexaFluor647), stained with 
DAPI, and then imaged for NET immunofluorescence by confocal microscopy. Quantification, 
using ImageJ analysis, of percentage of NETs formed from neutrophils challenged with CFSE-
labeled non-opsonized F. alocis (MOI 10), CFSE-labeled opsonized F. alocis (MOI 10) for 180 
min, or pre-treated with TNF-α (10 min) and then challenged with CFSE-labeled non-opsonized 
F. alocis (MOI 10), CFSE-labeled opsonized F. alocis (MOI 10) for 180 min.  Data are means +/- 



























































Figure 4-6. S. gordonii and P. stomatis induce significant NET formation in an MOI-
dependent manner.  
Neutrophils were unchallenged (Basal), or challenged with CFSE-labeled S. gordonii (MOI 
10/50/100), or CFSE-labeled P. stomatis (MOI 10/50/100), or CFSE-labeled non-opsonized F. 
alocis (MOI 10/50/100), or CFSE-labeled opsonized F. alocis (MOI 10/50/100) for 180 min. 
Following infection, cells were fixed, exposed to antibodies directed against MPO (Red- 
AlexaFluor647), stained with DAPI, and then imaged for NET immunofluorescence by confocal 
microscopy.(A) Representative confocal images (from 3 replicates of 100 quantified cells) of  
CFSE-labeled non-opsonized and opsonized F. alocis-challenged neutrophils and CFSE-labeled S. 
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gordonii and CFSE-labeled P. stomatis at 180 min at MOI 10. (B) Quantification, using ImageJ 
analysis, of percentage of NETs formed from neutrophils challenged for 180 min with CFSE-
labeled S. gordonii (MOI 10), or CFSE-labeled P. stomatis (MOI 10), or CFSE-labeled non-
opsonized F. alocis (MOI 10) or CFSE-labeled opsonized F. alocis (MOI 10). CFSE (green): 
bacteria, DAPI (blue): neutrophil nucleus/DNA, AlexaFluor647 (red): MPO, Merge: NET 
formation.  Data are means +/- SEM from 3 independent experiments. * p<0.05, *** p<0.001. (C) 
Representative confocal images (from 3 replicates of 100 quantified cells) of  CFSE-labeled non-
opsonized and opsonized F. alocis-challenged neutrophils and CFSE-labeled S. gordonii and P. 
stomatis at 180 min at MOI 50 and MOI 100. (D) Quantification, using ImageJ analysis, of 
percentage of NETs formed from neutrophils challenged for 180 min with CFSE-labeled S. 
gordonii (MOI 50, 100), or CFSE-labeled P. stomatis (MOI 50, 100) or CFSE-labeled non-
opsonized F. alocis (MOI 50, 100) or CFSE-labeled opsonized F. alocis (MOI 50, 100).  Data are 
means +/- SEM from 3 independent experiments. ** p<0.01, *** p<0.001. 














Figure 4-7. Coinfection of F. alocis with S. gordonii or P. stomatis does not reduce or 
exacerbate NET formation.   
Neutrophils were challenged with HI-labeled S. gordonii (MOI 100), or with HI-labeled S. 
gordonii (MOI 100) and CFSE-labeled non-opsonized F. alocis (MOI 10) or CFSE-labeled 
opsonized F. alocis (MOI 10) for 180 min or challenged with HI-labeled P. stomatis (MOI 50), or 
with HI-labeled P. stomatis (MOI 50) and CFSE-labeled non-opsonized F. alocis (MOI 10) or 
CFSE-labeled opsonized F. alocis (MOI 10) for 180 min. Following infection, cells were fixed, 
exposed to antibodies directed against MPO (Red- AlexaFluor647), stained with DAPI, and then 
imaged for NET immunofluorescence by confocal microscopy.  (A) Quantification, using ImageJ 
analysis, of percentage of NETs formed from neutrophils challenged for 180 min with HI-labeled 
S. gordonii (MOI 100) and HI-labeled S. gordonii (MOI 100) and CFSE-labeled non-opsonized 
and opsonized F. alocis (MOI 10) for 180 min.  Data are means +/- SEM from 3 independent 
experiments. (B) Quantification, using ImageJ analysis, of percentage of NETs formed from 
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Figure 4-8. F. alocis fails to degrade NETs formed by S. gordonii and P. stomatis. 
Neutrophils were challenged with HI-labeled S. gordonii (MOI 100) for 180 min, or HI-labeled S. 
gordonii (MOI 100) for 90 min and then with CFSE-labeled non-opsonized F. alocis (MOI 10) or 
CFSE-labeled opsonized F. alocis (MOI 10) for 90 min or challenged with HI-labeled P. stomatis 
(MOI 50) for 180 min, or HI-labeled P. stomatis (MOI 50) for 90 min and then with CFSE-labeled 
non-opsonized F. alocis (MOI 10) or CFSE-labeled opsonized F. alocis (MOI 10) for 90 min. 
Following infection, cells were fixed, exposed to antibodies directed against MPO (Red- 
AlexaFluor647), stained with DAPI, and then imaged for NET immunofluorescence by confocal 
microscopy. (A) Quantification, using ImageJ analysis, of percentage of NETs formed from 
neutrophils challenged for 180 min with HI-labeled S. gordonii (MOI 100) and HI-labeled S. 
gordonii (MOI 100) for 90 min and then with CFSE-labeled non-opsonized F. alocis (MOI 10) or 
CFSE-labeled non-opsonized F. alocis (MOI 10) for 90 min.  Data are means +/- SEM from 3 
independent experiments. (B) Quantification, using ImageJ analysis, of percentage of NETs formed 
from neutrophils challenged for 180 min with HI-labeled P. stomatis (MOI 50) and HI-labeled P. 
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CFSE-labeled non-opsonized F. alocis (MOI 10)  for 90 min.  Data are means +/- SEM from 3 
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Figure 4-9. F. alocis pre-treatment can cause significant decrease in NET formation induced 
by PMA. 
Neutrophils were challenged with PMA for 180 min, or pre-treated with non-opsonized and 
opsonized CFSE-labeled F. alocis for 30-60 min and then exposed to PMA (180 min). Following 
infection, cells were fixed, exposed to antibodies directed against MPO (Red- AlexaFluor647), 
stained with DAPI, and then imaged for NET immunofluorescence by confocal microscopy. (A) 
Representative confocal images (from 3 replicates of 100 quantified cells) of  neutrophils exposed 
to PMA (180 min) or pre-treated with non-opsonized CFSE- labeled F. alocis (60 min) before 
exposure to PMA (180 min). CFSE (green): bacteria, DAPI (blue): neutrophil nucleus/DNA, 
AlexaFluor647 (red): MPO, Merge: NET formation. (B) Quantification, using ImageJ analysis,  of 
percentage of NETs formed from neutrophils challenged for 180 min with PMA and pre-treated 
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Figure 4-10. F. alocis pre-treatment significantly decreases NET formation induced by S. 
gordonii but not by P. stomatis. 
Neutrophils were challenged with HI-labeled S. gordonii (MOI 100) for 180 min or HI-labeled P. 
stomatis (MOI 50) for 180 min, or pre-treated with non-opsonized and opsonized CFSE-labeled 
F. alocis for 30-60 min and then challenged with HI-labeled S. gordonii (MOI 100) for 180 min 















































or HI-labeled P. stomatis (MOI 50) for 180 min. Following infection, cells were fixed, exposed to 
antibodies directed against MPO (Red- AlexaFluor647), stained with DAPI, and then imaged for 
NET immunofluorescence by confocal microscopy. (A) Quantification, using ImageJ analysis, of 
percentage of NETs formed from neutrophils challenged for 180 min with HI-labeled S. gordonii 
(MOI 100) or neutrophils pre-treated with non-opsonized CFSE-labeled F. alocis for 30-60 min 
and then challenged with HI-labeled S. gordonii (MOI 100) for 180 min.  Data are means +/- 
SEM from 3 independent experiments. (B) Quantification, using ImageJ analysis, of percentage 
of NETs formed from neutrophils challenged for 180 min with HI-labeled S. gordonii (MOI 100) 
or neutrophils pre-treated with opsonized CFSE-labeled F. alocis for 30-60 min and then 
challenged with HI-labeled S. gordonii (MOI 100) for 180 min.  Data are means +/- SEM from 3 
independent experiments. * p<0.05, *** p<0.001. (C) Quantification, using ImageJ analysis, of 
percentage of NETs formed from neutrophils challenged for 180 min with HI-labeled P. stomatis 
(MOI 50) or neutrophils pre-treated with non-opsonized CFSE-labeled F. alocis for 30-60 min 
and then challenged with HI-labeled P. stomatis (MOI 50) for 180 min.  Data are means +/- SEM 
from 3 independent experiments. (D) Quantification, using ImageJ analysis, of percentage of 
NETs formed from neutrophils challenged for 180 min with HI-labeled P. stomatis (MOI 50) or 
neutrophils pre-treated with opsonized CFSE-labeled F. alocis for 30-60 min and then challenged 
with HI-labeled P. stomatis (MOI 50) for 180 min.  Data are means +/- SEM from 3 independent 
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Figure 4-11.  S. gordonii and P. stomatis induce NET formation in an MOI- and ROS-
dependent manner. 
Neutrophils were challenged with CFSE-labeled S. gordonii (MOI 100) or CFSE-labeled P. 
stomatis (MOI 50) for 180 min or exposed to DPI (10 µM) and then challenged with CFSE-
labeled S. gordonii (MOI 100) or CFSE-labeled P. stomatis (MOI 50) for 180 min. Following 
infection, cells were fixed, exposed to antibodies directed against MPO (Red- AlexaFluor647), 
stained with DAPI, and then imaged for NET immunofluorescence by confocal microscopy. (A) 
Quantification, using ImageJ analysis, of percentage of NETs formed from neutrophils 
challenged with CFSE-labeled S. gordonii (MOI 100) for 180 min or exposed to DPI (10 µM) 
and then challenged with CFSE-labeled S. gordonii (MOI 100) for 180 min.  Data are means +/- 
SEM from 3 independent experiments. ** p<0.01, *** p<0.001. (B) Quantification, using ImageJ 
analysis, of percentage of NETs formed from neutrophils challenged with CFSE-labeled P. 
stomatis (MOI 50) for 180 min or exposed to DPI (10 µM) and then challenged with CFSE-
labeled P. stomatis (MOI 50) for 180 min. Data are means +/- SEM from 3 independent 






Neutrophils, as professional phagocytes, are required to respond to a variety of stimuli 
that they encounter, which first begins with recognition and binding of the stimuli to receptors 
expressed on the plasma membrane of the cell. Given that F. alocis is a gram-positive organism, 
neutrophils recognize F. alocis through TLR2 receptors. Once receptor binding occurs, kinases 
(like ERK and p38 MAPK) are activated and further promote a variety of vital neutrophil 
functions such as cell activation, migration, and killing functions. Based on our data, it is clear 
that F. alocis triggers both ERK and p38 MAPK activation. We wanted to determine what 
neutrophil functions would be activated through TLR2-dependnet ERK and p38 MAPK signaling 
triggered by F. alocis challenge.   
Once neutrophils are activated, they will begin the mobilization of their granules to the 
plasma membrane or to the phagosome, in order to ready themselves for further functions. Our 
data showed that F. alocis challenge induces significant granule exocytosis of both secretory 
vesicles and specific granules, further showing cell activation and stimulation of neutrophil 
functions. These functions are linked to the initial activation TLR2 and further downstream to 
p38 MAPK and ERK, as studies performed blocking either TLR2 or p38 MAPK significantly 
reduced granule exocytosis.  
As the major cell type recruited to the periodontal pocket, it is important to first 
understand how neutrophils arrive at this site. Through responding to and deciphering signals 
from bacterial- and host- derived chemoattractant sources, neutrophils can perform directed
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 migration to their target site. Perhaps, the most important chemokine for the context of the oral 
cavity and periodontal disease, is IL-8, as it is produced in large amounts at the site of infection. 
Additionally, it is the primary cytokine neutrophils respond to and also secrete themselves. 
Usually, oral pathogens will employ mechanisms to inhibit neutrophil chemotaxis to the 
periodontal pocket, as observed with periodontal pathogen, P. gingivalis, which generates 
chemokine paralysis by antagonizing the synthesis and release of IL-8 from gingival epithelial 
cells (267).  In studies with T. denticola, it was observed that the bacterium effectively alters the 
balance of intracellular phosphoinositide, inhibits PI3-kinase activity, and increases phosphatase 
PTEN, which leads to inhibition of downstream signaling and compromised actin dynamics, 
which impair neutrophil chemotaxis (266).  
However, we observe that F. alocis enhances chemotactic migration to IL-8. This 
strategy must benefit the bacteria in some way, as the increased presence of neutrophils would 
help to ensure chronic inflammation and nutrient-rich environment for F. alocis. In the in vivo 
setting, early colonizers of the oral community, like S. gordonii, may initiate neutrophil migration 
to the site of bacterial plaque formation on the gingival epithelium (411). However once F. alocis 
is introduced into the community, this bacterium could trigger the recruitment of additional 
neutrophils to the oral cavity; however, they will be impaired in reaching the target site of 
bacterial infection on the gingival epithelium, further leading to destructive neutrophil killing 
mechanisms targeted instead at the host tissue.   
Additionally, our studies showed a preference in chemotactic migration to IL-8, an 
intermediary chemoattractant, over migration to fMLF, an end-target chemoattractant. This 
reveals that F. alocis influences the neutrophil’s ability to determine the most preferential and 
end-stage target site for its function. Further, neutrophils may not reach the site of bacterial 
presence in the oral cavity, and pre-maturely employ their killing mechanisms, negatively 
impacting the host tissues without damaging the bacteria, protected at the end-stage site, the oral 
cavity. In the context of a bacterial community, F. alocis could ensure a nutrient-rich 
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environment for other bacteria and allow survival and persistence of these pathogens in the oral 
cavity, as the neutrophils are not effectively migrating to this site.  
Interestingly, we observed that F. alocis is able to induce chemokinetic, or random 
migration, as neutrophils challenged with F. alocis showed enhanced migration to negative 
control buffer. In the absence of chemoattractant signaling cues, it is expected that migration 
would cease. However, if F. alocis manipulates neutrophils to migrate in a chemokinetic manner, 
this could disrupt the patrolling function of neutrophils, whose role is involved in maintaining 
host homeostasis and ensuring host health. This ensures continual host tissue destruction and a 
beneficial environment for an invading pathogen to thrive. The viability of an organism can 
impact its own ability to function as well as impact its interactions with other cells and bacteria. 
Therefore, our studies with cell migration pointed to a role for heat-stable components being 
responsible for the manipulation of cell migration of neutrophils, given that there was no 
difference in neutrophil migration challenged with heat-killed compared with viable bacteria.  
Based on the data observed in Chapter 2, it was determined that F. alocis is effectively 
recognized by neutrophils and further stimulates its functional capacities, like degranulation and 
cell migration. However, F. alocis impairs a vital function of neutrophils, deciphering 
chemoattractant cues, in order to ensure activated neutrophils are retained in the gingival crevice. 
It is tempting to speculate that these F. alocis-infected neutrophils won’t be able to release their 
antimicrobial components at the site of the bacterial plaque on the gingival epithelium, their ideal 
targeted site. Instead, granule exocytosis will occur in the gingival tissue, providing significant 
host tissue destruction and persistence of bacteria in the gingival crevice. Furthermore, our data 
shows that neutrophils are induced to undergo chemokinesis upon challenge with F. alocis, which 
leads to neutrophils that would normally be patrolling the environment in a low-level 
inflammatory state with no chemoattractant cues, to be in an activated state, potentially being 
retained in the gingival crevice and promoting host tissue damage. Not only is F. alocis providing 
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a safe haven for itself to colonize the gingival epithelium, but a niche for other oral bacteria, 
where they can colonize, persist and cause infection.  
Given our data from studies on TLR signaling, we determined F. alocis signals through 
TLR2 and further it is more likely thorough the heterodimer TLR 2/6 than TLR 2/1. Following 
recognition of F. alocis, neutrophils will begin their activation process leading to the induction of 
their antimicrobial killing mechanisms. The intracellular respiratory burst production by 
neutrophils in response to challenge is critical for the killing of internalized bacteria or 
particulates into the phagosome. In our studies, F. alocis is effectively internalized and observed 
to reside in the phagosome, however a minimal intracellular respiratory burst response is induced. 
Due to the low intracellular respiratory burst response produced by neutrophils 
challenged with F. alocis, we thought to assess the recruitment of the NADPH oxidase 
components to the bacterial-containing phagosome. Based on previous literature, we determined 
that performing recruitment studies across a time course would help to pinpoint the timing of 
assembly and activation of the complex to the F. alocis-containing phagosome, as this is the pre-
cursor step to the production of an efficient respiratory burst response. The role of the cytosolic 
component, p40phox, has recently been characterized (412) and its recruitment seems to play a key 
role in phagosomal ROS production (412). Our data shows a differential recruitment of p40phox 
between live and heat-killed F. alocis at the 15 min challenge. However, by the 60 min time 
point, the recruitment of p40phox is no longer impaired to the viable F. alocis-containing 
phagosome, indicating a delay in assembly of this component. Therefore, we believe that viability 
may play a role in the ability of the bacterium to manipulate neutrophil activation and assembly 
of the oxidase complex. Additionally, we can speculate that this component’s recruitment plays 
an important role in the context of our studies, and it may be a crucial positive regulator of 
oxidative burst induction.  
Perhaps the most studied of the NADPH oxidase components is p47phox. In our studies, 
p47phox is recruited effectively to both the viable and heat-killed F. alocis-containing phagosome 
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at the early time points, however at 60 mins, the component starts to come off only from the 
viable F. alocis-containing phagosome, which may indicate the time point when the oxidase is 
deactivated. Similarly, to what was observed with p40phox, viability of the bacterium is playing a 
role in the detachment of p47phox.  
Rac activation and recruitment to the phagosome is known to be another important step in 
superoxide production and is linked to many pathways downstream of the NADPH oxidase 
assembly and activation. The active GTP-bound form of Rac is crucial for the regulation and 
activation of the NADPH oxidase complex, as was determined with mice defective in Rac-2. 
Although the Rac2 activation is linked to several neutrophil functions, in our studies, it is 
important to note that a deficient Rac2 activation leads to a deficient superoxide production. Our 
data revealed viable F. alocis fails to effectively activate Rac2 by neutrophils, which is not 
observed with the heat-killed F. alocis, further allowing for speculation that the viable bacterium 
impairs Rac activation, in order to evade neutrophil oxidative-mediated killing.  
We can further speculate that there is an impairment in mechanisms involved in ROS 
production, like electron transfer, that can result in an impaired respiratory burst response, despite 
proper NADPH oxidase complex assembly. We know that heat-killed F. alocis induces a robust 
intracellular respiratory burst response, which could be explained by the retention of both p47phox 
and p40phox to the phagosomal compartment. The viable F. alocis induces a minimal intracellular 
respiratory burst response, however it effectively initiates the recruitment of both p47phox and 
p40phox, with disassembly only occurring at a late time point with p47phox. It is yet to be 
determined whether p40phox binds the PI3P site, which is known to be crucial for effective 
intracellular ROS production.  
Another crucial mechanism in producing a potent intracellular ROS response is the 
recruitment of neutrophil granules to the bacterial-containing phagosome. Data performed in our 
laboratory showed that azurophilic granules, which contain potent antimicrobial component, 
myeloperoxidase (MPO), were impaired in their recruitment to the bacterial-containing 
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phagosome. MPO is needed for the production of HOCl, which is highly effective at killing 
microbes inside the neutrophil phagosome. Additionally, the specific granules, which contain 
cytochrome b558 (composed of cytosolic NADPH oxidase components gp91phox and p22phox) and 
antimicrobial compounds lactoferrin and lysosome, are not effectively recruited to the F. alocis-
containing phagosome. This could help to explain F. alocis ability to evade neutrophil oxidative-
based intracellular killing mechanisms.  
 For those stimuli that are not effectively internalized into a phagosomal compartment, an 
extracellular respiratory burst response is induced, which is beneficial to ensure killing of 
extracellular stimuli, but can also serve detrimental to the host. Based on our studies, it appears 
that F. alocis does not trigger induction of this response, however it can pre-activate or prime the 
neutrophils to secondary stimuli. In the oral cavity, F. alocis could be priming neutrophils to have 
a more robust superoxide production, which could result in serious damage to the host tissues, 
allowing for periodontal disease progression through chronic inflammation.  
Now that we understand how F. alocis challenge impacts the induction of the 
intracellular and extracellular respiratory burst response, it is necessary to evaluate the survival of 
the bacterium. We observed that F. alocis is able to remain viable both intracellularly and 
extracellularly up to 4 h post neutrophil challenge. We can speculate that the bacteria remain 
viable intracellularly due to the minimal intracellular respiratory burst response produced in the 
F. alocis-containing phagosome. Considering the percentage of F. alocis that remains viable 
extracellularly, this indicates that neutrophil superoxide production is ineffective at killing the 
bacteria, and instead these highly potent superoxide radicals are produced and provide extensive 
collateral damage to the host.  
As seen with our data thus far, F. alocis challenge of neutrophils results in their 
activation; however, their functional responses and killing mechanisms are impaired. We sought 
to determine if NETs, would be induced by neutrophils challenged with F. alocis. NETs have 
been discovered in gingival epithelia and in oral bacteria biofilms. Our bacterium fails to induce 
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NETs, indicating that F. alocis manipulates the cells to inhibit NETs from forming or actively 
degrades NETs. The release of extracellular neutrophil elastase has been implicated to be 
involved in the formation of NETs, therefore in the case of F. alocis challenge, we wanted to 
determine if extracellular NE could be detected. As anticipated based on our confocal 
immunofluorescence studies, F. alocis challenge failed to produce extracellular NE. This could 
point to a reason why F. alocis fails to induce neutrophils to form NETs.  
It is clear that F. alocis may be unique to the oral bacteria community, as we saw 
neutrophils produced NETs in response to other oral bacteria, S. gordonii and P. stomatis. This 
also led us to speculate that NETs do play an important role in the context of the oral community, 
as two common bacteria found in the gingival epithelium, S. gordonii, a commensal organism, 
and P. stomatis, a pathogenic organism, are capable of inducing NETs. In the context of 
periodontal disease, it is possible that F. alocis can manipulate neutrophils from further induction 
of NETs upon encounter of oral bacteria that will stimulate their production. Additionally, it may 
be that F. alocis behaves self-sufficiently and only evades and fails to induce NETs, however it 
does not provide benefit to other members of the community that are capable of inducing NETs, 
which neutrophils will use to effectively trap and kill their target.    
Overall, our studies on NET formation led us to speculate that F. alocis is not capable of 
inducing NETs, but can manipulate cells to impair their ability to form NETs. F. alocis proves to 
be able to evade yet another potential neutrophil killing mechanism, NET formation, through a 
yet-to-be-determined mechanism. As F. alocis is effectively internalized into a bacterial-
containing phagosome, neutrophils may not benefit from employing an extracellular-killing 
mechanism like NETs, as a means to combat F. alocis challenge. Additionally, NETs have the 
potential to trap and kill bacteria, so their reduction in the oral cavity with F. alocis presence can 
ensure oral bacteria persist and survive. As NETs are shown to block the gingival epithelium to 
prevent colonization of an oral bacteria biofilm, F. alocis could be providing benefit to the entire 
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community, allowing for excessive bacterial plaque formation, and continual recruitment of 
neutrophils, chronic inflammation and further periodontal disease development.
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CHAPTER 6 
CONCLUSION AND FUTURE STUDIES
F. alocis challenge promotes activation of neutrophil kinase signaling pathways, leading to 
enhanced cell migration and degranulation 
Neutrophils are vital first responder cells and found in abundance in the periodontal 
pocket in response to oral bacteria, their targeted site of activation and killing, in order to ensure 
host health and homeostasis (179, 198). In order to get to the site of infection, they must decipher 
through a bombardment of chemoattract cues, both intermediary (IL-8) and end-target (like 
fMLF) (118, 120, 123). It is known that IL-8 is a chemotactic source found in high concentrations 
in the gingival crevice, therefore we utilized this as our intermediary chemoattractant source. It 
has been determined that neutrophils sampled from patients with chronic periodontitis have 
defective chemotactic migration capabilities (189), therefore, we wanted to determine neutrophil 
migration in the context of F. alocis challenge.  
When challenging neutrophils with F. alocis, we observed chemokinetic migration 
toward negative control buffer and an enhanced chemotactic migration towards IL-8, but not 
fMLF. Viability did not impair the bacterium’s ability to impact cell migration, as a similar trend 
was seen with challenge of heat-killed F. alocis. In order to determine how F. alocis-challenged 
neutrophils would respond to a choice of IL-8 or fMLF in comparison with unchallenged 
neutrophils, it would be necessary to perform under-agarose migration assays, which allow for 
study of cells exposed to multiple chemotactic sources in different spatial and temporal 
combinations (413).  
F. alocis, a gram-positive bacterium, is recognized by neutrophils through TLR2 (81) to 
further activate p38 MAPK and ERK kinase signaling pathways. In our studies, we determined 
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that F. alocis induced both p38 MAPK and ERK activation, with the maximum activation at 30 
mins that decreased by 60 min. The necessity for TLR2 recognition in further initiating kinase 
signaling was shown through blocking TLR2 and seeing a decrease in kinase phosphorylation.  
TLR signaling can also induce a variety of neutrophil functions including granule 
exocytosis, which may also play a role in chemotaxis (81, 249, 252, 414). We observed that F. 
alocis is capable of inducing both secretory vesicle and specific granule exocytosis, which was 
TLR2 and p38 MAPK dependent. To further delineate the potential role granule exocytosis plays 
in neutrophil chemotaxis, we utilized a granule exocytosis inhibitor, TAT-SNAP-23 (146), and 
then performed cell migration studies. When blocking granule exocytosis, we saw a significant 
inhibition in both chemokinesis and chemotaxis of neutrophils challenged with F. alocis.  
It would be important to further determine how neutrophil migration is impacted in the 
context of periodontal disease, which would be performed by challenging neutrophils with 
multiple oral bacteria, such as P. gingivalis and P. stomatis and quantify transwell migration after 
exposure to buffer, fMLF or IL-8. It would be necessary to determine if random and directed cell 
migration were impacted similarly, as observed in our studies with F. alocis.  
Strategies employed by F. alocis to ensure minimal respiratory burst production by neutrophils 
and mediate their survival from oxidative killing mechanisms  
We determined TLR2 signaling is responsible for recognition of F. alocis by neutrophils, 
however it is important to determine if this signaling is through the TLR2/1 or TLR 2/6 
heterodimer. Using known TLR 2/1 agonist (PAM3CSK4) and TLR 2/6 agonist (FSL-1), we 
were able to show that F. alocis challenge of neutrophils behaved similarly in its induction of 
superoxide production as FSL-1.  
Our studies into further deciphering the TLR 2/6 signaling require further experiments 
utilizing TLR 1 and TLR 6 neutralizing antibodies to determine if there is an impairment in the 
superoxide production of neutrophils exposed to neutralizing antibodies before F. alocis 
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challenge. Additionally, we will use TLR blocking antibodies to determine how the superoxide 
production is affected if TLR 2 or TLR 6 is unable to recognize and bind F. alocis.  
Given the low intracellular respiratory burst response we saw induced by neutrophils 
challenged with viable F. alocis, we sought to characterize the assembly of the NADPH oxidase 
complex to the bacteria-containing phagosome, as this is a crucial pre-cursor step to producing a 
sufficient intracellular respiratory burst response (143). However, we observed similar 
recruitment of p47phox, p67phox, gp91phox and p22phox by 15 mins to both viable and heat-killed F. 
alocis-containing phagosomes. The only difference in recruitment was seen with p40phox at an 
early time point but that difference was lost by 30 and 60 min post infection. This indicates that 
there is a delay in recruitment of the p40phox to the phagosome, which could explain the impaired 
intracellular respiratory burst response. Additionally, Rac activation, was impaired at 30 min with 
viable F. alocis challenge compared to heat-killed F. alocis, indicating that the viable bacterium 
is able to manipulate the Rac activation status and further impact the magnitude of the respiratory 
burst response produced by neutrophils.  
Additionally, as it has been determined that the oxidase components are in a dynamic 
‘On-Off’ state, it should be determined through time course studies with live-cell imaging if and 
when F. alocis manipulates the recruitment of the NADPH oxidase components. For these 
studies, we will utilize neutrophil differentiated PLB-985 cells with stable expression of yellow 
fluorescent protein (YFP)-tagged p67phox, YFP-tagged p47phox., and mCherry-tagged p40PX (142, 
324). 
Although impaired translocation of the NADPH oxidase components may not be the 
factor causing a low intracellular burst response, it will be important to also look at the 
phosphorylation status of the components, as their activation is critical for their functional 
capabilities (190, 356). To help to further characterize the NADPH oxidase assembly and 
activation and its role in the iROS response produced by neutrophils challenged with F. alocis, it 
will be necessary to perform Western blotting of the phosphorylated components to determine if 
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they are recruited effectively, but remain enzymatically inactive. As our data only revealed the 
disassembly of p47phox by 60 mins, future studies with the remaining components of the oxidase 
(p40phox, p67phox, gp91phox, p22phox) are needed to determine when their disassembly occurs.  
We observed that F. alocis remained viable both intracellularly (~65%) and 
extracellularly (~40%), up to 4 h post-neutrophil challenge. Furthermore, F. alocis challenge 
induced minimal ROS production. In order to determine if oxidants are required for bacteria 
killing if introduced into the system exogenously, we will utilize the glucose-glucose oxidase 
system (146, 415). To do so, neutrophils will be pre-incubated with glucose plus glucose-oxidase 
and then challenged with F. alocis and BacLight viability staining will be applied to assess 
internal and external viability of the bacteria. If F. alocis is effectively killed, this would lead us 
to determine that the activation of the oxidase is important to for neutrophil killing in our studies. 
Additionally, as F. alocis possesses sialidase and also superoxide reductase, it may be of benefit 
to inhibit these enzymes using neuraminidase or a sialidase inhibitor and determining if the 
intracellular ROS is produced. Future studies should help determine if and at what time point F. 
alocis is effectively killed by the neutrophils, therefore performing this experiment with a later 
time point challenge would be necessary. 
Lastly, in order to better characterize the neutrophil response in the context of periodontal 
disease, it would be beneficial to perform co-infection or multi-species studies with F. alocis and 
other oral microbes to determine if the bacterium overall can impact the community and the 
effectiveness of the neutrophil killing mechanisms. Additionally, pre-treating the neutrophils with 
F. alocis and then introducing another oral microbe or multispecies community would help to 
determine if the oxidative killing mechanisms can be inhibited by our bacterium. From a 
therapeutic standpoint, it is possible that the augmentation of enzymes that protect against 
oxidative stress could serve beneficial for treatment of periodontitis (286).  
F. alocis fails to induce NETs and further manipulates the neutrophil’s capacity to induce 
NETs in response to both pharmacological and bacterial stimuli  
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NETs are known to be induced from neutrophils in the oral cavity when they 
encounter oral pathogens (197, 367), however, it was yet-to-be-determined whether F. 
alocis is capable of inducing NETs. In our time course studies, we observed that viable F. 
alocis (non-opsonized and opsonized) and heat-killed F. alocis fail to induce NETs. 
Additionally, increasing the MOI of F. alocis did not cause NET induction. However, 
when we challenged neutrophils with two other oral bacteria, S. gordonii and P. stomatis, 
we saw there was significant NET induction and in the case of S. gordonii the NETs were 
induced in an MOI-dependent manner.  
To attempt to mimic a more physiologically relevant environment to the oral cavity, we 
performed co-infection studies with F. alocis and S. gordonii or P. stomatis. While F. alocis was 
incapable of reducing or exacerbating NET formation when in co-infection with S. gordonii or P. 
stomatis and the bacterium could not degrade pre-formed NETs induced by S. gordonii or P. 
stomatis, we observed that F. alocis is capable of manipulating neutrophils to impair their ability 
to form NETs when challenged with inducers like S. gordonii and PMA.  As the biofilm 
community is the natural environment for the oral cavity, it will be important to determine how F. 
alocis behaves in this context by exposing neutrophils to three or four species biofilms.  
Future studies should try to determine if NETs that are formed have antibacterial 
properties against S. gordonii or P. stomatis, and can effectively kill the bacteria. The best 
approach would be to perform survival studies using the BacLight viability assay. Additionally, 
to determine if NETs are the preferred killing method employed by neutrophils, studies will be 
performed where neutrophils will be exposed to actin-disrupting drugs (Latrunculin A or 
Cytochalasin D), which inhibit phagocytic-based killing mechanisms and then challenged with 
either S. gordonii or P. stomatis to see if the NET formation is reduced or exacerbated (151).  
Future studies are needed to further characterize the signaling mechanisms that F. alocis 
may manipulate in order to inhibit NET formation. The NET signaling pathway is complex and 
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has steps/stages that must occur that precede he extracellular extrusion of DNA, such as 
stimulation of receptors, Raf/MEK/ERK pathway activation, assembly of NADPH oxidase 
complex, ROS production, intracellular membrane disintegration, granular protein NE enters the 
nucleus and processes core histones, hypercitrullination and decondensation/mobilization of 
chromatin (168, 406). To do so, Western blotting studies will be performed to determine the 
activation or expression of Raf, MEK, PKC, PAD4, PI3K, Akt and mTOR (168, 365, 384, 406, 
416-418). 
Lastly, as NETs are known to be formed in the oral cavity, it will be important to 
determine if NETs are present, if they have antimicrobial properties against F. alocis. Neutrophils 
will be stimulated with PMA, S. gordonii or P. stomatis to induce NETs and these isolated NETs 
will be introduced to an F. alocis challenge setting and BacLight viability staining will be used to 
determine if it has antimicrobial properties towards F. alocis (165).  
Overall, the work presented in this dissertation is the first study of the oral pathogen, 
Filifactor alocis, and human neutrophils. A diagram summarizing our findings is depicted in Fig. 
6-1. Given the fact that the presence of F. alocis in the oral cavity is indicative of periodontal 
disease, it is crucial to further study this bacterium for use as a potential biomarker. Periodontal 
disease results from host and bacterial-derived factors, further implicating the importance of 
knowing how the neutrophils are manipulated by F. alocis, as they are the key cell recruited to 
the gingival epithelium and known to promote disease if retained in the host tissues inducing a 
state of chronic inflammation.
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